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II. SUMMARY 
 
RATIONALE: Temporal changes in the fetal environment, such as malnutrition and 
placental insufficiency induce intrauterine growth restriction (IUGR) and lead to a permanent 
changes of physiological processes later in life. Interestingly, epidemiological studies 
demonstrated an impairment of lung and renal function in young infants subsequent to IUGR. 
Complementary, experimental studies showed that IUGR induces a perinatal programming of 
the developing lung with persisting impairment of pulmonary structure and function. Besides 
IUGR, early postnatal hyperalimentation (pHA) is discussed as a crucial factor of IUGR-
associated diseases. Both extracellular matrix (ECM) and inflammatory processes have been 
shown to be dysregulated following IUGR and early pHA. However, the underlying 
molecular mechanisms of IUGR-associated diseases and the potential linkage of ECM and 
inflammation have not been addressed so far. Therefore, the ultimate goal of this project was 
to elucidate the role of regulation of ECM and inflammatory cytokines subsequent to IUGR 
and early pHA.  
AIMS: There are three specific aims: (1) to analyze the role of the TGF-ȕ signaling in lung 
development subsequent to IUGR, (2) to determine the regulation of inflammatory cytokines 
and ECM-molecules in lungs subsequent to IUGR, and (3) to characterize the 
pathomechanistic role of early pHA using the example of the kidney.   
METHODS: Two simultaneous sets of animal experiments were used. One animal model 
addressed pre- and postnatal nutritional intervention, the other was restricted to postnatal 
interventions only: (A) IUGR was induced in Wister rats by isocaloric low protein diet (8% 
casein; IUGR) during gestation. The control group received normal protein diet (17% casein; 
Co). At birth the litter size was reduced to 6 male pups to induce early pHA. During lactation 
the mothers of both groups were fed standard chow. (B) Early pHA was induced by litter size 
reduction to 6 (LSR6) or 10 (LSR10) male neonates. Home-cage control (HCC; mean litter 
size of 16) animals without any postnatal manipulation during lactation were included. At 
postnatal day (P) 28 as well as P70 animals underwent whole body plethysmography and in 
addition metabolic cages at P70. Serum and samples of lungs and kidney were obtained at P1, 
P12, P21, P42, and P70 for mRNA extraction, protein extraction as well as histological 
analyses. 
RESULTS: Both respiratory system resistance and compliance were impaired subsequent to 
IUGR at P28; this impairment was even more significant at P70. (1) These changes were 
accompanied by persistent attenuated activity of the TGF-ȕ signaling, assessed by 
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phosphorylation of Smad2 and Smad3. Expression analysis of TGF-ȕ-regulated ECM 
components in the lungs of IUGR animals at P1, such as collagen I, elastin, and tenascin N, 
revealed a significant deregulation. Consistently, in vitro inhibition of TGF-ȕ signaling in 
NIH/3T3, MLE 12 and endothelial cells by adenovirus-delivered Smad7 demonstrated a 
direct effect on the expression of ECM components. Interestingly, however, not just a 
deregulation of ECM components was detected at P1, but also attenuated apoptotic processes, 
e.g. decreased cleavage of PARP. (2)  Since the TGF-ȕ signaling has potent anti-
inflammatory effects, we next determined the dynamic expression of pro-inflammatory and 
pro-fibrotic markers as well of ECM components in the lung subsequent to IUGR at P1, P42 
and P70. The expression of ECM components and metabolizing enzymes was markedly 
deregulated and the deposition of collagen I was strikingly increased at P70. Concomitantly to 
the pro-fibrotic processes in the lung subsequent to IUGR, the expression of inflammatory 
cytokines and both the activity and the expression of target genes of Stat3 signaling were 
dynamically regulated, with unaltered or decreased expression at P1 and significantly 
increased expression art P70. (3) Assessment of renal function at postnatal day 70 revealed 
decreased glomerular filtration rate, proteinuria, and increased fractional sodium and 
potassium secretion following early pHA (LSR6). Moreover, the deposition of ECM 
molecules, such as collagen I, was increased. Interestingly, despite the elevated expression of 
pro-inflammatory leptin and IL-6 expression the phosphorylation of Stat3 and ERK1/2 in the 
kidney, however, was decreased after LSR6. In accordance, neuropeptide Y (NPY) gene 
expression – sympathetic co-neurotransmitter regulated by Stat3 signaling – was down-
regulated. In accordance, suppressor of cytokine signaling (SOCS)3 protein expression, an 
inhibitor of Stat3 and Erk1/2 signaling, was strongly elevated and colocalized with NPY. 
Interestingly, NPY is co- localized with SOCS3 in the distal tubules in the cortex and outer 
medulla, and in the proximal tubules, but no expression of SOCS3 was detectable in 
glomeruli.  
CONCLUSION: Taken together, IUGR has a direct and strong negative impact on 
respiratory resistance and compliance of the lung. There are two major underlying 
mechanisms linking IUGR and deregulation of ECM: first, the attenuated TGF-ȕ signaling 
during late lung development; and second, the increased expression of inflammatory 
cytokines subsequent to IUGR. In addition, the missing anti-inflammatory effect of TGF-ȕ 
signaling could contribute to the increased inflammatory response following IUGR. 
Furthermore we demonstrated that early pHA leads to organ-intrinsic increased expression of 
NPY via a postreceptor-leptin-receptor leptin resistance. This leptin resistance could 
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contribute to the observed profibrotic processes, and ultimately to a long-term impairment of 
renal function. Thus, both IUGR and early postnatal hyperalimentation have a strong impact 
on perinatal programming of multi-organ inflammatory response.  
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III. ZUSAMMENFASSSUNG 
 
 
HINTERGRUND: Kurzzeitige intrauterine Einlüsse, wie maternale Unterernährung oder 
Plazentainsuffizienz führen zu einer intrauterinen Wachstumsrestriktion (IUGR) und letztlich 
zu dauerhaften Veränderungen physiologischer Prozesse. Epidemiologische Studien zeigen 
sowohl renale als auch pulmonale Funktionsstörungen in Kindern nach IUGR. Ergänzende 
experimentelle Arbeiten konnten zudem perinatale Programmierung persistierender struktureller 
Veränderungen in Lunge und Niere nach IUGR aufweisen. Neben der IUGR selbst wird die 
frühe postnatale Hyperalimentation (pHA) als zentraler Faktor der IUGR-assoziierten 
Erkrankungen diskutiert. Es ist zudem gezeigt worden, dass sowohl die extrazellulären Matrix 
(ECM) als auch inflammatorische Prozesse nach IUGR und früher pHA dysreguliert sind. 
Dennoch sind die zugrunde liegenden Mechanismen der IUGR-assoziierten Erkrankungen sowie 
der potentielle Zusammenhang zwischen Veränderungen der ECM und inflammatorischen 
Prozessen noch weitgehend ungeklärt. Aus diesem Grunde war das zentrale Ziel dieser Studie, 
die Rolle der Regulation der ECM und inflammatorischer Zytokine nach IUGR und früher pHA 
zu untersuchen.  
ZIELE: Drei spezifische Ziele sollten an Rattenmodellen verfolgt werden: (1) Analyse der 
Rolle der TGF-ȕ Signalkaskade in der Lungenentwicklung nach IUGR, (2) Untersuchung der 
Regulation inflammatorischer Zytokine sowie der ECM-Moleküle nach IUGR, und (3) 
Charakterisierung der pathomechanistischen Bedeutung früher pHA am Beispiel der Niere.  
METHODS: Zwei parallele unabhängige Tierexperimente wurden genutzt Das erste 
Tiermodel umfasst prä- und postnatale, das zweite hingegen nur postnatale nutritive 
Intervention: (A) IUGR wurde in Wistar Ratten induziert durch isokalorische 
Proteinmangeldiät (8% Casein; IUGR) während der Gestation. Die Kontrollgruppe erhielt 
Normalproteindiät (17% Casein, Co). An der Geburt wurden die Würfe auf sechs männliche 
Nachkommen reduziert, um eine frühe pHA zu induzieren. In der Laktationsphase wurde den 
Muttertieren Standardfutter gefüttert. (B) Frühe pHA wurde durch Wurfreduktion auf 6 
(LSR6) beziehungsweise 10  (LSR10) männliche Neonaten induziert. Eine zusätzliche 
Gruppe ohne Wurfreduktion (HCC; mittlere Wurfgröße 16) wurde ergänzt. Am postnatalen 
Tag (P) 28 und am P70 wurden Ganzkörperplethysmography sowie metabolischen 
Untersuchungen in metabolischen Käfigen am P70 durchgeführt. Serum sowie Lungen- und 
Nierenproben wurden am P1, P12, P21, P42 und P70 für mRNA Extraktion, Proteinextraktion 
sowie histologische Untersuchungen gewonnen. 
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ERGEBNISSE: Sowohl der Atemwegswiderstand als auch die dynamische Compliance 
waren eingeschränkt nach IUGR am P28. Diese pulmonale Funktionsstörung war am P70 
sogar noch ausgeprägter. (1) Die funktionellen Veränderungen der Lunge waren begleitet von 
einer persistierend erniedrigten Aktivität der TGF-ȕ Signalkaskade mit verminderter 
Phosphorylierung von Smad2 und Smad3. Dementsprechend wies die Genexpressionsanalyse 
TGF-ȕ-regulierter ECM Komponenten, wie Collagen I, Elastin und Tenascin N, eine 
signifikante Dysregulation auf. Im Einklang mit diesen in vivo Daten, führte die in vitro 
Inhibition der TGF-ȕ Signalkaskade in NIH/3T3, MLE-12 und Endothelzellen durch 
adenovirale Überexpression von Smad7 zu den entsprechenden Expressionsveränderungen 
der ECM Komponenten. Interessanterweise waren am P1 auch apoptotische Prozesse nach 
IUGR gehemmt. (2)  Da TGF-ȕ auch starke anti-inflammatorische Wirkung besitzt, haben wir 
als nächstes die Expression pro-inflammatorischer  und -fibrotischer Marker sowie von ECM 
Komponenten in der Lunge nach IUGR am P1, P42 und P70 untersucht. Die Expression der 
ECM-Komponenten und der metabolisierenden Enzyme war deutlich alteriert und zudem die 
Ablagerung von Collagen I am P70 beachtlich erhöht. Begleitend zu diesen pro-fibrotischen 
Veränderungen war die Expression inflammatorischer Zytokine und die Aktivität der Stat3 
Signalkaskade mit einer signifikanten Steigerung an P70 reguliert. (3) Die Analyse der 
Nierenfunktion am P70 zeigte eine erniedrigte glomeruläre Filtrationsrate, Proteinurie, 
erhöhte fraktionelle Natrium- sowie Kaliumsekretion nach früher pHA (LSR6). Strukturell 
zeigte sich eine gesteigerte Ablagerung von Collagen I in der Niere. Interessanterweise, war 
trotz der starken Expression des pro-inflammatorischen Leptins und des Interleukin 6 (IL-6) 
die Phosphorylierung von Stat3 und Erk1/2 in der Niere erniedrigt nach früher pHA. 
Entsprechend der erniedrigten Aktivität der Stat3 Signalkaskade war die Genexpression von 
Neuropeptid Y (NPY) – ein von Stat3-regulierter sympathischer Co-Neurotransmitter – 
erniedrigt. Die Proteinexpression von suppressor of cytokine signaling (SOCS)3 – ein 
Inhibitor des Stat3 und Erk1/2 Signalweges – war deutlich erhöht. Bemerkenswert ist zudem, 
dass NPY mit SOCS3 im distalen Tubulus der Nierenrinde und des -marks co-lokalisiert ist, 
aber SOCS3 nicht im Glomerulus detektierbar war.  
SCHLUSSFOLGERUNG: Diese Studie zeigt, dass IUGR einen direkten negativen Einfluss 
auf den Atemwegswiderstand und die dynamische Compliance der Lunge hat. Zwei zentrale 
zugrunde liegende Mechanismen wurden aufgewiesen: erstens, die erniedrigte Aktivität der 
TGF-ȕ Signalkaskade während der späten Lungenentwicklung und zweitens, eine gesteigerte 
Expression inflammatorischer Zytokine. Zusätzlich kann die fehlende anti-inflammatorische 
Wirkung von TGF-ȕ nach IUGR zu der erhöhten inflammatorischen Reaktion nach IUGR 
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beitragen. Des Weiteren konnten wir zeigen, dass die frühe pHA zu einer organspezifischen 
gesteigerten Expression von NPY über eine postrezeptor-Leptinrezeptor Leptinresistenz führt. 
Diese Leptinresistenz könnte zu den bebachteten pro-fibrotischen Prozessen und letztlich zu 
den renalen Langzeitfolgen nach früher pHA beitragen. Zusammenfassend kann man sagen, 
dass sowohl IUGR als auch frühe pHA eine tragende Rolle in der perinatalen 
Programmierung inflammatorischer Prozesse haben.  
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1. INTRODUCTION 
 
1.1. Lung Development 
The development of the human lung encompasses a time period starting with the appearance 
of the trachea as the ventral outpouching of the foregut in the fourth post-conceptional week 
and ending in early infancy. Lung development occurs in six distinct stages: (1) embryonic, 
(2) pseudoglandular, (3) canalicular, (4) saccular, (5) alveolar, and finally (6) vascular 
maturation stage (1-4). The overall goal of these six developmental stages is to maximize the 
gas exchange surface area, while minimizing the blood-air barrier. To achieve a normal and 
concerted course of these developmental processes a finely tuned and balanced cellular 
interaction by growth factors, transcription factors as well as postnatal mechanical forces is 
mandatory (5-7). Since lung development is highly regulated, it is thus susceptible to 
influences by environmental conditions. Therefore, both intrauterine and early postnatal 
environmental changes lead to alterations of pulmonary structure and thereby of lung function 
(8-13).  
 
1.1.1. Stages of Lung Development 
Two major processes are required for maximization of gas exchange surface area: first, 
branching of the conducting airways up to the terminal bronchi, and second, subdivision of 
the developing airspaces into alveoli, a process also named septation (2).  
The early stage of lung development comprises the embryonic and pseudoglandular phases. In 
the subsequent canalicular phase the airway branching is completed and the development of 
the gas exchange region is initiated and represents the start of the stages of late lung 
development: growth of pulmonary parenchyma, thinning of connective tissue between the 
airspaces, maturation of the surfactant system, septation of secondary crests as a well vascular 
maturation are key processes of the saccular, alveolar and vascular stage (1, 14) (figure 1).  
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(1) embryonic stage 
[4–7 weeks post conception (p.c.) in humans, embryonic day (E) E9.5–E12 in mice] 
In the embryonic stage, the lung bud appears as a ventral outpouching of the primordial 
foregut, which forms the prospective ventral trachea, and the dorsal oesophagus. The ventral 
trachea elongates caudally and subsequently branches into left and right bronchial buds. 
These are the primary bronchi, which continue migrating into the mesenchymal tissue by 
dichotomous branching, creating the conducting airway tree (1, 15, 16). 
 
(2) pseudoglandular stage  
 (5–17 weeks p.c. in humans, E12–E16.5 in mice). 
The dichotomous branching of the initial conducting airways forming the bronchi and finally 
the terminal bronchioles is the predominant process of the pseudoglandular stage. Arterial 
branches accompany the newly-formed airways; veins spread in the mesenchymal tissue, and 
extend between each generation of airway branching. The prospective conductive airways 
have been formed, and the acinar limits are apparent. Moreover, during pseudoglandular stage 
the cell differentiation continues: ciliated cells, goblet cells and basal cells appear, while the 
transition of mesenchymal cells to smooth muscle and cartilage cells begins (1, 15, 16). 
 
(3) canalicular stage 
(16–26 weeks p.c. in humans, E16.5–E17.5 in mice) 
Once the phase of early lung development with the major aim of airway branching is 
successfully completed, late lung development proceeds with forming gas exchange airspaces. 
Therefore, the distal cuboidal epithelium differentiates into type I and type II cells and signals 
the start of surfactant production. Moreover, vascularization takes place with the formation 
embryonic pseudoglandular canalicular saccular alveolar 
E 9.5-
4.-7. w.p.c. 
E 12-16.5 
4.-17. w.p.c. 
E 16.5- 17.5 
16.- 26. w.p.c. 
E 17.5-P4 
24.-38. w.p.c. 
P4-P21  mouse  
human 
early lung development late lung development 
36.w.p.c.-4.year 
Figure1: Schema depicting the different stages of early and late lung development in 
human and mouse 
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and spreading of capillaries in the interstitium. The endothelial cells of the newly-formed 
capillaries interact with the adjacent respiratory epithelium, and induce thereby the 
development of the air-blood barrier. Finally, the bronchioli appear, and the interstitial tissue 
mass diminish. Furthermore, the pulmonary epithelial cells differentiate into different cell 
types with highly specific functions, such as pulmonary neuroendocrine cells (PNECs) (1, 15, 
16). 
 
(4) saccular stage 
[24–38 weeks p.c. in humans, E17.5–postnatal  day (P) 4] 
The distal airways next form saccular units in the saccular stage. There are three key 
processes preparing the lungs in this period towards extrauterine life: first, the growth of the 
pumonary parenchyma; second, the thinning of the connective tissue between the airspaces; 
and finally, the maturation of the surfactant system to decrease the superficial tension. At the 
end, the distal airways spread and expand at the expense of the mesenchyme forming the 
transitory airspaces, also called sacculi (1, 15, 16). 
 
(5) alveolar stage 
(36 weeks p.c. to 36 months postnatal in humans; P4–P28 in mice)  
Finally, at the end of intrauterine development and at birth the lung is functionally ready. 
However, the alveoli as the units of gas exchange are missing and therefore the lung structure 
is still immature. Secondary septa subdivide the sacculi in smaller units, forming the mature 
alveoli. This process during the alveolar stage is called septation, and finds its origins in low 
ridges that arise from the saccular wall. The major goal of alveolar stage is to maximize the 
gas exchange surface of the lung (1, 15, 16).  
 
(6) vascular maturation stage 
(36 weeks p.c. to 36 months postnatal in humans; P4–P28 in mice)  
The newly-formed secondary septa during alveolar stage contain a double capillary layer 
separated by a sheet of connective tissue. These immature septa need to undergo further 
maturation to minimize the blood-air barrier. Therefore the last stage of lung development is 
characterized by mircrovascular maturation, consisting of the fusion of the double-layered 
capillary network within the immature alveolar septum forming a final single layered 
capillary septum (1, 4, 15, 16).  
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1.1.2.   Molecular Mediators of Lung Development 
Both early and late lung development are sequences of finely-tuned processes, which are 
tightly regulated by the concerted action of growth factors, transcription factors, and 
mechanical stretching. Each stage of lung development demands the action of certain 
transcription factors as well as of growth factors (5-7, 14).  
Regarding late lung development, there are several growth factors playing a pivotal role, 
notable amongst them is transforming growth factor ȕ (TGF-ȕ) (16), bone morphogenetic 
protein (BMP)(15), fibroblast growth factor (FGF) (17, 18), and vascular endothelial growth 
factor (VEGF) (19, 20).  
 
(a) Transforming growth factor (TGF)-ȕ system and lung development 
 
Transforming growth factor ȕ (TGF-ȕ) exerts pleiotropic roles in regulating cell proliferation, 
transformation and apoptosis as well as production, deposition and remodeling of 
extracellular matrix (ECM) (11, 21, 22). In line with these distinct functions, TGF- ȕ has been 
demonstrated to be a key regulator of branching and alveolarization (2, 23, 24). This signaling 
pathway is finely-tuned and highly sensitive to perinatal influences, such as mechanical 
ventilation (25) and oxygen supply (11). Both over-expression and under-expression of    
TGF-β have been shown to impact alveolarization: rodents over-expressing TGF-ȕ either by 
adenoviral transfer of TGF-β1 (26) or by conditional over-expression of bioactive TGF-β1 
(21) exhibited defective alveolarization, yielding lung structural abnormalities, such as 
reduced numbers of alveoli and lung blood vessels. In line with these findings, in studies with 
preterm infants with bronchopulmonary dysplasia (BPD) – characterized by thickened 
alveolar septa as well as fewer alveoli – levels of TGF-β1 in tracheal aspirates were increased 
(27, 28). Similar structural abnormalities of the lung and its vasculature – decreased formation 
of alveoli and microvessels - are evident in animal models of BPD (11, 29, 30). In contrast, 
blockade of TGF-β signaling by either ablation of Smad3 (31, 32) or Smad3 defiency in mice 
(33) resulted in progressive airspace enlargement and disruption of alveolarization. These 
studies indicate that TGF-β does not only act as a negative regulator but also a potent positive 
mediator of normal lung development. Thus, TGF-β signaling is finely-regulated during lung 
development; both too much and also too little TGF-β activity has serious impact on lung 
structure and lung function.  
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(b) Bone morphogenetic protein (BMP) system and lung development 
 
Several studies demonstrate that BMP signaling has strong implication in both early and late 
lung development (15, 34-36). The BMPs have been ascribed numerous functions in lung 
development, including cell differentiation, migration, proliferation, and apoptosis (37). 
BMP-4 stimulates lung branching in vitro (38, 39), whereas the dysregulated expression of 
BMP-4 in the distal lung epithelium causes an enlargement of airspace and consequently 
leads to an impaired lung growth (35). Bone morphogenetic protein receptor 1a (Bmpr1a) and 
Bmpr1b play an important role in the regulation of proliferative and apoptotic processes (40). 
Bmpr1a and Bmpr1b generally promote opposing functions: signaling via Bmpr1a promotes 
proliferation, while signaling via Bmpr1b is antiproliferative, promoting mitotic arrest and 
apoptosis (40). In accordance to these findings, prenatal lung epithelial cell-specific 
abrogation of bmpr1a results in strong apoptosis, leading to a disruption of distal airway 
formation and ultimately to lung malformation and respiratory failure (41). Furthermore, it 
has been demonstrated that antisense knockdown of smad1, a key intracellular transducer of 
BMP signals, negatively regulates lung branching (2, 42). Moreover, it has been shown that 
BMP signaling is strongly activated during late lung development and exhibits dramatic 
changes in spatial localization during late lung development, and thereby these data indicate a 
strong impact of BMP-signaling in normal late lung development (15). Furthermore, this 
study gave initial evidence that Bmpr1a-directed signaling is favoured as normal, late lung 
development proceeds (15). In addition, BMP ligands regulate myocyte differentiation (43), 
ECM production by pulmonary myofibroblasts (44), and cell cycle in alveolar epithelial cells 
(45, 46). Taken together, BMP signaling appears to be a key regulator of proliferation and 
apoptosis during early and postnatal lung development. Dysregulation of this signaling 
pathway ultimately disrupts normal airway formation and lung maturation.  
 
(c) Fibroblast growth factor (FGF) and lung development 
 
Fibroblast growth factor (FGF) signaling pathway is another growth factor playing a 
fundamental role in the morphogenesis of branching organs such as the lung (47). The 
intracellular signaling of the secreted FGFs occurs via the activation of their cognate specific 
cell surface receptors (FGFRs) encoded by four distinct genes, namely FGFR1-4 (48). In the 
developing lung, FGF signaling is a pivotal regulator of the crosstalk between mesenchyme 
and epithelium, directing branching of the airways (49). Only a limited number of FGF 
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ligands are expressed and present in the lung during embryonic development, notable among 
this and well investigated are FGF7 and FGF10 (49-51). A disruption of genes encoding these 
FGFs is known to be involved in the pathogenesis of pulmonary hypertension as well as 
congenital diaphragmatic hernia (52-56). FGF10 is dynamically expressed and has 
chemoattractant function in the lung mesenchyme surrounding the distal buds and regulates 
thereby the induction and outgrowth of lung epithelium through FGFR2 (50, 57). Moreover, 
fgf10(-/-) mice have been shown to fail to develop lungs, ultimately leading to neonatal death 
(48, 58). In accordance to the important role of the FGF ligands, also FGFR2 and FGFR3 
have been shown in animal studies to be expressed during late lung development, indicating 
an important role on alveolarization (48). Lung morphometric analyses of fgfr3(-/-) and fgfr4(-/-) 
mice revealed thinner mesenchyme as well as an enlargement of airspace (59-62). In 
conclusion, FGF signaling is a key mediator of early and postnatal lung development, 
directing the crosstalk between mesenchyme and epithelium and thereby regulating branching 
and alveolarization. 
 
(d) Vascular endothelial growth factor (VEGF) and lung development 
 
Finally, alveolarization is a complex process depending on the interaction of several cell 
types. It is not only characterized by the subdivision of sacculi by secondary septa and the 
differentiation of alveolar type I and type II cells but also by the formation of microvessels. 
Vascular endothelial growth factor (VEGF) is one of the key mediators of vascular 
development. VEGF is not only essential for the formation of the pulmonary vasculature,  but 
it is also essential for branching morphogenesis of the developing airway epithelium (63) 
(64). Blocking VEGF signaling decreases the formation of alveoli and lung capillaries in 
newborn rats, mimicking changes seen in BPD (65). Moreover, VEGFR2 blockade also has 
been shown to disrupt lung development in neonatal mice, inducing a disruption of normal 
formation of alveoli (66, 67). However, VEGF treatment restores normal lung architecture 
and promotes lung capillary formation in neonatal rats exposed to several days of extreme 
hyperoxia (19). On the one hand these findings clearly demonstrate the key role of VEGF in 
alveolarization; on the other hand it shows that deregulation of VEGF signaling plays an 
important role in the pathogenesis of lung diseases, such as ventilation-induced or hyperoxia-
induced lung injury (25, 29, 30, 68-72). Taken together, VEGF is a predominant growth 
factor directing vascularization and thereby alveolarization during late lung development.  
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1.2. The Kidney: Anatomy and Kidney Development 
The kidney serves several vital regulatory functions and essential in whole-body homeostasis: 
(1) natural filter of the blood, (2) urine production, (3) detoxification of substances such as 
urea and ammonium, (4) regulation of electrolytes, (5) maintenance of acid-base balance, 
regulation of blood pressure through maintaining salt and water balance [renin-angiotensin-
aldosteron system (RAAS)], (6) reabsorption of water, glucose and amino acids, and finally 
(7) synthesis of hormones such as calcitriol, erythropoietin, and the enzyme renin. The kidney 
coordinates these homeostatic functions both independently and in concert with other organs, 
especially the endocrine system.  
 
 
 
 
The kidney is composed of renal cortex and renal medulla (figure1). The basic structural and 
functional unit of the kidney is named nephron –1.2 Million nephrons per adult kidney. Each 
nephron is subdivided in an initial filtering component (renal corpuscle), and a tubular system 
(renal tubule). The renal corpuscle is composed of two anatomic structures: (1) the 
glomerulus, a capillary tuft, receiving its blood supply from an afferent arteriole of the renal 
circulation; both the oncotic and hydrostatic pressure in the glomerulus induces the filtration 
of water and soluble substances in the (2) Bowman’s capsule (73). The glomerular filtrate, 
also called primary urine, is then transferred in the renal tubular system, specialized for 
reabsorption and secretion, which is subdivided in: 
renal medulla 
renal cortex 
renal capsule 
renal papilla 
renal pyramid 
ureter 
renal artery 
renal vein 
renal pelvis 
Figure1: macroscopic anatomy of the kidney:  the kidney is enclosed in a membrane called the renal 
capsule and divided into two main areas: (1) the outer area called the renal cortex, and (2) the inner 
area, the renal medulla. Within the medulla there are 8 or more cone-shaped sections known as renal 
pyramids with the renal papilla at the cone end. The renal pyramids are oriented to the renal pelvis, 
which extends to the ureter. (modified from:  
http://content.p-i-n.com/pics/diabetesaktuell/koerper/nierenanatomie.gif) 
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• Proximal convoluted tubule  
• Loop of Henle  
o Descending limb of loop of Henle 
o Ascending limb of loop of Henle  
 Thin ascending limb of loop of Henle 
 Thick ascending limb of loop of Henle  
• Distal convoluted tubule 
Once the glomerular filtrate has passed through the renal tubule and has been concentrated, 
the filtrate continues to the collecting duct system, which is not part of the nephron. The 
kidney generates 180 liters of filtrate a day, while reabsorbing a large percentage in the renal 
tubular system, allowing the generation of only approximately 2 liters of urine (74, 75). 
 
1.2.1. Stages of Renal Development 
Kidney development, also called nephrogenesis, has its origin in the intermediate mesoderm 
and is characterized by three successive phases, starting at day 22 of human gestation and 
terminating at gestational week 36: (1) the pronephros, (2) mesonephros, and (3) 
metanephros. The nephrogenesis in vertebrates reflects the phylogenesis of the kidney (76, 
77).  
 
(1) Pronephros 
 
The pronephros serves as an excretory organ in less developed fishes and has no specific 
function in humans. The paired pronephroi develop in the cervical region of the embryo and 
are apparent towards the cranial end of the intermediate mesoderm during day 22 of human 
gestation. Next, the epithelial cells form tubules, namely the nephrotomes, which then join 
laterally with the pronephric duct.  
 
(2) Mesonephros 
 
The pronephric duct proceeds its elongation caudally and induces the intermediate mesoderm 
to differentiate in epithelial tubules, called mesonephric tubules. Branches of the aorta sprout 
in these mesonephric tubules and form a capillary tuft inside, allowing the filtration of the 
blood. The filtrate is drained via the mesonephric tubule to the mesonephric duct, also called 
Wolffian duct. The mesonephros develops in reptiles, birds and mammals, representing a 
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transient stage of renal development and degenerating while the mesonephric duct extends 
towards the cloaca.  
 
(3) Metanephros 
 
The ureteric bud originates from the mesonephric duct as an outpouching during the fifth 
week of gestation and is called metanephrogenic diverticulum. The elongated stalk of the 
metanephrogenic diverticulum forms the metanephric duct, the ureter. The ureter undergoes 
several series of branching and thereby developing the renal pelvis, the renal calices, and the 
collecting duct system. The tips of the branching ureteric bud interact with the 
undifferentiated intermediate mesoderm, and induce thereby the formation of renal tubules in 
the so called metanephrogenic blastema. These newly formed renal tubules coalesce with the 
connecting ducts of the collecting duct system, allowing a continuous passage from the renal 
tubule to the collecting duct. At the same time, vascular endothelial cells begin to accumulate 
at the tips of the renal tubules and to differentiate to the definitive glomerulus. In humans, the 
formation of the functional unit “nephron” is completed by 32 to 36 weeks of gestation. 
However, these structures will continue to mature after birth.  
 
Table1: Time course of renal development after Sáxen (76); days of gestation:  
 
 
1.2.2. Molecular Mechanisms of Renal Development 
The development of mammalian kidneys depends on a tightly regulated program of reciprocal 
inductive interactions between two primordial tissues: (1) metanephric mesenchyme, and (2) 
ureteric bud. This interaction induces the branching of the ureteric bud and is directed by the 
concerted action of numerous transcription factors, growth factors, proteases and components 
of the extracellular matrix (ECM) (78-81).  
 
 
 
 Pronephros  Mesonephros  Metanephros  
human 22  24  35-37  
rat 10 11.5 12.5 
mouse 8 9.5 11 
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(a) Transcription factors and growth factors in renal development 
 
The zinc finger transcription factor Wilms tumor-1 (Wt1) is ubiquitously expressed in the 
metanephric mesenchyme and is essential for initial differentiation. In line with these 
findings, mice with wt-1 null mutation exhibit a kidney agenesis, indicating, that Wt-1 is vital 
for the initiation and even more for the formation of the ureteric bud (82, 83). Another 
transcription factor playing a pivotal role in the induction of branching o the ureteric bud and 
its interaction with the metanephric mesenchyme is paired box gene 2 (Pax-2). In accordance 
with the findings, mice with pax-2 null mutation causes kidney agenesis with defective 
branching morphogenesis (84). Moreover, in pax-2 knockout mice, expression of glial cell 
line-derived neurotrophic factor (GDNF) is absent (85). GDNF is expressed in the 
metanephric mesenchyme area and its receptor “rearranged during transfection” (Ret and its 
co-receptor Glial cell line-derived neurotrophic factor receptor alpha (Gfra) are expressed in 
the Wolffian duct (86). It has been shown, that GDNF is one of the key metanephric 
mesenchyme-derived growth factors of initiation of forming the ureteric bud and its branching 
afterwards. In accordance, in mice with null mutations of gdnf, ret, or gfra the ureteric 
outpouching and subsequent elongation and branching is severely affected (87-93). In 
conclusion, not only growth factors such as GDNF and its receptors are vital for normal renal 
development, but also the transcription factor, e.g. Pax-2.  
Another group of growth factors essential for budding and tubulogenesis is the BMPs, 
members of the transforming growth factor ȕ (TGF-ȕ) superfamily (94-96). Experimental 
studies determining the role of BMP family members demonstrated a crucial function of 
BMPs throughout renal development: For example BMP7 mutant mice die within the first 
24h due to renal failure, indicating that BMP7 plays an essential role in branching 
morphogenesis. It has been suggested that BMP7 may function as an inducer of metanephric 
mesenchyme, promoting survival (97-100). To conclude, BMP signaling plays a crucial role 
in early and late renal development, especially in induction of metanephric mesenchyme and 
regulation of the interaction between the tips of the uretric bud and the metanephric 
mesenchyme.  
 
(b) Extracellular matrix components and enzymes in renal development 
 
In addition to transcription factors and growth factors, the ECM appears to play an 
underestimated role in branching morphogenesis (101, 102). Ureteric bud, for example, 
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requires type I collagen and matrigel to form tubules in vitro (103). Furthermore, hyaluronic 
acid prevents cell death and promotes uretric bud branching morphogenesis in three-
dimensional cell culture systems (104). Moreover, it has been shown that several integrins, 
such as Į3, Į6, ȕ1, and ȕ4 as well as laminin-5 are involved in branching processes of renal 
development (105). In line with these findings, integrin Į3 knockout mice exhibit decreased 
collecting ducts (106). Furthermore, ECM-metabolizing enzymes, such as metalloproteinases 
(MMP) 9 and MMP2 as well as their cognate inhibitor tissue inhibitor of metalloproteinases 
(TIMP) have been suggested to regulate branching processes (107-109).  
 
1.3. Perinatal Programming  
The term Perinatal Programming describes a process during a critical fetal and postnatal 
period of development, in which various influences, such as nutrition, hormones and 
inflammation, form permanent physiological processes and organ functions (110, 111). 
Therefore, disturbances and interruptions in these critical phases of development ultimately 
lead to permanent alterations of organ structure, and physiological processes with a severe 
impact on organ function throughout life (112).  
The basic concept of Perinatal Programming is rooted in the hypothesis of the french 
biologist Lamarck in 1809: the phenotype could be induced by environmental “programming” 
(Lamarck JB: Philosophie zoologique. Paris, Dentu, 1809). In the1960s Dubos et al. 
introduced the term of “biological Freudianism” (113), particularly referring to the 
intrauterine influence on the development of postnatal body weight. Günter Dörner at the 
Charité in Berlin merged these concepts of the last centuries and expanded them to a more 
fundamental developmental biological and medical ultimate principle. He did not only 
hypothesize, that alterations of the intrauterine environment has long-term effects in the 
offspring, but he also introduced the concept of “intrauterine Programming” (114, 115). 
 
1.3.1. Intrauterine Growth Restriction: Definition and Incidence 
Small for gestational age (SGA) infants are those, who are small in size for their gestational 
age, most commonly defined as a weight below the 10th percentile for the gestational age. 
Intrauterine growth restriction (IUGR) and SGA are often used interchangeably but the 
distinction is important. IUGR is the pathological form of SGA. Not all infants born SGA are 
pathologically growth restricted and, actually might be constitutionally small. IUGR refers to 
an intrauterine condition or insult, which impairs the growth of the fetus and ultimately leads 
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to restriction of growth, impeding the fetus to reach its growth potential. IUGR incidence in 
newborns is between 3% and 7% of the pregnancies (116-119). The causes of IUGR are 
miscellaneous, but they can be subdivided in three major groups: 
 
(1) maternal factors: including poor nutritional status, alcohol and/or drug use, smoking, 
pulmonary, cardiovascular as well as renal disease, diabetes, and hypertension. 
(2) Uteroplacental factors: preeclampsia, uterine malformations, placental insufficiency. 
(3) and fetal factors: chromosomal abnormalities, and intrauterine infection. 
 
Over decades the management of early postnatal nutrition of infants with IUGR has been 
discussed. Since the importance of postnatal environmental nutrition has been recognized for 
optimal neurological and cognitive development in low birth weight infants (120-122), the 
issue of whether early postnatal hyperalimentation and thereby catch-up growth might bear in 
turn impaired renal function, as well as metabolic syndrome is considerable important. 
Several epidemiological studies investigated the long-term consequences of small size at birth 
and give compelling evidence, that infants who where born with low birth weight and 
subsequently showed increased postnatal weight gain, namely catch-up growth, displayed a 
higher susceptibility for obesity, type 2 diabetes, insulin resistance, and cardiovascular disease 
(123-133). These controversial observations – low intrauterine growth velocity versus 
accelerated postnatal weight gain – led to the so called “mismatch theory”: thoug the 
physiological processes of an infant subsequent to IUGR are adapted to poor nutritional 
supply – thrifty phenotype – they are exposed to nutritional abundance (134). However, the 
impact of IUGR on catch-up growth, the role of early postnatal hyperalimentation itself, and 
the exact vulnerable window where increased postnatal weight gain has adverse effects on 
organ development and function still remains largely unknown.  
 
1.3.2. Fetal Programming: The Barker Hypothesis 
The term fetal programming reflects the hypothesis that temporary environmental influences 
during intrauterine development lead to permanent alterations of physiological processes later 
in life. This ground-breaking idea was coined by Barker et al. in the 1990s, describing the 
positive correlation between low birth weight at birth (<2.5kg) and the increased relative risk 
to develop features of metabolic syndrome, such as type II diabetes in adulthood (110, 127). 
These data imply that maternal nutritional fetal supply has long-term implications for the 
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health of the fetus in adulthood. Further studies showed that low birth weight is also 
associated with an increased risk of hypertension (130, 133, 135, 136). This led ultimately to 
the so called “Fetal Origins Hypothesis”, which proposes that coronary heart disease, and the 
diseases related to it, originates from responses to undernutrition during fetal life and infancy. 
In line with these findings, he showed that the lower the birth weight, the higher the risk for 
coronary heart disease in later life (133). Barker and Hales combined these features of infants 
born with low birth weight to the so called thrifty phenotype. The thrifty phenotype hypothesis 
says that reduced fetal growth results from an adaptation of the fetus in an environment 
limited in its supply of nutrients. Such an infant is prepared for survival in an environment in 
which resources are likely to be short. In other words, the thrifty phenotype is considered as 
the capacity of the offspring to respond to environmental cues during early development. 
 
1.3.3.   Metabolic Programming 
The prevalence of obesity in children is dramatically increasing in the last decades and the 
incidence of metabolic syndrome is emerging as a worldwide epidemic (137). The incidence 
of obesity has doubled for children 2 to 5 years of age, almost tripled for youth 6 to 19 years 
of age. In 2004, the World Health Organization (WHO) estimated that 22 million children 
under 5 years of age, and 10% of all children 5-17 years of age were overweight or obese, and 
predicted that childhood obesity will continue to increase in both developed and developing 
countries (138). Furthermore, there is an increase in the prevalence of pediatric type 2 
diabetes in obese children (139-142).  
Indeed, there is already no doubt, that food intake and food quality plays a vital role in the 
development of obesity. Pre- and postnatal nutritional stressors were delineated as central risk 
factors predisposing the individual to later increased features of metabolic syndrome (143-
145). Over half century ago, first studies gave initial evidence, that nutrition during early 
postnatal life has long-lasting effects showing  life-time changes in growth and body size 
subsequent to early abundant or restricted maternal milk in rodents (146). In the 90s, Barker 
and Hales coined the concept of fetal programming of diseases in adulthood (127). 
Plagemann et al. next extended this concept on postnatal events, such as nutritional factors 
and described this process as metabolic programming (111).  
Metabolic programming describes a process whereby a nutritional stimulus during a 
vulnerable period of development hast permanent effect on organ physiology and function. 
The idea of perinatal programming of diseases implies that an insult, acting during a narrow 
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phase of sensitivity in the perinatal period of life induces permanent physiological alterations 
leading to diseases in adulthood. Since the vital relevance of postnatal environmental nutrition 
has been recognized over the last decades, numerous studies suggested that accelerated 
growth and weight gain in the early postnatal period bear the risk of long term impaired renal 
function, as well as in metabolic syndrome (143, 147-150). However, it still remains unclear, 
whether enhanced early postnatal nutrition of premature infants may either influence 
favourably the postnatal continuation of nephrogenesis or accelerate the progression toward 
renal insufficiency.  
 
1.4. Intrauterine Growth Restriction and Organ-Specific Diseases 
 
1.4.1. Intrauterine Growth Restriction and Lung Disease  
The incidence of respiratory illness increased during the past decades (151). Asthma is the 
most common cause of chronic childhood disease in developed countries. Its prevalence has 
nearly doubled over the last 2 decades, putting a serious socioeconomic burden on the 
families (152). The pathomechanisms are based on the interaction between multiple genes and 
environmental factors (153). Prenatal influences, such as maternal smoking during gestation 
and intrauterine malnutrition of the fetus adversely affect later respiratory health (154-164). In 
accordance with these findings, epidemiological studies demonstrated an impairment of lung 
function with reduced forced expiratory volume (FEV1) in young infants subsequent to IUGR 
(8). Interestingly, there is an increasing body of evidence that IUGR induces changes in the 
developing lung with a persisting impairment of pulmonary structure and function (10, 155, 
165, 166). Few experimental studies have demonstrated morphometric pulmonary alterations 
and imbalance of ECM composition in lungs of animals subsequent to IUGR (167, 168). 
Furthermore, analysis of lung structure in growth restricted animals revealed an impaired 
development of the lung, accompanied by a delayed maturation of the surfactant system (10, 
163). Moreover, several studies show that a severely perturbed metabolism of the key ECM 
components contributes to this structural disorder of the lung (167, 168) and thereby suggest a 
regulatory effect of IUGR on the production and metabolism of the ECM. Consistently, Joss-
Moore et al. suggested a pivotal role of ECM molecules, such as elastic fibers in the 
pathomechanism of IUGR-associated lung disease (167). 
Lung structure and function are already determined during early and late lung development (1-3, 
5, 14). Interference with the developmental program of the lung during any of these phases 
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may render the lung less effective in gas exchange or more susceptible to disease. However, 
the pathogenesis of IUGR-associated lung disease is largely unknown. There are two central 
processes potentially involved: (1) ECM and its maintenance during alveolarization is thought to 
play a pivotal role (167, 168). Disruption of critical signaling pathways that direct lung 
development may contribute to the altered lung structure subsequent to IUGR. (2) Inflammatory 
cytokines and their effect on the regulation of the composition and function of the ECM. 
 
1.4.2.   Intrauterine Growth Restriction and Renal disease  
Low birth weight as a result of IUGR has been demonstrated to be directly associated with a 
rising risk to develop renal diseases in later life or to aggravate their course (169-173). 
Indeed, there are studies reporting a higher incidence of end-stage renal disease at adulthood 
in patients with former IUGR (174, 175). Moreover, numerous studies demonstrated a greater 
incidence of glomerular disease as well as complications and aggravation of nephrotic 
syndrome in children subsequent to IUGR (176-178). For example, children with IUGR and 
low birth weight were shown to be at higher risk to develop progressive glomerulosclerosis 
compared to children without IUGR (179). In line with these findings, another study 
demonstrated that IUGR is significantly associated with low-normal kidney function 
(creatinine clearance) (169). 
These observations in humans were verified in several experimental animal studies of IUGR 
either induced by maternal low protein diet or by ligation of the uterine artery (173, 180-182). 
Furthermore, morphometric investigations give strong evidence, that IUGR impairs 
nephrogenesis and thereby leads to a reduction of nephron number after birth (182, 183). In 
line with these results, there is a strong epidemiological relationship between IUGR/low birth 
weight and adult hypertension (182, 184). In the late 80s, Brenner and Anderson coined the 
concept “reduction in nephron number” suggesting an inverse correlation between the total 
renal filtration surface area and the risk of arterial hypertension (185). What impairs 
nephrogenesis subsequent to IUGR? (1) increased inflammatory response (173, 180); (2) 
dysbalance of apoptotic processes (186); (3) deregulation of the renin-angiotensin-aldosteron 
system (RAAS) (187-189); and (4) secondary effects of features of metabolic syndrome, such 
as hyperglycemia (190). However, the underlying molecular mechanism of IUGR-associated 
renal diseases still remains unclear and the role of postnatal nutrition requires further 
elucidation to gain a broader understanding of the effects of IUGR on renal development and 
maturation.  
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1.4.3.  Early Postnatal Hyperalimentation and  
Metabolic Programming  
It is well known that obesity entails a high risk for pulmonary illness and chronic kidney 
disease (161, 191-193), independently of diabetes and hypertension (190, 194). These facts 
underline how obesity is a real threat not only for adults, but also for the health of children 
and adolescent (195, 196). Both kidney and lung are susceptible to weight gain and obesity-
induced diease:  
(1) Obesity-related glomerulopathy, a secondary form of focal-segmental glomerulosclerosis 
(FSGS), presents proteinuria and progressive renal dysfunction (197). Moreover, prenatal risk 
factors for obesity, such as being small for gestational age or born prematurity, in addition to 
imposing an additional risk of hypertension, and T2DM later in life, are also risk factors for 
reduced nephron mass and progression of kidney disease in childhood (174, 175, 182, 198-
200). Few studies have addressed the question whether postnatal nutrition can influence 
nephrogenesis when it is prolonged postnatally (148, 149). Nephrogenesis is achieved 
prenatally in the human, most nephrons being formed between 28 and 34 weeks of gestation 
(76). After birth, postnatal maturation consists among other changes of increased glomerular 
size and tubular length. Postnatal alteration has been experimentally induced by postnatal 
dietary intervention, showing that, postnatally, ongoing nephrogenesis is influenced by 
nutrition (148, 149). Furthermore, hyperleptinemia in the obese patients can contribute to 
renal damage not only because of its profibrotic effects but also because it is a strong stimulus 
for sympathetic system (201-205). Leptin-mediated sympathetic stimulation could be a 
relevant player in obesity-related glomerulopathy. 
 
(2) The process of alveolarization begins before birth and proceeds until early infancy (1). 
Environmental influences during this critical period of pulmonary development have long-
term effects on pulmonary structure and function (9, 11, 166). It is intriguing though, that 
only a few studies have addressed the important question, whether early postnatal 
hyperalimentation programs lung structure and function (13, 206-208). The results are 
controversial: one study gives initial evidence, that adult forced expiratory volume in 1 
second (FEV1) and forced vital capacity (FVC) are positively associated with weight gain in 
the first year of life (13, 208). Another study demonstrated that low birth weight and lower 
weight gain in early childhood correlate with modest reduction in adult lung function with 
lower diffusing capacity (13). In line with this study, Canoy D. et al. did not only show that 
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birth weight is continuously associated with adult respiratory function but also that poor 
growth in early life may restrict normal lung development (209). In contrast to these findings, 
other studies gave strong evidence that weight gain in infancy is associated with impaired 
lung function and transient asthma symptoms (208, 210).  
 
However, enhanced early postnatal hyperalimentation may either influence favourably the 
postnatal continuation of nephrogenesis and alveolarization. To date, the studies are 
controversial and the effect of early postnatal hyperalimentation remains still unclear. 
 
1.5. Transforming Growth Factor ȕ Signaling Pathway 
 
1.5.1.   Transforming Growth Factor ȕ Superfamily and its Ligands 
Transforming growth factor-ȕ (TGF-ȕ) superfamily comprises a large number of growth 
factors – more than 35 structurally-related cytokines – that exert pleiotropic effects on 
different cell-types. The different members of the TGF-ȕ superfamily play a vital role in 
developmental processes, cellular differentiation, expression and remodeling of ECM, 
regulation of proliferation and apoptosis as well as modulation of the immune response. 
Almost all cell types synthesize TGF-ȕ; the active form of TGF-ȕ is a 25 kDa dimer in which 
the two polypeptides interact via a disulfide bond and hydrophobic interactions. TGF-ȕ is 
initially synthesized as an inactive propeptide precursors, and is then processed and secreted 
as inactive homodimers, noncovalently bound to a latency-associated peptide (LAP) (211, 
212) (213). The inactive precursor molecule consists of: (1) N-terminal signal peptide that is 
required for secretion, (2) pro-region [called latency associated peptide or (LAP)], and (3) C-
terminal region, which represents the mature TGF-ȕ molecule subsequent to release from the 
pro-region by proteolytic cleavage. The latent form is activated extracellularly through 
proteolysis by numerous factors: thrombin, thrombospondin, plasmin, metalloproteases, 
retinoids, low pH, or reactive oxygen species (ROS) (212) . Moreover, the ĮȞȕ6 integrin-
expressing cells also induce activation of TGF-ȕ1 (214).  
 
There are three distinct TGF-ȕ isoforms expressed in mammals: TGF-ȕ1, TGF-ȕ2, and     
TGF-ȕ 3, and they are not functionally redundant. In line with these argue, they are encoded 
by different genes, and exhibit diverse expression patterns in vivo. Interestingly, TGF-ȕ1 is 
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selectively induced by oncogenes and early genes; in contrast the expression of the other 
isoforms is more developmentally and hormonally regulated (215, 216).  
In particular, TGF-ȕ1 isoform is secreted by numerous cell types, such as, platelets and 
immune cells (21, 22, 217). In the lung, especially the fibroblasts and epithelial cells produce 
this cytokine. Moreover, TGF-ȕ1 has been shown to have a strong impact on lung 
development. Several studies have indicated that TGF-ȕ signaling plays a critical and finely-
tuned role in branching and alveolarization (2, 5, 16): TGF-ȕ ligands inhibited airway 
branching in vitro (218, 219). Additional studies demonstrate that an abrogation of TGF-ȕ 
signaling, by genetic down-regulation either of TȕRII, or of Smad2, Smad3, or Smad4 
enhances lung branching in vitro (31, 220). Consistent with these observations, 
overexpression of Smad7, which antagonizes TGF-ȕ signaling, promoted lung branching in 
vitro (221, 222). However, a conditional overexpression of TGF-ȕ1 gene in the mouse lung in 
the postnatal period disrupted lung development (21, 26). Of interest, Smad3 deficiency in 
mice resulted in progressive airspace enlargement with age (Bonniaud et al., 2004)(32). These 
studies implicate, that TGF-ȕ signaling is both a positive and a negative regulator of lung 
branching and alveolarization. Taken together, these data indicate that TGF-ȕ plays a key role 
in lung development, as well as in the maintenance of pulmonary structure. Furthermore, TGF-ȕ 
has an important role in diverse human pathologies, such as autoimmune and 
fibroproliferative diseases, affecting several organs like the kidney, lung and liver. 
 
1.5.2. Transforming Growth Factor ȕ Receptors:              
Classification and Structure 
There are three types of TGF-ȕ receptors: 
(1) TGF-ȕ-receptor I (Tgfbr1; also called TȕR-I) 
(2) TGF-ȕ-receptor II (Tgfbr2; also called TȕR-II)  
(3) and TGF-ȕ-receptor III (Tgfbr3; also called TȕR-III or betaglycan) 
Structural and biochemical analyses have shown that they represent transmembrane 
serine/threonine kinases, which have the ability to associate in a homo- and heteromeric 
complex. Several studies have demonstrated the impact of both the type II and type I 
receptors as the signaling mediators. Moreover the type III receptor, is widely expressed in 
fetal and adult tissues, including mesenchymal, epithelial, neuronal and other cell types. The 
type III receptor binds all three TGF-ȕ isoforms. Interestingly, recombinant expression of type 
III receptor does not only lead to the synthesis of a transmembrane protein, but also to a 
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secreted protein – soluble betaglycan. As a consequence of its ability to bind TGF-ȕ, the 
soluble type III receptor could competitively inhibit TGF-ȕ-binding to the transmembrane 
receptors (211, 213, 223-225).  
Endoglin is an accessory TGF-ȕ-receptor, which is expressed in a limited set of cell types, 
primarily vascular endothelial cells and several hematopoietic cell types. Endoglin binds all 
three TGF-ȕ isoforms: TGF-ȕ1 and -ȕ3 (211, 225, 226).  
 
1.5.3. Transforming Growth Factor ȕ Pathway:                        
Intracellular Signaling 
Intracellular TGF-ȕ signaling is primarily mediated by Smad signaling molecules. The name 
Smad is derived from the founding members of this family, the Drosophila melanogaster 
protein MAD (mothers against decapentaplegic). The Smad family of transcription factors is 
composed of eight proteins: Smad1 through to Smad8 (224, 227). They are functionally 
subdivided in three groups: 
 
1) Receptor-regulated Smads (R-Smads): Smad2 and Smad3    
The R-Smads represent cytoplasmic effector molecules, which are receptor-associated. They 
are directly phosphorylated by the type I receptor kinases (211, 227, 228).  
 
2) Common-partner Smad (Co-Smad): Smad4 
The interaction between the R-Smads and various DNA-binding proteins is mediated by 
Smad4. Moreover, it plays a central role for the nuclear import of the R-Smads, and in the 
activation of gene transcription (211). 
 
3) Inhibitory Smads (I-Smads): Smad6 and Smad7 
The I-Smads are antagonistic Smads; they inhibit the TGF-ȕ signaling cascade by associating 
with the activated type I receptor and thereby preventing the binding and activation of the    
R-Smads (224, 228) .  
 
TGF-ȕ signaling is initiated by binding of TGF-ȕ to the type II TGF-ȕ receptor (TȕRII), 
which subsequently forms a complex with the type I receptor [also called activin-like kinase 
(ALK)-5] or Acvrl1 (also called ALK-1). The type I receptor transmits signals within the cell 
via second-messenger R-Smad proteins, namely Smads 2 and 3. Moreover, transforming 
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growth factor-ȕ signaling is also regulated by the inhibitory Smads, Smad6 and Smad7, which 
antagonize TGF-ȕ signaling. The phosphorylated and thereby activated R-Smads bind Smad 4 
and are then translocated into the nucleus, where these R-Smads regulate gene transcription, 
and hence, cell function (211, 228) (figure2). 
 
 
 
 
Figure 2: Schematic diagram of the transforming growth factor-ȕ signaling pathway 
from the cell membrane to the nucleus. The arrows indicate signal flow. At the cell 
surface, the ligand binds to the type I and type II receptor complex, and induces 
phosphorylation of the GS segment (red) of the type I receptor. Consequently, receptor-
regulated Smads (R-Smads) are phosphorylated at the C-terminal serine residues, which 
then form a complex with Smad4. This complex translocates into the nucleus to regulate 
the transcription of target genes, assisted by either co-activators or co-repressors. Both R-
Smads and Smad4 shuttle between the nucleus and the cytoplasm. Smurf1, Smurf2, 
Smad6, and Smad7 function as inhibitors of the phosphorylation of the R-Smads 
[copyright permission is existent]. 
 
 
1.6. Leptin and Interleukin-6 signaling pathway 
 
1.6.1.  Leptin  
Leptin is a 16-kDa protein, encoded by the ob gene, and mainly produced in adipocytes of 
white adipose tissue. Recent evidence has shown that placenta, skeletal muscle and possibly 
kidney are additional sites of leptin synthesis (229, 230). There is an accumulating body of 
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evidence that leptin exerts as a multifunctional hormone diverse actions, extending beyond 
those involved in regulation of appetite and body weight. Some of these include proliferation, 
sympathetic nervous activation, wound healing, fibrosis, and inflammation (201-205). 
However, a more direct role for leptin in promoting renal pathophysiology via leptin receptors 
has arisen in the last years. Leptin stimulates the proliferation of cultured glomerular 
endothelial cells (201). Moreover, leptin increases type I collagen mRNA and protein 
production (204). Glomerular expression of type IV collagen was significantly enhanced in, 
and urinary protein excretion significantly increased leptin-treated rats (201). 
 
1.6.2.  Interleukin-6  
Interleukin 6 (IL-6) was first described as a B-cell differentiation factor, which activates       
B-cells into immunoglobulin-producing cells. Consequently, it was initially named B-cell 
stimulatory factor 2 (B-cell stimulatory factor-2) (231). IL-6 is synthesized by numerous cell 
types, including immune cells (T-cells, B-cells, and monocytes), fibroblasts, endothelial cells, 
mesangial cells, and adipocytes and exerts a variety of biological functions (232). 
Interestingly, the IL-6 signaling cascade is involved in multiple physiological and 
pathological processes: (1) organ development (233), (2) inflammatory processes (234, 235), 
(3) growth and cell differentiation, (4) apoptosis, (5) pathogenesis of tumors, (6) bone and 
cartilage metabolism as well as rheumatoid arthritis, (7) lipid and glucose metabolism (232).  
 
1.6.3.  Intracellular Signaling of Leptin and Interleukin-6: 
 Stat3 and Erk1/2 Signaling Pathway 
Leptin acts through leptin receptor (ObR), which belongs to the interleukin 6 (IL-6) familiy of 
class 1 cytokine receptors. Five alternatively spliced isoforms of ObR with different lengths 
of C-termini have been identified in mice (236-238). Long form (ObRb) and short form 
(ObRa) are the most studied isoforms; only ObRb is fully capable of activating intracellular 
signaling (239-242) (figure3).  
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Interleukin-6 (IL-6) exerts its biological function via IL-6 receptor (IL-6R, also called         
IL-6RĮ, gp80, and CD126) and gp130 (also named IL-6Rȕ, and CD130). IL-6R is essential 
for ligand binding, whereas the cytoplasmatic domain of gp130 is the central mediator of 
intracellular signaling (243-246). Interestingly, gp130 initiates downstream signaling via an 
intrinsic kinase domain, but through various regions, which then associate with a non-receptor 
tyrosine kinase: Janus-kinase, also called JAK (232). Binding of IL-6 to the membrane-bound 
IL-6R induces a homodimerization with gp130 and thereby forming a functional receptor 
complex of IL-6, IL-6R, and gp130. In addition, the soluble IL-6R (sIL-6R), which lacks the 
intracytoplasmatic domain, can also bind IL-6, and consequently form a complex with gp130 
(IL-6 trans-signaling) (232, 247). Based on the fact, that membrane-bound gp130 is expressed 
ubiquitously, the IL-6-sIL-6R complex can bind to each cell type and thereby mediate IL-6 
Figure 3: Schematic diagram of the leptin signaling pathway: leptin binds to the full 
length form of the leptin receptor (ObRb) and initiates thereby the janus-kinase (JAK)-
mediated phosphorylation of three intracellular tyrosine residues of the receptor. This leads 
to the phosphorylation of signal transducer and activator of transcription (Stat) 3 molecules 
as well as extracellular-signal regulated kinase (Erk) 1/2. The activated Stat3 and Erk1/2 
translocate to the nucleus and induce transcription of numerous target genes, notable among 
these suppressor of cytokine signaling (SOCS)3, which in turn negatively regulates the 
activation of Stat3 and Erk1/2, representing a negative feedback loop.  
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function. However, gp130 is also circulating as soluble form (sgp130) and has the ability to 
bind IL-6-sIL-6R complex and thereby acting as a natural inhibitor of IL-6 signaling (248, 
249) (figure4). 
 
 
 
 
 
 
 
 
 
Moreover, gp130 is also transmits the intracellular signaling of other members of the IL-6 
family, including LIF (leukaemia inhibitory factor), CNTF (ciliary neurotrophic factor), and 
IL-11 (232, 250).  
 
 
 
Figure 4: Schematic diagram of the Interleukin (IL)-6 signaling pathway: IL-6 binds to 
interleukin-6 receptor (IL-6R), which then forms a complex with the membran-bound 
glycoprotein (gp)130 and thereby initiates the janus-kinase (JAK)-mediated phosphorylation 
of the intracellular tyrosin residues of the receptor. This leads to the phosphorylation of signal 
transducer and activator of transcription (Stat) 3 molecules as well as extracellular-signal 
regulated kinase (Erk) 1/2. The activated Stat3 and Erk1/2 translocate to the nucleus and 
induces transcription of numerous target genes. 
INTRODUCTION 
 
 
 - 33 - 
1.7. Aims 
A growing body of evidence has suggested that nutritional stimuli play a pivotal role in organ 
development, and that both IUGR and early postnatal hyperalimentation are known to have an 
impact on perinatal programming of lung and renal function. However, the underlying 
mechanism of pulmonary and renal perinatal programming remains still unclear. It is the 
overall goal of this study to investigate the mechanisms perinatal programming of pulmonary 
and renal organ function. Therefore, we will test the hypothesis that inflammatory processes 
as well as the TGF-ȕ signaling are regulated subsequent to nutritional stimuli in the perinatal 
period.  
This idea will be explored in the following four sub-hypotheses: 
 
1. TGF-ȕ signaling is regulated in the lung and contributes to the impairment of lung 
function subsequent to IUGR. 
 
2. Key inflammatory cytokines are increased in the lung subsequent to IUGR and 
early postnatal hyperalimentation. 
 
3. Early postnatal hyperalimentation has an mpact on renal function. 
 
4. Leptin and interleukin-6 signaling in the play a role in the pathogenesis of renal 
disease subsequent to early postnatal hyperalimentation. 
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2.  RESULTS 
2.1. Inhibition of TGF-ȕ signaling and decreased apoptosis in                
IUGR-associated lung disease in rats 
Alejandre Alcázar MA, Morty RE, Lendzian L, Vohlen C, Oestreicher I, Plank C, Schneider 
H, Dötsch J. PLoS One, 2011 
Intrauterine growth restriction is associated with impaired lung function in adulthood. It is 
unknown whether such impairment of lung function is linked to the transforming growth 
factor (TGF)-ȕ system in the lung. Therefore, we investigated the effects of IUGR on lung 
function, expression of extracellular matrix (ECM) components and TGF-ȕ signaling in rats.  
IUGR was induced in rats by isocaloric protein restriction during gestation. Lung function 
was assessed with direct plethysmography at postnatal day (P) 70. Pulmonary activity of the 
TGF-ȕ system was determined at P1 and P70. TGF-ȕ signaling was blocked in vitro using 
adenovirus-delivered Smad7. 
At P70, respiratory airway compliance was significantly impaired after IUGR. These changes 
were accompanied by decreased expression of TGF-ȕ1 at P1 and P70 and a consistently 
dampened phosphorylation of Smad2 and Smad3. Furthermore, the mRNA expression levels 
of inhibitors of TGF-ȕ signaling (Smad7 and Smurf2) were reduced, and the expression of 
TGF-ȕ-regulated ECM components (e.g. collagen I) was decreased in the lungs of IUGR 
animals at P1; whereas elastin and tenascin N expression was significantly upregulated. In 
vitro inhibition of TGF-ȕ signaling in NIH/3T3, MLE 12 and endothelial cells by adenovirus-
delivered Smad7 demonstrated a direct effect on the expression of ECM components. Taken 
together, these data demonstrate a significant impact of IUGR on lung development and 
function and suggest that attenuated TGF-ȕ signaling may contribute to the pathological 
processes of IUGR-associated lung disease. 
 
Contribution to Publication I 
Once I had formed the hypothesis and designed the experiments for this project, I established 
and validated successfully a new system for whole body plethysmography in rats. I next 
instructed Lisa Lendzian, who then conducted the experiments for P70 by herself as part of 
her MD-thesis. Furthermore, as it was in part a joined project of her and mine, she performed 
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the western blots and real-time RT-PCR for P1 as part of her MD-thesis, whereas I assessed 
these experiments for P70 and in addition the immunhistochemical stainings. Moreover, Dr. 
Rory Morty supported me greatly with the morphometric analyses. I designed and performed 
the western blots for apoptotic processes as well as the cell culture experiments using 
adenoviral Smad7 vector. I finally calculated the statistics, designed and wrote the 
manuscript. The manuscript was proofread by Prof. Dr. Holm Schneider, and Prof. Dr. 
Dötsch. 
 
Table1 
Primers and TaqMan probes were designed by Miguel Angel Alejandre Alcazar. 
 
Figure1:  
Physiological data of the animals and respiratory system compliance at P70 were assessed, 
and illustrated by Lisa Lendzian, whereas the morphometric analyses of the lung and the 
assessment of the mRNA expression of genes encoding surfactant proteins were performed by 
Miguel Angel Alejandre Alcazar.  
 
Figure2, Figure3, Figure4, and Figure 5, and Figure6  
The assessment of mRNA expression of extracellular matrix (ECM) proteins and modulators 
of the ECM as well as of the TGF-ȕ signaling machinery and the activity of the TGF-ȕ 
signaling in neonatal rat lungs (P1) was performed by Lisa Lendzian, whereas Miguel Angel 
Alejandre Alcazar assessed the same set of experiments for P70. In addition, Miguel Angel 
Alejandre Alcazar performed immunostaining for phosphorylated Smad2 and 
phosphorylated Smad3 at P70 as well as western blots for apoptotic processes at P1. 
 
Figure7:  
Miguel Angel Alejandre Alcazar explored the effects of the inhibition of intracellular TGF-
ȕ signaling by adenoviral Smad7 overexpression on the expression of ECM components in 
vitro. 
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2.2.  Developmental Regulation of Inflammatory Cytokine-Mediated 
Stat3 Signaling: The Missing Link between Intrauterine Growth 
Restriction and Pulmonary Dysfunction? 
Alejandre Alcazar MA, Ostreicher I, Appel S, Rother E, Vohlen C, Plank C, Dötsch J.                       
J Mol Med, 2012 
Intrauterine growth restriction (IUGR) is a risk factor for impairment of lung function in 
adolescence and adulthood. Inflammatory and proliferative processes linking IUGR and 
perturbed extracellular matrix (ECM) as an underlying mechanism have not been addressed 
so far. Therefore, in this study we aimed to investigate the developmental regulation of 
inflammatory and profibrotic processes in the lung subsequent to IUGR.  
IUGR was induced in rats by isocaloric protein restriction during gestation. Lung function 
was assessed with direct plethysmography at postnatal day (P) 28 and P70. Lungs were 
obtained at P1, P42 and P70 for assessment of mRNA, protein expression, 
immunohistochemistry, and gelatinolytic activity.  
Both, respiratory system resistance and compliance were impaired subsequent to IUGR at P28 
and this impairment was even more pronounced at P70. In line with these results, the 
expression of ECM components and metabolizing enzymes was deregulated. The deposition 
of collagen was increased at P70. In addition, the expression of inflammatory cytokines and 
both the activity and the expression of target genes of Stat3 signaling were dynamically 
regulated, with unaltered or decreased expression at P1 and  significantly increased 
expression at P70.  
Taken together, these data give evidence for an age-dependent impairment of lung function as 
a result of a developmentally regulated increase of inflammatory and profibrotic processes 
subsequent to IUGR. 
 
Contribution to Publication II 
As I described in the “Contribution to Publication I” I established and validated successfully a 
new system for whole body plethysmography in rats. I next perfomed the lung function tests, 
including provocation of bronchoconstriction via inhalation of methacholine at P28, and after 
I instructed Lisa Lendzian she conducted the experiments for a later time point P70 by herself 
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as part of her MD-thesis. Furthermore, I formed the hypothesis and designed the experiments. 
Dr. med. Iris Östreicher assessed part of mRNA expression of inflammatory cytokines. 
Moreover, Christina Vohlen supported me greatly with the performance of western blot 
analyses. I finally calculated the statistics, designed and wrote the manuscript by myself. The 
manuscript was proofread by Dr. rer. nat. Sarah Appel, Dr. med. Eva Rother, PD Dr. med. 
Christian Plank, and Prof. Dr. Dötsch.  
 
Table1 
Primers and TaqMan probes were designed by a joint project of Iris Östreicher and             
Miguel Angel Alejandre Alcazar. 
 
 
Figure1, Figure2  
Physiological data of the mothers as well of the offspring were calculated and analysed by          
Miguel Angel Alejandre Alcazar. Respiratory function was assessed using whole body 
plethysmography by Miguel Angel Alejandre Alcazar at P28 and by Lisa Lendzian at P70. 
 
 
Figure3, Figure4, Figure7 
The expression of genes encoding adrenoceptor ȕ1 and ȕ2 as well as ECM molecules and 
modulators of the ECM was assessed by Miguel Angel Alejandre Alcazar. 
 
Figure5, Figure6 
The compostion of the ECM as well as proliferation in the lung was analyzed by             
Miguel Angel Alejandre Alcazar using real-time PCR, western blots, gelatine zymographie 
as well as immunhistochemistry.  
 
Figure7, Figure8 
The expression of genes encoding inflammatory and profibrotic cytokines was assessed by 
Iris Östreicher and Miguel Angel Alejandre Alcazar. The western blots for Stat3 signaling 
were analyzed by Miguel Angel Alejandre Alcazar. 
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2.3.  Persistent Changes within the Intrinsic Kidney-Associated            
NPY system and Tubular Function by Litter Size Reduction 
Alejandre Alcázar MA, Boehler E, Amann K, Klaffenbach D, Hartner A, Allabauer I, 
Wagner L, von Hörsten S, Plank C, Dötsch J. Nephrology Dialysis and Transplantation, 2011. 
Intrauterine growth restriction (IUGR) is associated with an increased risk of renal diseases in 
adulthood. However, while low-birth-weight-infants often undergo accelerated postnatal 
growth, the impact of postnatal environmental factors such as nutrition and early postnatal 
stressors on renal development and function remains unclear. In this context, Neuropeptide Y 
(NPY) may act as a critical factor. NPY is a sympathetic coneurotransmitter involved in blood 
pressure regulation and tubular function. Yet, little is known about the expression and 
function of endogenous NPY in the kidney and the functional relevance for the transmission 
of persistent postnatal-induced effects.  
IUGR was induced in Wistar rats by isocaloric protein restriction in pregnant dams. We 
reduced the litter size to 6 (LSR6) or 10 (LSR10) male neonates. To differentiate the effect of 
postnatal nutrition and stressors we additionally included home-cage-control (HCC) animals 
without any postnatal manipulation. Animals were sacrificed at day 70. Litter size reduction 
(LSR6) but not IUGR increased mRNA expression of endogenous NPY and downregulated 
the NPY-receptors Y1 and Y2. Furthermore dipeptidylpeptidase IV (DPPIV) – an enzyme 
that cleaves NPY – was decreased after litter size reduction (LSR). The expression and the 
phosphorylation of MAPKinase 42/44 (intracellular signalling pathway of the receptor Y1) 
were altered. An impaired renal function with pronounced kaliuresis and natriuresis was 
observed at day 70 after LSR. In conclusion, postnatal nutrition and stressors such as LSR 
lead to dysregulated signaling of NPY. These data demonstrate that factors in the early 
postnatal environment exert important changes in the tubular function, which may predispose 
to corresponding pathology.  
 
Contribution to Publication III 
In this project I designed the concept and established the experimental techniques, such as 
real-time RT-PCR, protein purification, western blotting as well immunohistochemistry. Once 
the mRNA extraction and the real-time RT-PCR were ready-to-use, I instructed Eva Böhler 
on the assessment of the expression of Neuropeptid Y (NPY), NPY-receptor 1 (Y1) and Y2, 
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which was part of her MD-thesis. Both Prof. Dr. Amann as well as Ida Allabauer supported 
me regarding immunhistochemical stainings and access to microscopy facilities. Moreover, 
Leona Wagner performed the DPPIV enzyme-activity assays. Furthermore, I assessed the 
physiological data, the parameters of renal function as well as the western blot analyses. I 
finally calculated the statistics, designed and wrote the manuscript. The manuscript was 
proofread by Dr. med. Daniela Klaffenbach, Prof. Dr. Stephan v. Hoersten, PD Dr. med. 
Christian Plank, and Prof. Dr. Dötsch.  
 
Table1, Table2, Table3 and Figure1  
Primers and TaqMan probes were designed as well as physiological data of animals were 
assessed using results of metabolic studies, weight and length of the animal by               
Miguel Angel Alejandre Alcazar.  
 
Figure2, Figure3, Figure4, and Figure5 
Localization of NPY, Y1 and Y2 receptor in the kidney using immunofluorescence was 
analyzed by Miguel Angel Alejandre Alcazar with the kind support of Prof. Dr. Amann’s 
and Prof. Dr. v. Hörsten’s lab. The Expression pattern of NPY, Y1 and Y2 was assessed by 
Eva Böhler, whereas the expression of mineral corticoid receptor (MCr), renin, angiotensin 
receptor (ATR) 1a, and ATR1b was assessed by Miguel Angel Alejandre Alcazar using 
real-time RT-PCR. 
 
Figure 6, and Figure7 
The DDPIV enzyme activity was assessed by Leona Wagner. The western blots for DPPIV, 
phosphorylated MAPK 42/44, total MAPK 42/44, and ȕ-Actin were performed by             
Miguel Angel Alejandre Alcazar.  
 
Figure8 
The calculation of sodium and potassium excretion in the urine for 24h as well as excreted 
fraction of the filtered sodium (FeNa), and excreted fraction of the filtered potassium (FeK) 
were calculated and analyzed by Miguel Angel Alejandre Alcazar. 
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2.4.  Early Postnatal Hyperalimentation Impairs Renal Function                
via SOCS-3 Mediated Renal Postreceptor Leptin Resistance 
Alejandre Alcázar MA, Boehler E, Rother E, Amann K, Vohlen C, von Hörsten S, Plank C, 
Dötsch J. Endocrinology, 2012 
Early postnatal hyperalimentation (pHA) has long-term implications for obesity and 
developing renal disease. Suppressor of cytokine signalling (SOCS) 3 inhibits 
phosphorylation of Stat3 and ERK1/2, and plays thereby a pivotal role in mediating leptin 
resistance. In addition, SOCS-3 is induced by both leptin and inflammatory cytokines. 
However, little is known about the intrinsic-renal leptin synthesis and function. Therefore, 
this study aims to elucidate the implications of early pHA on renal function and on the 
intrinsic-renal leptin signaling.  
Early pHA in Wistar rats during lactation was induced by litter size reduction at birth either to 
10 (LSR10) or 6 (LSR6), compared to home-cage-control (HCC) male rats. Assessment of 
renal function at postnatal day 70 (P70) revealed decreased glomerular filtration rate, and 
proteinuria after LSR6. In line with this impairment of renal function, renal inflammation and 
expression and deposition of ECM molecules, such as collagen I, were increased. 
Furthermore, renal expression of leptin and interleukin-6 was upregulated subsequent to 
LSR6. Interestingly, the phosphorylation of Stat3 and of Erk1/2 in the kidney, however, was 
decreased after LSR6, indicating postreceptor leptin resistance. In accordance, NPY gene-
expression was downregulated. Moreover, SOCS-3 protein expression – a mediator of 
postreceptor leptin resistance – was strongly elevated and colocalized with NPY.  
Thus, our findings do not only demonstrate impaired renal function and profibrotic processes, 
but also provide compelling evidence of a SOCS-3-mediated intrinsic-renal leptin resistance 
and concomitant upregulated NPY-expression as an underlying mechanism.  
 
Contribution to Publication IV 
Within this study I generated the hypothesis and the major aims as well as the designing of 
the experiments. I established the experimental techniques, such as real-time RT-PCR, protein 
purification, western blotting as well immunohistochemistry. Once I instructed Eva Böhler on 
western blot and immunhistochemistry, she performed the assessment of Stat3 expression, 
phosphorylation of Stat3, SOCS-3, and ȕ-Actin as well as the localization and quantification 
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of collagen I by herself as part of her MD-thesis. In addition, she calculated the glomerular 
filtration rate as well as the proteinuria using the metabolic study, also as part of her         
MD-thesis. Prof. Dr. Amann supported me regarding immunhistochemical staining, 
assessment of indices of renal damage, and access to microscopy facilities. PD Dr. med. 
Christian Plank perfomed the measurement of blood pressure. I finally calculated the 
statistics, designed and wrote the manuscript. The mansuscript was proofread by Prof. Dr. 
Stephan v. Hoersten, and Prof. Dr. Dötsch.  
 
Table1, Figure1, and Figure2 
Primers and TaqMan probes were designed as well as leptin ELISA, and analysis of data 
regarding indices of renal damage were conducted by Miguel Angel Alejandre Alcazar. Eva 
Böhler calculated the physiological data of animals, such as body weight, body length, and 
glomerular filtration rate as well as proteinuria and supported me with the ELISA. PD Dr. 
med. Christian Plank performed the measurements of blood pressure.  
 
Figure3, and Figure4 
The mRNA expression of ECM-metabolizing enzymes was assessed by                        
Miguel Angel Alejandre Alcazar.  The deposition of collagen I and collagen IV was 
quantified as a joined project of Eva Böhler (collagen I), and Miguel Angel Alejandre 
Alcazar (collagen IV). Accordingly, we also assessed the proliferation within the different 
compartment of the kidney using immunhistochemical stainig of PCNA. 
 
Figure5, and Figure6:  
The measurements of the intrinsic renal, and adipose tissue mRNA expression of leptin, obese 
receptor b (ObRb), and ObRa was assessed by Miguel Angel Alejandre Alcazar. The 
localizazion of leptin within the kidney was analyzed by Miguel Angel Alejandre Alcazar 
with the kind support of Prof. Dr. Amann’s lab. The western blots for phosphorylation of 
Stat3 was performed by Eva Böhler, whereas western blots of Erk1/2 signaling was conducted 
by Miguel Angel Alejandre Alcazar.  
 
Figure7  
The expression of proinflammatory cytokines as well as of genes encoding adrenoceptors-
Į1a,-Į1d, -ȕ1, and -ȕ2 was assessed by Miguel Angel Alejandre Alcazar. 
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Figure8  
The assessment of the expression of SOCS-3 was performed by Eva Böhler using western 
Blot analysis. The analysis of the renal localization and expression of SOCS-3 was conducted 
by Miguel Angel Alejandre Alcazar.  
2.5. Hypothalamic JNK1 and IKKȕ Activation and Impaired Early      
Postnatal Glucose Metabolism after Maternal Perinatal              
High-Fat Feeding 
Rother E, Kuschewski R, Alejandre Alcazar MA, Oberthuer A, Bae-Gartz I, Vohlen C, Roth 
B, Dötsch J. Endocrinology, 2012. 
Hypothalamic inflammation has been demonstrated to be an important mechanism in the 
pathogenesis of obesity-induced type 2 diabetes mellitus. Feeding pregnant and lactating 
rodents a diet rich in saturated fatty acids has consistently been shown to predispose the 
offspring for the development of obesity and impaired glucose metabolism. However, 
hypothalamic inflammation in the offspring has not been addressed as a potential underlying 
mechanism. In this study, virgin female C57BL/6 mice received high-fat feeding starting at 
conception until weaning of the offspring at postnatal d 21. The offspring developed increased 
body weight, body fat content, and serum leptin concentrations during the nursing period. 
Analysis of hypothalamic tissue of the offspring at postnatal d 21 showed up-regulation of 
several members of the toll-like receptor 4 signaling cascade and subsequent activation of c-
Jun N-terminal kinase 1 and IțB kinase-ȕ inflammatory pathways. Interestingly, glucose 
tolerance testing in the offspring revealed signs of impaired glucose tolerance along with 
increased hepatic expression of the key gluconeogenic enzyme phosphoenolpyruvate 
carboxykinase. In addition, significantly increased hepatic and pancreatic PGC1Į expression 
suggests a role for sympathetic innervation in mediating the effects of hypothalamic 
inflammation to the periphery. Taken together, our data indicate an important role for 
hypothalamic inflammation in the early pathogenesis of glucose intolerance after maternal 
perinatal high-fat feeding. 
 
Contribution to Publication V 
In this project I supported Dr. med. Eva Rother with the analyses of the western blots for 
JNK1/2 signaling, IțB kinase-ȕ inflammatory pathways as well as insulin-stimulated Akt 
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phosphorylation in liver. Furthermore I contributed to discussion of the results and to 
proofreading of the manuscript.  
 
Figure1, and Figure2 
The physiological data of the mothers and the offspring were assessed by Eva Rother and 
Ruth Kuschewski. 
 
Figure3 
Three-dimensional view of a principal component analysis performed with global gene 
expression information was assessed by André Oberthür. 
 
Figure4, Figure5, and Figure6   
The mRNA expression was assessed by Eva Rother using real-time RT-PCR. The western 
blot analysis was performed as a joined project by Eva Rother and                        
Miguel Angel Alejandre Alcazar. Moreover the densitometric analyses were assessed by                        
Miguel Angel Alejandre Alcazar.  
2.6. Prevention of Early Postnatal Hyperalimentation Restores                
TGF-ȕ/BMP Signaling in the Lung subsequent to IUGR  
Alejandre Alcazar MA, Vohlen C, Rother E, Plank C, Dötsch J.  (Manuscript in Preparation) 
 
Intrauterine growth restriction (IUGR) is intimately linked with accelerated postnatal catch-up 
growth leading to an impairment of lung structure and function in infancy and adulthood. 
Deregulation of Transforming Growth Factor ȕ (TGF-ȕ) superfamily as well as inflammatory 
processes has been shown to play a vital role in the underlying mechanism of IUGR-
associated lung disease. Interestingly, to date, the programming impact of early postnatal 
hyperalimentation (pHA) has not been addressed so far. Therefore, in this study we aimed to 
investigate whether prevention of pHA shield the lung from programming of vital 
mechanisms involved in IUGR-associated lung disease: (1) TGF-ȕ/BMP pathway, (2) IL-6 
signaling, and (3) extracellular matrix composition (ECM).  
IUGR was induced in rats by isocaloric protein restriction during gestation. At birth litter size 
was either reduced to 6 to induce pHA (IUGR-pHA) or adjusted to 10 (IUGR). In addition, 
we examined a control group without IUGR and litter size adjustment to 10 (Co). Lungs were 
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obtained at P70 for assessment of mRNA and protein expression as well as gelatinolytic 
activity.  
Analysis of lung homogenates demonstrated: (1) Prevention of pHA restores mRNA 
expression pattern of the TGF-ȕ/BMP signaling machinery, namely tgfbr1, tgfbr3, tgfbr3, 
bmpr1a, bmpr1b, bmpr2, smad1, smad2, smad3, smad4, and smad5). In line with these results 
we demonstrated a reconstitution of the TGF-ȕ/BMP activity in the lungs of former IUGR rats 
using immunoblot of phosphorylated Smad2 and Smad3 (TGF-ȕ system) as well as 
phosphorylated Smad1/5/8 (BMP system). Consistently, we showed a normalization of the 
expression of a target gene of the BMP system encoding inhibitor of differentiation 1 (id1). 
(2) Additionally, we observed massively increased expression of Interleukin-6 and its target 
gene AP-1 following pHA, while prevention of pHA completely normalized the expression of 
both. Moreover, we detected the same effect of prevention of pHA on IL-13, another 
proinflammatory cytokine, whereas the anti-inflammatory cytokine IL-10 was even 
upregulated preventing pHA subsequent to IUGR.(3) Finally, perturbed expression of 
collagen1Į1, osteopontin, and metalloproteinases (MMP), important components of the 
pulmonary extracellular matrix, could be restored by prevention of pHA. Assessment of 
MMP-2 by gelatinase zymography showed a normalization of expression when pHA 
subsequent to IUGR is prevented.  
In conclusion, these data give strong evidence that prevention of pHA subsequent to IUGR 
has massive effect on key regulatory mechanisms of IUGR-associated lung disease offering 
new avenues to expand this knowledge to develop innovative preventive strategies for perinatal 
programming of lung diseases later in life. 
 
Contribution to Publication VI 
Within this study I formed the hypothesis and designed the experiments. I designed the 
primers and established the RT-PCR. Once I instructed Christina Vohlen she supported me 
with the mRNA extraction as well as with the RT-PCR. The protein purification as well as the 
western blots were performed by myself. Moreover, Christina Vohlen supported me greatly 
with the assessment of gelatinase activity. I finally calculated the statistics, designed and 
wrote the manuscript by myself. The manuscript is now in preparation and is proofread by Dr. 
med. Eva Rother, PD Dr. med. Christian Plank, and Prof. Dr. Dötsch.  
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3.  DISCUSSION 
 
3.1.  TGF-ȕ and IUGR-associated Lung Disease1 
 
Intrauterine growth restriction (IUGR) does not only have an impact on lung morphometry, 
but also on lung structure in childhood. Only a few studies have addressed the underlying 
mechanism of IUGR-associated lung disease, most of them referring to the role of ECM, its 
composition as well as its metabolism. However, none so far has addressed lung function and 
the impact of TGF-ȕ on the IUGR-associated lung disease. Therefore, I aimed to elucidate 
mechanistic clues linking TGF-ȕ signaling and changes in pulmonary structure and function 
subsequent to IUGR  
Our data demonstrate that IUGR in rats leads to a reduced dynamic compliance and increased 
respiratory system resistance later in life. This is in line with human studies demonstrating an 
impairment of lung function with decreased forced expiratory volume (FEV) in former IUGR 
infants (8). In accordance with this functional impairment, morphometric analysis at P70 
revealed a increased alveolar tissue/alveolarization, assessed by measurement of a decreased 
mean linear intercept (MLI) after IUGR. These results are in contrast to previously reported 
morphometric lung analyses subsequent to IUGR demonstrating an impaired alveolarization 
(10, 165). However, those previous studies differ from our in various points: (1) species, (2) 
induction of IUGR and (3) catch up growth.  
Extracellular matrix components are essential for forming alveoli and determine thereby lung 
function. Interestingly, the expression analysis revealed a clear deregulation of both ECM 
components, such as elastin, and tenascin as well as ECM regulators, such as matrix 
metalloproteinases-2 (MMP-2) and tissue inhibitor of metalloproteinases-2 (TIMP-2). How is 
ECM production and metabolism regulated during lung development subsequent to IUGR? 
TGF-β signaling is known to regulate key cell proliferative and migratory pathways and is 
active during late lung development (11, 251-253). Both over-expression and inhibition of 
TGF-β have been shown to impact alveolarization: rodents over-expressing TGF-ȕ exhibited 
defective alveolarization (21, 26), including reduced numbers of alveoli; inhibition of TGF-ȕ 
signaling in mice by genetic ablation of Smad3, or Smad3 deficiency, resulted in progressive 
airspace enlargement with age (Bonniaud et al., 2004)(32).  
                                                 
1
  This section of the discussion is predominantly extracted of the publication of Alejandre-Alcazar et al., PLoS 
One, 2011 
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In line with the altered alveolar structure in former IUGR rats, we demonstrate in these lungs 
that IUGR decreases pulmonary TGF-ȕ signaling persistently. TGF-ȕ1 mRNA and protein 
levels were reduced immediately after birth and at P70. In accordance, the activation of the 
intracellular signaling, assessed by phosphorylation of both Smad2 and Smad3 is significantly 
derogated at both P1 and P70 in the rat lung. Based on the fact that TGF-ȕ positively regulates 
ECM components, we demonstrated that the damped Smad2 and Smad3 activation is 
accompanied by reduced expression of genes encoding collagen I, collagen III, and fibrillin 
mRNA. Moreover, in animals of arrest of alveolarization MMP-2 is decreased and TIMP-1 is 
increased (Hosford et al., 2004, Dik et al., 2001). In contrast to these findings, we show in our 
study an increment of alveolar tissue and opposing regulation of MMP-2 and TIMP-1. Taken 
together, this study gives strong evidence that IUGR leads to an inhibition of the TGF-ȕ 
signaling and consistently to a decreased expression of TGF-ȕ-regulated ECM components. 
 
In addition to the in vivo study, we investigated in vitro the impact of an inhibition of the 
TGF-ȕ activity by adenoviral Smad7 on mRNA expression of previously named TGF-ȕ-
regulated ECM molecules. Interestingly, we detected distinct effects depending on the cell 
type used, confirming that it is essential to differentiate between the cell types of the 
compartments of the lung. While an inhibition of TGF-ȕ signaling led to a tremendous 
upregulation of elastin and tenascin N in alveolar epithelial cells (MLE-12), the gene 
expression of these molecules was either unaffected in fibroblasts (NIH/3T3) or even down-
regulated in murine endothelial cells. Moreover, we observed a marked effect of the inhibition 
of the TGF-ȕ signaling on ECM-metabolizing enzymes: MMP-2 as well as TIMP-2 were 
dramatically decreased in NIH/3T3, whereas the expression of MMP-9 was unchanged and 
even increased in MLE-12. In summary, these data demonstrate that the expression of genes 
encoding ECM components is regulated by an inhibition of the TGF-ȕ signaling. In addition, 
these results suggest that there is a causal link between the inhibited TGF-ȕ activity in lungs 
and the perturbed ECM as well as the altered pulmonary structure subsequent to IUGR.  
Despite regulation of ECM composition and metabolism, TGF-ȕ signaling has further vital 
functions in the process of alveolarization, such as proliferation and cell differentiation of 
type II pneumocytes (254, 255). Our study shows that in lungs of IUGR rats the decreased 
activation of the TGF-ȕ system is accompanied by reduced expression and cleavage of 
caspase-3 and consistently by reduced cleavage of Poly(ADP-ribose)-Polymerase 1 (PARP). 
These findings indicate disturbed apoptotic processes. Furthermore, these results are endorsed 
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by the fact that caspase-3 is a downstream molecule of the TGF-ȕ system (256), whereby 
TGF-ȕ signaling has potent antiproliferative and pro-apoptotic effects on epithelial cells (251, 
252, 257, 258).  
 
Interstingly, in our study the mRNA expression of tgfbr3 is significantly upregulated in IUGR 
lungs at P1. Based on the fact that the soluble type III receptor could competitively inhibit 
TGF-ȕ binding to the transmembrane receptors (211, 224-226), an increased expression of 
tgfbr3 could have additional inhibitory effect on the TGF-ȕ signaling subsequent to IUGR and 
thereby contribute to the observed altered pulmonary structure. In addition, another group 
postulates that TGF-ȕ receptor III (TȕRIII) could act as a protective factor in apoptotic 
processes in cardiac fibroblasts by negative regulation and inhibition of TGF-ȕ signaling 
(259).  
In conclusion, the data presented here suggest that IUGR affects lung structure and lung 
function by at least two functional consequences: 1) IUGR attenuates TGF-ȕ signaling after 
IUGR which leads to a dysregulated expression of ECM and ECM-remodeling components, 
and 2) IUGR decreases apoptosis in the lung. These mechanisms significantly contribute to 
the altered lung development and impaired lung function after IUGR. The amenability of 
these pathways to genetic and pharmacological manipulation could provide alternative 
avenues for the therapy of IUGR-associated lung disease.  
 
3.2.  Inflammatory Response in the Lung Subsequent to IUGR and Early 
Postnatal Hyperalimentation2  
 
We demonstrated that IUGR decreases the activity of TGF-ȕ signaling in the lung subsequent 
to IUGR. Furthermore, these findings were accompanied by perturbed expression of key 
molecules of the ECM as well as decreased apoptosis in the lung and thereby contributing to 
the pathomechanisms of IUGR-associated lung disease. Interestingly, TGF-ȕ does not only 
regulate ECM and apoptosis, but has also anti-inflammatory function in the lung. However, 
the underlying molecular mechanisms of IUGR-associated lung disease still remain unclear. It is 
intriguing though, that the impact of pulmonary inflammation as a potential link between IUGR 
                                                 
2
 This section of the discussion is predominantly extracted of the publication of Alejandre-Alcazar et al., Journal 
of Molecular Medicine, 2012 
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and pulmonary disease has not been addressed to date. Therefore, we aimed to explore the 
inflammatory processes as well as ECM over time, starting at P1 and terminating at P70.  
In line with human studies as well as animal studies (8, 260), we show increased airway 
hyperresponsiveness in former IUGR rats. Based on the fact, that enhanced deposition and a 
deregulated expression of ECM is associated with obstructive lung disease (261, 262), as well as 
ECM composition in the lung is regulated by IUGR, we investigated the expression of ECM 
components and ECM-metabolizing enzymes subsequent to IUGR over time using real-time 
PCR, western blot, immunhistochemistry and gelatine zymograph. Analyses of the results 
revealed an interesting time-dependent pattern:  at P1 we detected a decreased production of 
ECM molecules, such as collagen III and fibrillin, whereas the expression increased steadily over 
time with a significant increment at P70. Interestingly, not only the gene expression of ECM 
components was increased, but there was also a striking increment of deposition of collagen IĮ in 
the different compartments of the lung at P70, indicating profibrotic processes. These results are 
in line with experimental studies of Maritz et al. (10, 165), giving strong evidence of a 
persistently thicker blood-air barrier and thicker septa in lungs subsequent IUGR.  
The ECM is continuously metabolized and remodelled by a variety of proteases, notable among 
them the matrix-metalloproteinases (MMP) and their cognate inhibitors, tissue inhibitor of 
metalloproteinases (TIMP). Both of them are strongly expressed in rodents during lung 
development (263) and also in fibrotic processes (264) indicating thereby a pivotal role of 
matrix remodelling in the lung. In our study, we demonstrate that IUGR decreased expression 
of pro-MMP-2 at P70, assessed by gelatine zymography. In line with this deregulation, we 
detected a significantly increased expression of TIMP-1 and TIMP-2 at P70. Both findings – 
decreased synthesis of MMP-2 and increased expression of its inhibitors – indicate a 
perturbed ECM metabolism. Interestingly, an augmented deposition of collagen IĮ in the lung 
was detected by immunhistochemical analyses at the same time. To sum up, our data 
collectively suggest that IUGR swing the balance in favour of interstitial ECM deposition 
preventing thereby turnover of ECM components in the lung.  
Based on the fact, that fibrotic processes are not only characterized by increased deposition of 
ECM components, but also by increased proliferative processes, we next determined whether 
proliferation is regulated in lungs at P70 subsequent to IUGR. The gene expression p21 as well 
as the synthesis of proliferating cell nuclear antigen (PCNA) were increased at P70. Several 
studies report the impact of p21 on the regulation of cell cycle and cell ageing/senescence by 
inhibiting the activity of cyclin-dependent kinases (265). In line with the pronounced 
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proliferative state in IUGR-lungs at P70, our group demonstrated that rats following IUGR 
exhibit an increased amount of alveolar tissue and a dampened apoptosis. Thus, the findings we 
describe in both studies give a strong body of evidence that the balance between apoptosis and 
proliferation is perturbed and proliferation is favoured the more development and age proceed.  
 
It is intriguing that inflammatory response over time as a potential underlying molecular 
mechanism of perturbed tissue remodeling and subsequent fibrosis in IUGR-animals has not 
been addressed to date. Strikingly, this study clearly shows a continuously increasing 
expression of inflammatory cytokines, such as IL-6, IL-13 and plasminogen activator 
inhibitor (PAI-1), starting being markedly decreased at P1 and significantly upregulated at 
later time points (P42 and P70). There are only a few studies giving initial evidence of 
fibrosis and inflammation in other organs subsequent to IUGR (173) and the potential role of 
IL-6 in the pathomechanism (266). For example, it has been shown, that IUGR aggravates the 
course of thy1-glomerulophritis. The kidneys presented clear features of renal inflammation 
and fibrosis (173): (1) upregulated renal expression of IL-6, PAI-1 and monocyte chemotactic 
protein-1 (MCP-1), and (2) augmented deposition of ECM components. Inflammatory 
cytokines, such as IL-6, does not only mediate inflammation and subepithelial fibrosis with 
collagen deposition (267), but does also play a pivitol role in lung development. There is 
strong evidence, that IL-6 induces catch-up growth of hypoplastic lungs (233). Interestingly, 
in our study, the expression of IL-6 is significantly downregulated at the transition from 
saccular to alveolar phase at P1 – a critical and vulnerable period in lung development – and 
could thereby contribute to the deregulation of lung morphogenesis subsequent to IUGR. At 
P42 and P70, however, the expression of IL-6 is reversed: not only the expression of IL-6, but 
also the expression of other cytokines, such as IL-13, PAI-1 and tumor necrosis factor    
(TNF)-Į is significantly increased. In conclusion, our data suggest three roles of IL-6 in the 
lungs of former IUGR rats with postnatal catch-up growth: (1) a pivotal role during lung 
morphogenesis at the early stage of life (P1); (2) and inducer of catch-up growth of the lung; and 
finally (3) a pro-inflammatory and profibrotic function at P70. Therefore IL-6 may be a link 
between IUGR and the observed lung disease in former IUGR rats.  
Other central cytokines, markedly regulated in lungs subsequent to IUGR are IL-13 and PAI-1, 
both of them shown to promote fibrosis and inflammation. Zhu and colleagues (268) 
demonstrated a strong impact of IL-13 in the pathogenesis of an asthmatic phenotype. This 
cytokine was associated with mononuclear inflammation, subepithelial fibrosis, and airway 
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obstruction. In addition, PAI-1 and the plasminogen system inhibit MMPs and thereby prevents 
degradation of ECM (269). Moreover, it has been demonstrated that PAI-1-deficient mice are 
protected from bleomycin-induced pulmonary fibrosis (270).  
 
Previous studies of our group showed that IL-6 was the cytokine with the most striking 
increment in gene expression subsequent to either IUGR (173). Interestingly, IL-6 is also 
strongly elevated in the present study. However, the intracellular signaling of IL-6 via Stat3 
has not been addressed so far in lungs subsequent to IUGR and catch-up growth. Therefore, 
we analyzed the activity of Stat3 signaling over time, starting at P1 and terminating at P70, 
using western blot technique. In accordance to the IL-6 expression, the analysis of Stat3 
phosphorylation revealed a significant deregulation. Strikingly, we detected an augmentation in 
phosphorylation over time, starting with no changes at P1 and terminating with a significant 
increment on phosphorylation compared to the control group at P70. In accordance to the 
significantly increased activity of Stat3 at P70, we detected an elevated gene expression of the 
Stat3 target genes encoding TIMP-1 and activator protein (AP-1). 
In this study, we demonstrate that the increment of inflammatory response is paralleled by 
elevated expression and deposition of ECM components. In conclusion, these findings 
suggest that inflammation may be a potential underlying mechanism of the profibrotic 
pulmonary processes observed in lungs subsequent to IUGR.  
It will be promising to determine the effect of an anti-inflammatory therapy on the 
development of IUGR-associated lung diseases in further studies in order to address the 
question whether such treatment strategies may help to prevent the onset of pulmonary 
damage and improve long term lung function following IUGR.   
 
In conclusion, the present study shows that IUGR with catch-up growth leads to a dynamic 
upregulation of inflammatory cytokines in the lung and subsequent activation of intracellular 
Stat3 signaling. These pro-inflammatory processes could contribute to a profibrotic 
remodeling of ECM in the lung over time. Thus, our study does not only provide evidence to 
gain a broader understanding of IUGR in infants, but also elucidates the pathomechanistic 
aspects of IUGR-associated lung disease.  
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3.3.  Impact of Leptin and Interleukin-6 Signaling in the Kidney 
Subsequent to Early Postnatal Hyperalimentation3 
 
 
As described under 3.2. IUGR with subsequent catch-up growth leads to impaired pulmonary 
function, in particular to an airway hyperresponsiveness in later life. Focussing on the 
underlying molecular mechanism, we deciphered a vital role of an enhanced inflammatory 
response as well as profibrotic processes. However, the impact of early postnatal 
hyperalimentation (early pHA) as well as the question whether these effects are lung-specific 
remain poorly understood. Therefore, we next tested the hypothesis, that early postnatal 
hyperalimentation induced by litter size reduction leads to a deregulation of inflammatory 
response and ultimately to an impairment of renal function.  
Interestingly, clinical studies support these idea demonstrating elevated serum inflammatory 
markers in overweight children and adolescents (271), as well as in patients with CKD (272). 
Furthermore, there is arising evidence for obesity-related nephropathy in infant, adolescent 
and adult humans (273) (110) (198, 199). In accordance to these findings in humans, we 
demonstrated in our study an impairment of both glomerular and tubular function in adult rats 
at P70 subsequent to early pHA. In particular, the animals exhibited the following impairment 
of renal function: (1) decreased glomerular filtration rate, (2) proteinuria, (3) increased 
fractional sodium excretion, and (4) increased fractional potassium excretion. Note, that this 
impaired glomerular and tubular function was not accompanied by a metabolic syndrome. 
Several studies support our findings by giving evidence that obese individuals often develop 
renal dysfunction before the occurrence of diabetes and severe hypertension (200, 274). 
Adipose tissue-secreted adipocytokines, such as IL-6 and PAI-1 exert numerous inflammatory 
and atherosclerotic effects: (1) increase of sympathetic activity, (2) contribution to insulin 
resistance as well as hypertension, and (4) impairment of renal function. Moreover, there are 
also peptide hormones, such as leptin, closely linked to obesity-related diseases (275). 
Interestingly, there are several studies demonstrating not only an adipose-tissue specific but 
also an intrinsic renal synthesis (230) and function of leptin (201, 202, 229). Leptin exerts a 
variety of biological functions, notable among these profibrotic, proliferative effects (204, 
229), and stimulation of sympathetic nervous system (203). In the present study, leptin plasma 
levels were not significant elevated in the group following early pHA. However, the intrinsic 
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 This section of the discussion is predominantly extracted of the publication of Alejandre-Alcazar et al., 
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renal expression of leptin and its receptor (obRb) is strikingly upregulated after early pHA. 
Thus, intrinsic renal leptin could exhibit an auto- and paracrine effect, independent of 
circulating leptin secreted by adipose tissue. Furthermore, we detected an increased 
expression of IL-6 in the kidney of rats subsequent to early pHA.  
Both IL-6 and leptin regulate various functions within the kidney, such as renal cell 
proliferation (201, 205), differentiation, and production of components and metabolizing 
enzymes of the ECM (229, 276-278). In accordance, our study shows that an elevated 
expression of IL-6 and leptin goes along with perturbed ECM deposition and metabolism.  
Specifically, we demonstrate a decreased expression of ECM-metabolizing enzymes (TIMP-1 
and TIMP-2) and increased deposition of collagen I and collagen IV in the renal interstitium 
and glomeruli.  
The effects of IL-6 as well as of leptin are both mediated via Stat3 and Erk1/2 signaling 
pathway. Interestingly, the target genes of these signaling pathways, such as TIMP-1, TIMP-2 
(279, 280) and antinflammatory cytokines as IL-10 (281) are markedly downregulated in 
kidney homogenates subsequent to early pHA, whereas the sympathetic co-neurotransmitter 
Neurotransmitter (NPY) is strikingly upregulated (282, 283). These findings suggest an 
inhibition of the Stat3 and Erk1/2 signaling and are indeed in contrast to the detected elevated 
levels of IL-6 and leptin in the kidneys following early pHA . To gain a better understanding 
of these initially controversially data, we performed western blot analysis to determine the 
phosphorylation of Stat3 as well as of Erk1/2. These analyses revealed a strong inhibition of 
both signaling pathways subsequent to early pHA. In conclusion, the elevated intrinsic-renal 
specific leptin expression combined with an inhibition of Stat3 and Erk1/2 signaling as well 
as the increased expression of NPY indicates a peripheral leptin resistance subsequent to 
pHA. 
Neuropeptide Y does not only have orexigenic function regulating enery homoestasis, but 
does also have direct proinflammatory and renal tubular function affecting natriuresis and 
kaliuresis via NPY-receptors Y1 and Y2 (284, 285). Thus, our study suggests that NPY and 
the resulting neuro-immune interaction could enhance the inflammatory response after early 
pHA and thereby contribute to the obesity-related nephropathy. Further experiments showed a 
significant renal downregulation of the NPY-receptor 1 (Y1) and Y2 following early pHA. 
But how does an increased renal NPY expression exert an inflammatory effect via a decreased 
expression Y1 receptor? The inflammatory effects of NPY are predominantly mediated via 
Y1-receptor, which is present on the surface of macrophages and granulocytes (285-287). 
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Therefore, the renal-specific Y1-receptors might not be essential for the NPY-mediated 
inflammatory effect on renal tissue, but the Y1 receptors of both granulocytes and/or 
macrophages.   
How is intrinsic renal leptin resistance mediated without systemic hyperleptinemia and an 
underlying metabolic syndrome? There is initial evidence of an obesity-induced leptin-
independent leptin resistance (288). The underlying mechanisms are controversially 
discussed: (1) endoplasmatic reticulum stress-associated leptin resistance (289), and (2) 
inflammation (IL-6) and therefore postreceptor-mediated leptin resistance (278, 290). 
Suppressor of cytokine signaling 3 (SOCS-3) is induced by phosphorylated Stat3 via IL-6. 
Interestingly, SOCS-3 – inhibitor of Stat3 and Erk 1/2 phosphorylation – represents 
endogenous negative feedback mechanism of Stat3 signaling and is thereby thought to be 
causal for postreceptor leptin resistance (290). Therefore, we explored the SOCS-3 
localization and expression in kidney. First, we determined that SOCS-3 is strikingly 
upregulated subsequent to pHA. Interestingly, we did not detect SOCS-3 in the glomeruli. 
Consequently, based on the fact, that Stat3 and Erk1/2 signaling are not inhibited by SOCS-3 
in the glomeruli, both leptin as well as IL-6 can exert exert its glomerular proliferative effect 
subsequent to early pHA. This idea is supported by Rodrigues AL et al. (282) who 
demonstrated that pHA leads to a higher SOCS3 expression in the hypothalamus. However, 
Gomez-Guerrero et al. (291) give initial evidence that SOCS-3 reduces renal lesions in an 
animal model of diabetic nephropathy and improves thereby renal function in diabetic 
rodents. At first glance these results are in contrast to our study, but, interestingly, SOCS-3 
was not just localized in the interstitial compartment of diabetic kidneys, but also in the 
glomeruli. These facts indicate that the underlying pathomechanism of hyperglycemia-
induced renal damage is distinct to the one to pHA.  
Obesity and early pHA disrupt critical signaling pathway which have a strong regulatory 
impact on numerous biological function, such as cell proliferation, ECM composition, and 
renal function. There are numerous underlying mechanisms discussed: 1) adipocytokines (IL-
6, PAI-1) directly induce renal cell proliferation and fibrotic processes. 2) hyperleptinemia 
due to obesity and pHA stimulate sympathetic activity and thereby contributes to renal 
damage and 3) hyperleptinemia-independent intrinsic renal leptin resistance leads to increased 
expression of NPY and enhances proinflammatory processes. Furthermore, we demonstrate in 
our study an altreration of the NPY-System: we detected an increased expression of NPY and 
a decreased expression of its receptors Y1 and Y2 subsequent to pHA, potentially indicating 
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an increased sympathetic activity. In line with the deregulation of NPY we observed in our 
study a downregulation of adrenoceptors Į1a and Į1d following early pHA, whereas 
adrenoceptor ȕ1 and ȕ2 where significantly upregulated, supporting the idea of an increased 
activity of the sympathetic system after pHA.  
To sum up, early pHA contributes to impaired renal function in later life. This study presents 
evidence for (1) a role of SOCS-3 in mediating postreceptor leptin resistance, and (2) 
subsequent regulation of sympathetic activity (NPY) and inflammatory response in the 
underlying pathomechanism of pHA-induced nephropathy.  
In conclusion, this study gives an accumulating body of evidence, that the early postnatal 
period and the environmental influence, in particular nutrition has a dramatic impact not just 
on weight gain, but also on organ-specific inflammatory response and ultimately on organ 
function. A more profound understanding of the underlying mechanistic aspects of early 
postnatal hyperalimentation will ultimately allow defining more effective preventional and 
therapeutic strategies of nephropathy in childhood and beyond. 
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Intrauterine growth restriction is associated with impaired lung function in adulthood. It is unknown whether such
impairment of lung function is linked to the transforming growth factor (TGF)-b system in the lung. Therefore, we
investigated the effects of IUGR on lung function, expression of extracellular matrix (ECM) components and TGF-b signaling
in rats. IUGR was induced in rats by isocaloric protein restriction during gestation. Lung function was assessed with direct
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signaling was blocked in vitro using adenovirus-delivered Smad7. At P70, respiratory airway compliance was significantly
impaired after IUGR. These changes were accompanied by decreased expression of TGF-b1 at P1 and P70 and a consistently
dampened phosphorylation of Smad2 and Smad3. Furthermore, the mRNA expression levels of inhibitors of TGF-b signaling
(Smad7 and Smurf2) were reduced, and the expression of TGF-b-regulated ECM components (e.g. collagen I) was decreased
in the lungs of IUGR animals at P1; whereas elastin and tenascin N expression was significantly upregulated. In vitro
inhibition of TGF-b signaling in NIH/3T3, MLE 12 and endothelial cells by adenovirus-delivered Smad7 demonstrated a direct
effect on the expression of ECM components. Taken together, these data demonstrate a significant impact of IUGR on lung
development and function and suggest that attenuated TGF-b signaling may contribute to the pathological processes of
IUGR-associated lung disease.
Citation: Alejandre Alca´zar MA, Morty RE, Lendzian L, Vohlen C, Oestreicher I, et al. (2011) Inhibition of TGF-b Signaling and Decreased Apoptosis in IUGR-
Associated Lung Disease in Rats. PLoS ONE 6(10): e26371. doi:10.1371/journal.pone.0026371
Editor: Dominik Hartl, University of Tu¨bingen, Germany
Received July 18, 2011; Accepted September 25, 2011; Published October 20, 2011
Copyright:  2011 Alejandre Alca´zar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The animal experiments were in part supported by a grant to Jo¨rg Do¨tsch, Christian Plank and Wolfgang Rascher by the Deutsche
Forschungsgemeinschaft, Bonn, Germany; SFB 423, Collaborative Research Centre of the German Research Foundation: Kidney Injury: Pathogenesis and
Regenerative Mechanisms, Project B13; by a grant to Christian Plank and Miguel Angel Alejandre Alca´zar by the Erlanger Leistungsbezogene Anschubfinanzierung
und Nachwuchsfo¨rderung (ELAN) Erlangen; and by a grant to Miguel Angel Alejandre Alca´zar by Ko¨ln Fortune, University of Cologne. The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: miguel.alejandre-alcazar@uk-koeln.de
Introduction
The term fetal programming reflects the assumption that a
temporary environmental influence during intrauterine develop-
ment may lead to permanent alterations of physiological processes
later in life [1], [2], [3]. Intrauterine undernourishment can
represent such an environmental factor, leading to intrauterine
growth restriction (IUGR) and, in most cases, to low birth weight
(LBW). Furthermore, there is evidence that being born with LBW
also has an impact on lung development and function [4], [5], [6].
Organogenesis of the lung occurs in five stages: 1.) the
embryonic stage, 2.) the pseudoglandular stage, 3.) the canalicular
stage, 4.) the saccular stage, and 5.) the alveolar stage. A sixth stage
- microvascular maturation - has also been proposed [7]. The
process of lung development is highly regulated and thus
susceptible to modification by perinatal environmental conditions
[7], [8]. Consequently, disturbed intrauterine growth may induce
changes in lung structure, which predispose lungs to later disease.
Several observational studies have described decreased lung
function with reduced forced expiratory volume in one second
(FEV1) in young infants [9], in school children [10], and in young
adults born with LBW [11], [12]. The terms IUGR and ‘‘small for
gestational’’ age (SGA) are often used synonymously, but the
distinction between them is important. IUGR is the pathological
form of SGA. It affects growth and predisposes to diseases later in
life. Intrauterine protein restriction has been shown to be a reliable
animal model of IUGR [13], [14], and several animal studies
addressing structural changes of the pulmonary system have also
demonstrated reduced lung function following IUGR [15], [16],
[17].
Lung structure and function are determined during early and
late lung development [18], [19], [20]. While the pathogenic
processes leading to IUGR-associated lung disease have not yet
been elucidated, extracellular matrix (ECM) and its maintenance
during alveolarization is thought to play a pivotal role in disease
pathogenesis [21], [22]. Disruption of critical signaling pathways
may be involved [19], [23], including signaling by the transform-
ing growth factor (TGF)-b superfamily [23], [24]. TGF-b signaling
is initiated by binding of TGF-b to the type II TGF-b receptor
(TbRII), which then forms a complex with either the type I
receptor (TbRI) or activin A receptor type II-like 1 (Acvrl1, also
called ALK-1). The type I receptor transmits signals within the cell
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via second-messenger Smad proteins, namely Smad1-Smad4, or
by Smad-independent pathways [25]. TGF-b signaling is also
regulated by Smad6 and Smad7, inhibitory Smads which
antagonize TGF-b signaling. Several studies have indicated that
TGF-b signaling plays a critical and finely tuned role in
pulmonary branching and alveolarization [18], [23], since TGF-
b ligands inhibited airway branching in vitro [26], [27].
Furthermore; abrogation of TGF-b signaling by genetic ablation
of TbRII [28], Smad2, Smad3 or Smad4 enhanced lung
branching in vitro [29]. Consistent with these observations,
overexpression of Smad7 promoted lung branching [30]. Howev-
er, conditional overexpression of the TGF-b1 gene in the mouse
lung during the postnatal period disrupts lung development [31].
Interestingly, Smad3 deficiency in mice results in progressive
airspace enlargement with age [32]. These studies implicate TGF-
b signaling as a regulator of lung branching and alveolarization.
Together with reports that TGF-b might be associated with fetal
growth in pregnancy [33], they have led us to hypothesize that
IUGR due to protein restriction during gestation may influence
TGF-b signaling and contribute to impaired lung function and
structural changes in later life.
Methods
Induction of intrauterine growth restriction
All procedures performed on animals were done in accordance
with the German regulations and legal requirements and were
approved by the local government authorities (Regierung von
Mittelfranken, AZ # 621-2531.31-11/02 and AZ # 621-2531.31-
14/05).
Adult and neonatal Wistar rats were housed in humidity- and
temperature controlled rooms on a 12:12-h light-dark cycle.
IUGR in rats was induced as previously described [14]. In brief,
virgin female Wistar rats were obtained from our own colony.
Dams were time-mated by the appearance of sperm plugs, then
fed either a normal diet containing 17.0% protein (control group)
or a low protein isocaloric diet containing 8.0% protein (casein)
throughout pregnancy (IUGR group). Diets were obtained from
Altromin, Germany (# C1000, C1003). Rats delivered spontane-
ously at day 23 of pregnancy. On the first postnatal day (P1) the
litters were reduced to six pups per dam. During lactation, dams
were fed standard chow. Weaning was at P23. IUGR and control
animals were sacrificed at P1 and P70 and assigned to four groups:
IUGR P1, Control P1, IUGR P70, and Control P70. Body weight
and weight of the lung were obtained immediately after sacrificing
the animals. Means 6 standard error of the mean were calculated.
Measurement of airway responsiveness
At P70, lung function was assessed by measuring respiratory
system dynamic compliance (Cdyn) with direct plethysmography
(FinePointeTM RC; Wellington, NC, USA). Cdyn is defined as a
measure of the ability of the lung to distend in response to
pressure. Decreased compliance means that a greater change in
pressure is needed for a given change in volume, as in atelectasis,
edema, fibrosis, pneumonia, or absence of surfactant. Rats were
deeply anesthetized by intramuscular injection of ketamine
(100 mg/kg body weight) and midazolame (5 mg/kg body
weight), tracheotomized and ventilated. Cdyn was measured at
baseline.
Processing of lung tissue and morphometric analysis
Following anesthesia with ketamine (100 mg/kg body weight)
and midazolame (5 mg/kg body weight) the animals were
exsanguinated by aortic transection. Neonatal animals at P1 were
euthanized by decapitation. The right lobe of the lung was
removed after ligation of the bronchus, and one portion was
immediately snap-frozen in liquid nitrogen for mRNA and protein
analysis. The left lobe was inflated via tracheotomy and pressure-
fixed at 20 cm H2O with 4% (mass/vol) paraformaldehyde, and
the trachea was ligated. Lungs and hearts were excised en bloc,
submersed in 4% (mass/vol) paraformaldehyde overnight for
paraffin embedding and sectioning as described previously [34].
Paraffin sections (1 mm) were mounted on poly-L-lysine-coated
glass slides, dewaxed with xylene (3–5 min) and rehydrated in a
graduated series of ethanol solutions (100%, 95%, and 70% (vol/
vol), finally PBS). The mean linear intercept (MLI) and septal
thickness were determined on sections stained for smooth muscle
actin and counter-stained with hematoxylin and eosin as described
previously [35], [36].
RNA extraction and real-time PCR
Total RNA was isolated from unfixed lung tissue or cultured
cells as previously described [37], followed by DNase treatment to
remove any contaminating genomic DNA. Total RNA was
screened for mRNA encoding ALK-1, ALK-5, TbRII, TbRIII,
Smad2, Smad2, Smad3, Smad4, Smad6, Smad6, Smurf2, elastin
(Eln), tenascin N (TenN), collagen I (Coll I), collagen III (Coll III),
fibrillin (Fbl), matrix metalloproteinases (MMP) 2, MMP 9, tissue
inhibitor of matrix metalloproteinases (TIMP) 1, TIMP 2,
plasminogen activator inhibitor-1 (PAI-1), surfactant protein A
(SP-A), SP-C, and SP-D. Quantitative changes in mRNA
expression were assessed by quantitative real-time PCR as
described previously [14] using the IQ TM SYBR-Green 
Supermix and a BioRad iQ5-Cycler (Bio-Rad Laboratories,
Hercules, CA, USA) or the 7500 Real-time PCR system (Applied
Biosystem, Foster City, CA, USA) [14]. In all samples, the relative
amount of specific mRNA was normalized to the ubiquitously
expressed glyceraldehyd-3-phosphat-dehydrogenase (GAPDH)
and b-actin gene. Primer pairs and TaqMan probes are listed in
Table 1. Oligonucleotides were designed with Primer Express
software (Perkin-Elmer, Foster City, CA, USA).
Protein detection by immunoblot
Frozen unfixed lung tissue was homogenized in lysis buffer as
previously described [14]. Cultures cells were harvested using a
cell scraper and lysed in the same buffer. Protein concentration
was determined with a Bio-Rad DC protein assay (Bio-Rad,
Hercules, CA). Lysates resolved on a 10% reducing SDS-PAGE
gel were transferred to a nitrocellulose membrane. Blots were
probed with the following antibodies: polyclonal rabbit-anti-rat-
phospho Smad2 (Cell Signaling, Danvers, MA, # 3101, 1:1000),
monoclonal rabbit-anti-rat-phospho Smad3 (Cell Signaling, Dan-
vers, MA, # 9520, 1:1000), polyclonal rabbit-anti-rat-Smad2/3
(Cell Signaling, Danvers, MA, # 3102, 1:1000), polyclonal rabbit-
anti-rat-Smad4 (Cell Signaling, Danvers, MA, # 9515), polyclonal
rabbit-anti-rat-Smad7 (R&D Systems, Wiesbaden, Germany,
MAB2029, 1:1000), polyclonal rabbit-anti-rat-cleaved Caspase-3
(Cell Signaling, Danvers, MA, # 9661, 1:1000), polyclonal rabbit-
anti-rat-Caspase-3 (Cell Signaling, Danvers, MA,# 9662, 1:1000),
polyclonal rabbit-anti-rat-poly (ADP-ribose) polymerase (PARP)
(Cell Signaling, Danvers, MA, # 9542, 1:2000), monoclonal
mouse-anti-rat-proliferating cell nuclear antigen (PCNA) (DAKO,
Glostrup, Denmark, Clone PC10, M0879, 1:10.000). Monoclonal
mouse-anti-rat-b-Actin (Cell Signaling, Danvers, MA, # 3700,
1:1000) served as a loading control. Anti-mouse IgG, HRP-linked
(Cell Signaling, Danvers, MA, # 7076, 1:2000), and HRP-linked
anti-rabbit IgG (Cell Signaling, Danvers, MA, # 7074, 1:2000)
were used as secondary antibodies.
TGF-b Signaling and IUGR-Associated Lung Disease
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Densitometric analysis of protein bands was performed using
Advanced Image Data Analyzer-Software (Version 4.15, Fuji
Photo Film Co., Omiyama, Japan) and Bio-Rad ImageLab
software (Bio-Rad, Munich, Germany). Band intensities from
samples were normalized for loading using the b-actin band from
the same sample.
Immunostaining of lung tissue sections
Expression of Smad molecules was assessed on 1-mm tissue
sections, prepared as described above for morphometric analysis.
Antigen retrieval and quenching of endogenous peroxidase activity
with 3% (vol/vol) H2O for 20 min was performed. Sections were
incubated with the relevant primary antibody: polyclonal rabbit-
anti-rat-phospho Smad2 (Cell Signaling, Danvers, MA, # 3101,
1:1000) or monoclonal rabbit-anti-rat-phospho Smad3 (Cell
Signaling, Danvers, MA, # 9520, 1:100). Immune complexes
were visualized with an avidin/biotin-DAB (3,39-diaminobenzi-
dine) detection system (Vector Lab, Burlingame, CA, USA). Each
slide was counterstained with hematoxylin.
Optimization of the multiplicity of infection (M.O.I.)
NIH/3T3, MLE-12 and mouse endothelial cells were seeded in
24-well tissue culture plates at a density of 16104/well, incubated
for approximately 12 h until 50% confluent, washed with PBS and
then incubated in serum-free OptiMEM medium (Invitrogen,
Darmstadt, Germany; 1000 ml per well) for 30 min at 37uC before
addition of the virus. To define the best suitable multiplicity of
infection (M.O.I.), an adenoviral LacZ vector (AdLacZ) carrying a
b-galactosidase reporter gene was used. AdLacZ was diluted in
PBS to a final concentration of 16106 plaque forming units
(p.f.u.)/ml, applied to the cells with increasing M.O.I. (10, 50, 100,
200 and 500 ml per well), follwed by incubation of the cells at 37uC
for 3 h. The volume of the culture medium was then increased by
addition of OptiMEM (1500 ml per well). After incubation for 6 h
the medium was replaced by the appropriate culture medium
containing FCS and the incubation was continued for a total of
48 h. All experiments were performed in triplicate. After 48 h of
incubation cells were fixed in 2% formaldehyde/0.2% glutaralde-
hyde for 15 min, washed with PBS supplemented with 0.02%
Nonidet P40 and analyzed for nuclear bacterial b-galactosidase
activity indicated by the characteristic blue staining in a PBS
solution containing K3Fe(CN)6 (5 mM), K4Fe(CN)6 (5 mM),
MgCl2 (2 mM), 0.02% Nonidet P40, 0.01% sodium deoxycholate
and X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside dis-
solved in N,N-dimethylformamide) at a concentration of 0.8 mg/
ml. The cells were stained overnight protected from light.
Table 1. Primer pairs and TaqMan probes used.
PAI-1 forward 59-TCCGCCATCACCAACATTTT-39
reverse 59-GTCAGTCATGCCCAGCTTCTC-39
probe 59(FAM)- CCGCCTCCTCATCCTGCCT-
AAGTTCTCT-(TAMRA)39
TGFb-1 forward 59-CACCCGCGTGCTAATGGT-39
reverse 59-GGCACTGCTTCCCGAATG-39
probe 59(FAM)-ACCGCAACAACGCAATC-
TATGACA-(TAMRA)39
tgfbr1 forward 59-ACCGCGTGCCAAATGAAGAGGAT-39
reverse 59-GGTAAACCTGATCCAGACCCTGAT-39
Tgfbr2 forward 59-GAGCAACTGCAGCGTCACC-39
reverse 59-CCAGAGTAATGTTCTTGTCGTTC-39
Tgfbr3 forward 59-CTTGACAGCAGAAACAGAGG-39
reverse 59-AAACACTTGATCTTCTCCCAC-39
Smad2 forward 59-AATTACATCCCAGAAACACCAC-39
reverse 59-TGTCCATACTTTGGTTCAACTG-39
Smad3 forward 59-CACCAGTGCTACCTCCAGTGT-39
reverse 59-TAGTGTTCTCGGGGATGGAA-39
Smad4 forward 59-CTACTTACCACCATAAC-
AGCACTACCA-39
reverse 59-GTGCTGAAGATGGCCGTTTT-39
Smad6 forward 59-CCCCCTATTCTCGGCTGTCT-39
reverse 59-TGGTGGCCTCGGTTTCA-39
Smad7 forward 59-AGATACCCGATGGATTTTCTCAAA-39
reverse 59-TCGTTCCCCCGGTTTCA-39
Smurf2 forward 59-GGTCTCAGCGACATAGAAATTACATG-39
reverse 59-TGTTGTGTTGTCCTCTGTTCATAGC-39
SARA forward 59-GCCAACGTGCCTATCCTAATTC-39
reverse 59-ACTGCCCTTTCCTGTTGTCTGA-39
Elastin forward 59-GAAAACCCCCGAAGCCCT-39
reverse 59-CCCCACCTTGATATCCCAGG-39
Tenascin N forward 59-AGGTGGACTATTACAAGCTTCGGTAT-39
reverse 59-GCAGACCGGTGATGTCATATCTAC-39
Collagen I a forward 59-AGAGCGGAGAGTACTGGATCGA-39
reverse 59-CTGACCTGTCTCCATGTTGCA-39
probe 59(FAM)-CAAGGCTGCAACCTGGA-
TGCCATC-(TAMRA)39
Collagen III forward 59-GGACCTCCTGGTGCTATTG -39
reverse 59-GAATCCAGGGATACCAGCTG-39
Fibrillin forward 59-TGCTCTGAAAGGACCCAATGT-39
reverse 59-CGGGACAACAGTATGCGTTATAAC-39
mCollagen I forward 59-TCACCTACAGCACCCTTGTGG -39
reverse 59-CCCAAGTTCCGGTGTGACTC-39
mTenascin N forward 59-AGAAGCTGAACCGGAAGTTGAC-39
reverse 59-CGTCTGGAGTGGCATCTGAAA-39
mElastin forward 59-GGCTTTGGACTTTCTCCCATT-39
reverse 59-CCACCTTGGTATCCCAGGG-39
mMMP-2 forward 59-ATGCGGAAGCCAAGATGTG-39
reverse 59-GTCCAGGTCAGGTGTGTAAC-39
mb-Actin forward 59-GACATCAGGAAGGATCTCTATG-39
reverse 59-CTTCTGCATCCTGTCAGCAA-39
SP-A forward 59-GGGATAGTAGCCATGTCACTGTGT-39
reverse 59-CGTCTGTCACATTGCACTTGATAC-39
SP-C forward 59-CCTGAGTGAACACACAGACACCAT-39
reverse 59-GTCAGGAGCCGCTGGTAGTC-39
SP-D forward 59- TAGAGGCTGCCTTTTCTCGCTAT -39
reverse 59-GCCGCCCTGAAGATTTTGT-39
TIMP-2* forward 59-TCAAAGGACCTGACAAGGACATC-39
reverse 59-CGCCTTCCCTGCAATTAGATAT-39
probe 59(FAM)-TCTACACGGCCCCCTCCTCAGCA-
(TAMRA)39
MMP-2* forward 59-CTGGAGATACAATGAAGTAAAGAAGA-
AAAT-39
reverse 59-CACGACTGCATCCAGGTTATCA-39
probe 59(FAM)-TTTCCCGAAGCTCATCGCAGA-
CTCC-(TAMRA)39
GAPDH forward 59-ACGGGAAACCCATCACCAT-39
reverse 59-CCAGCATCACCCCATTTGA-39
probe 59(FAM)-TTCCAGGAGCGAGATCCC-
GTCAAG-TAMRA)39
*TIMP-1, TIMP-2 and MMP-2 were detected by TaqMan
realtime-PCR analysis.
doi:10.1371/journal.pone.0026371.t001
Table 1. Cont.
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Infection with an adenoviral Smad7 vector
The E1A/E1B-deleted adenoviral vector AdSmad7 was diluted
in PBS to a final concentration of 16106 p.f.u./ml and applied to
the cells (NIH/3T3, MLE-12, and mouse endothelial cells) at an
M.O.I. of 100. The incubation was continued for a total of 48 h.
All experiments were performed in triplicate.
AdSmad7-infected cells were stimulated with TGF-b1 (2 ng/ml)
for 12 and 24 h. The cells were then lysed and processed for
mRNA extraction. Uninfected cells served as control.
Data analysis
The results of real-time RT-PCR were calculated based on the
DDCt method and expressed as fold induction of mRNA
expression compared to the corresponding control group (1.0-fold
induction). For quantitative immunoblot analysis densitometry was
performed and values were normalized to b-actin. Two-tailed
Mann-Whitney test and one-way ANOVA followed by a
Bonferroni post-test were used to assess the significance of
differences between IUGR and control animals at given time
points. A p value,0.05 was considered as significant. All results
are shown as means 6 standard error of the mean.
Results
Auxometry of neonatal and adult rats after IUGR
A marked effect of low protein diet during gestation on growth,
as assessed by body length and body weight, was observed
(Figure 1A). At day P1 average body weight (5.8660.092 g) of the
undernourished pups (IUGR) was significantly lower than that of
age-matched pups of mothers fed with normal protein (control
group: 4.5560.068 g). However, by P70 the IUGR group
exhibited a slightly reduced body mass (38366.32 g) in compar-
ison with the control group (41664.61 g). This difference was not
significant when tested by one-way ANOVA followed by
Bonferroni post-test (Figure 1A). Thus, low protein diet during
gestation led to IUGR without affecting survival or adult body
weight.
Lung morphology of adult rats formerly affected by IUGR
Total lung weight at P1 and P70 did not differ between IUGR
and control animals. However, alveolar development was
impaired in IUGR animals, evident by fewer and larger air spaces
(Figure 1B), compared to animals with appropriate birth weight.
The mean linear intercept (MLI) is roughly inversely proportional
to the alveolar surface (37). By P70, IUGR animals exhibited a
MLI approximately 30% lower than that of the control group. To
evaluate the interstitium and accumulation of ECM components
we assessed septal thickness. There were no differences between
IUGR and Co.
Respiratory parameters of adult rats formerly affected by
IUGR
A marked effect of IUGR on dynamic respiratory compliance
(Cdyn) was observed at P70. IUGR animals exhibited a Cdyn 40%
lower than that of age-matched controls (Figure 1C). Cdyn reflects
the elasticity and function of the pulmonary connective tissue.
Interestingly, lung compliance was significantly lower in IUGR
animals under baseline conditions.
Expression pattern of surfactant protein A (SP-A), SP-C,
SP-D
To address surface tension as a regulator of lung compliance, we
assessed mRNA expression of genes encoding surfactant protein A
Figure 1. Body weight, respiration and physiological lung
parameters of IUGR rats. A: Body weight (g) and relative lung weight
(lung weight/body weight) of rats after IUGR (white bars) and control
rats (black bars) at days P1 and P70; n = 8–15 for each bar. B:
Architectural changes in lung structure were evident in hematoxylin
and eosin-stained lung sections from IUGR rats and control rats at day
P70. Measurement of septal thickness (mm) and mean linear intercept
(MLI; mm) in IUGR rats and control rats (CO) at day P70; n = 6–10 for each
bar. C: Assessment of respiratory system compliance by whole body
plethysmography in IUGR rats (white bars) and in the control group
(CO; black bars) at P70. n = 15–17 for each bar. D: Expression pattern of
genes encoding surfactant protein A (SP-A), SP-C, and SPD. IUGR rats
(white bars) and control group (black bars). n = 6–15 for each bar. The
significance for each bar is indicated by p values, IUGR vs. Co, n.s. = not
significant; two-tailed Mann-Whitney test.
doi:10.1371/journal.pone.0026371.g001
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(SP-A), SP-C, and SP-D at P1 and P70. There was no significant
difference detectable, neither at P1 nor at P70 (Figure 1D).
Effect of IUGR on TGF-b-induced ECM proteins and
modulators of the ECM in neonatal and adult rat lungs
To address whether the dramatic alterations in dynamic
respiratory compliance (Cdyn) and respiratory system resistance
(Res) in IUGR animals are associated with altered expression of
ECM components, we assessed the mRNA levels of genes
encoding ECM molecules. Expression of collagen I, collagen III,
fibrillin (Figure 2A) and the ECM regulators MMP-9 and TIMP-1
(Figure 2B) was downregulated at the critical developmental time
point P1. In contrast, the expression of elastin (Eln), tenascin N
(TenN) (Figure 2A), as well as that of MMP-2, a regulator of ECM
remodeling enzymes, and its inhibitor TIMP-2 (Figure 2B) was
elevated. These results indicate a dysregulated composition and
remodelling of the ECM during the stage of alveolarization.
Effect of IUGR on the expression of TGF-b1 and the
methylation of CpG islands of the promoter region of
TGF- b1
To address whether the alterations in the expression of ECM
components at the critical phase of lung development at P1 are
associated with an altered expression of the growth factor TGF-b1
in the neonatal lungs of IUGR rats, we measured the expression of
the gene encoding TGF-b1 and the TGF-b responsive gene PAI-1.
Both TGF-b1 mRNA and protein were decreased in IUGR pups
at P1 (Figure 3A, Figure 3B), consistent with the downregulation of
expression of the TGF-b-responsive gene PAI-1 at P1 (Figure 3A).
TGF-b1 protein was detected at lower amounts in lungs of IUGR
animals at P70 (Figure 3B, 3C).
Next, we wanted to investigate why the expression of the ligand
TGF-b1 is changed after IUGR. Therefore we analyzed the
methylation of CpG islands in the promoter region of the TGF-b1
gene by PCR amplification of bisulfite-treated DNA, separation by
agarose gel electrophoresis, and gel extraction and purification of
the PCR products. Analysis of the PCR products did not reveal
any significant difference of methylation in lungs of IUGR rats
compared to the controls (data not shown).
Effect of IUGR on the expression of TGF-b signaling
molecules in rat lungs
Next, we assessed expression of the components of TGF-b
signaling by quantitative real-time PCR. The results demonstrate a
significant increase of the transforming growth factor receptor type
I (TbRI) and TbRIII in lungs of IUGR animals, but no changes
for TbRII at P1. At P70 the expression of the receptors did not
differ between the two groups (Figure 4A). The mRNA expression
of the regulatory Smad2 was reduced, whereas the mRNA levels of
Smad3 and Smad4 were significantly increased at P1. At P70
Smad2 expression was downregulated, while no remarkable
difference for Smad3 or Smad4 was observed (Figure 4B).
Expression of the inhibitory molecule of the TGF-b system,
Smad7, was slightly decreased and expression of Smad-specific E3
ubiquitin protein ligase 2 (Smurf2), which inhibits Smad2 and
Smad3, was significantly reduced. The expression of Smad anchor
for receptor activation (Sara) as a protein presenting Smad2 and
Smad3 to the TGF-b-receptors, was significantly increased
(Figure 4C).
Additionally, where antibodies were available, lung homoge-
nates at P1 and P70 were probed by immunoblotting to investigate
whether IUGR due to undernourishment during gestation resulted
in changes on the protein level between IUGR and control groups.
Indeed, pronounced alterations were observed for some intracel-
lular signaling components of the TGF-b system. The abundance
of co-Smad4 and of inhibitory Smad7 was decreased at P1
(Figure 5A). At P70 the expression of Smad4 was unchanged,
while expression of Smad7 was persistently downregulated
(Figure 5A). The expression of regulatory Smad2 and Smad3,
transducers of TGF-b signals, was altered neither at P1 nor at P70
(Figure 5A).
Effect of IUGR on the activity and localization of TGF-b
signaling in rat lungs
The results obtained so far indicate a regulation of the
expression of the TGF-b system due to IUGR. To further
elucidate whether the activity of TGF-b signaling was changed in
lungs of IUGR rats, we analyzed the phosphorylation of
Figure 2. Effect of IUGR on the expression of extracellular
matrix (ECM) proteins and modulators of the ECM in neonatal
rat lungs. Expression of TGF-b-regulated genes encoding elastin (Eln),
tenascin N (Ten), collagens (Coll) I, Coll III, and Fibrillin (A), and genes of
ECM modulators including matrix metalloproteinase (MMP)-2, MMP-9,
tissue inhibitor of metalloproteinases (TIMP)-1, and TIMP-2 (B) in lungs
extracted at day P1 from neonatal rats after IUGR and control rats. The
mRNA expression, illustrated as relative fold induction, was assessed by
real-time PCR. The control group was normalized to 1 as indicated by a
scattered line; n = 15 for each group. The significance for each bar is
indicated by p values, IUGR vs. Co; two-tailed Mann-Whitney test.
doi:10.1371/journal.pone.0026371.g002
TGF-b Signaling and IUGR-Associated Lung Disease
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26371
intracellular Smad2 and Smad3 by immunoblot. At P1 and P70
phosphorylation of Smad2 and Smad3 was significantly dimin-
ished (Figure 5B), indicating that the activity of TGF-b signaling
was decreased in lungs of IUGR rats.
To localize the activity of TGF-b signaling within the different
compartments of the lung we performed immunohistochemical
analysis of lung tissue at P70. Consistent with the immunoblotting
data, the phosphorylation of both Smad2 and Smad3 was less in
the bronchi and in the alveoli of lungs after IUGR (Figure 5C).
Effect of IUGR on apoptosis in neonatal and adult rat
lungs
The observed impaired pulmonary TGF-b signaling in IUGR
rats is likely to influence apoptosis and proliferation during the
vulnerable perinatal period and may thereby contribute to the
increase in alveolar surface and lung tissue in adulthood.
Therefore, we next sought to examine key markers of apoptosis
and proliferation in the developing lung at P1 and in the adult lung
at P70. We assessed expression of caspase-3 and polyclonal rabbit-
anti-rat-poly (ADP-ribose) polymerase (PARP) by immunoblot-
ting. Total caspase 3 levels were reduced in lungs of IUGR rats at
P1 at P70, whereas PCNA levels were not changed. Additionally,
cleaved caspase-3 and the cleaved fragment of PARP were
markedly diminished after IUGR at both time points, indicating
decreased apoptosis in lungs after of IUGR rats (Figure 6).
Effect of the inhibition of the TGF-b signaling by
adenoviral Smad7 on the expression of extracellular
matrix proteins
The inhibition of TGF-b signaling by AdSmad7 was confirmed
by immunoblotting of both phospho-Smad2 and phospho-Smad3.
Additionally we assessed baseline transcriptional activity of the
cells infected by AdSmad7. Accordingly, the induction of
transcription was normalized to AdSmad7/Co (Figure 7A).
To assess the impact of TGF-b signaling on the expression of
ECM components, we next performed cell culture experiments.
Phosphorylation of Smad2 and Smad3 was inhibited by infecting
NIH/3T3 cells (fibroblasts), MLE-12 epithelial cells and murine
Figure 3. Effect of IUGR on the expression of TGF-b1 in lungs of neonatal and adult rats. A: Expression of genes encoding TGF-b1 and
TGF-b-inducible plasminogen activator inhibitor-1 (PAI-1) during late lung development (day P1). The mRNA expression was assessed by quantitative
real-time PCR. The control group was normalized to 1 as indicated by a scattered line; n = 15 for each group. The significance for each bar is indicated
by p values, IUGR vs. Co; two-tailed Mann-Whitney test. B: representative immunoblots illustrating expression of TGF-b1 in lungs extracted at day P1
and P70 from rats with and without IUGR. b-actin served as loading control. Immunoblot data were quantified for both day P1 and P70; n = 6 for each
bar. The significance for each bar is indicated by p values, IUGR vs. Co; two-tailed Mann-Whitney test.
doi:10.1371/journal.pone.0026371.g003
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endothelial (mEnd) cells with a constitutively-expressing Smad7
adenoviral vector (AdSmad7). Inhibition of intracellular TGF-b
signaling led to cell type-dependent expression. Collagen I was
significantly downregulated in NIH/3T3 cells and slightly, but not
significantly in MLE-12 and mEnd cells. Messenger RNA
expression of tenascin N was slightly increased in NIH3T3 and
dramatically upregulated in MLE-12, whereas no changes could
be detected in mEnd. The expression of elastin increased strikingly
in MLE-12 cells after inhibition of the Smad-dependent pathway.
Matrix metalloproteases-2 (MMP-2) expression was not altered in
MLE-12 cells, but was down- or upregulated in NIH3T3 and
mEnd cells, respectively (Figure 7B). Taken together, these data
demonstrate a direct effect of the inhibition of TGF-b signaling by
AdSmad7 on ECM components. The results are consistent with
our in vivo data and underline the impact of a decreased TGF-b
activity on the ECM.
Discussion
Several studies have examined ECM molecules and morpho-
metric parameters of lungs after IUGR [38], but none so far has
addressed lung function and the impact of growth factors such as
TGF-b on the pulmonary system. Here, we aimed at elucidating
mechanistic clues linking IUGR and subsequent changes in the
pulmonary architecture.
Dynamic lung compliance is a dimension for the lung scaffold
and ECM, and the pulmonary ability to distend in response to
pressure. Our data demonstrate that IUGR following maternal
isocaloric protein restriction during gestation leads to a reduced
dynamic compliance. This is in line with studies demonstrating an
airway disease in former IUGR infants [12]. Further, morpho-
metric analysis at P70 revealed a decreased MLI after IUGR,
indicating an increase of alveolar tissue, whereas there was no
alteration of septal thickening. These results are in contrast to
previously reported morphometric lung analyses subsequent to
IUGR demonstrating an impaired alveolarization [16], [17].
However, those previous studies differ from our in various points:
(1) species, (2) induction of IUGR and (3) catch up growth.
Consistent with our observations, expression of both ECM
components (elastin, tenascin N, collagens I and III) and ECM
regulators (MMP-2 and TIMP-2) was markedly dysregulated. This
is in contrast to the findings of Maritz et al. [38], who reported a
lower number of alveoli per respiratory unit and thicker
interalveolar septa in IUGR lambs. In addition, we investigated
the surfactant proteins, based on the fact that lung compliance is
determined by them, but did not detect any difference. The cause
of IUGR is of utmost importance and determines the phenotype
later in life [39]. Maritz et al. used a model of placental
insufficiency, whereas the present study is based on a low protein
diet model. That may explain, at least in part, the different
observations.
How could IUGR dysregulate ECM components during lung
development? The process of alveolarization is regulated by
growth factor-mediated interaction of different cell types [18],
[19]. The TGF-b family controls cell proliferation, transformation
and apoptosis, as well as ECM deposition and remodelling [8],
[18], [19]. There are studies demonstrating that several mod-
ificators, such as RAGE-products [40] and hypoxia [41], are
involved in lung disease and regulation of TGF-b signaling.
Recent studies of our group did not indicate placental or fetal
hypoxia subsequent to IUGR induced by low protein diet during
gestation. Overexpression of TGF-b1 during gestation leads to
septal thickening and lung fibrosis [31], [42], whereas Smad3-
deficient mice develop a hypoplastic lung [32], [43]. Here we
show, for the first time, that IUGR in rats decreases pulmonary
TGF-b signaling persistently. TGF-b1 mRNA and protein levels
were reduced immediately after birth and at P70. Such persistent
changes could be the result of epigenetic modifications, for
example methylation of promoter regions (CpG islands) influenc-
ing gene expression and possibly inducing gene silencing. Some
studies revealed an effect of IUGR due to maternal protein
restriction on DNA methylation and on the expression of essential
growth or transcription factors [44], [45], [46]. We could not
Figure 4. Expression of the TGF-b signaling machinery in lungs
of neonatal and adult rats. Changes in the expression of genes
encoding components of the TGF-b signaling machinery as assessed by
real-time RT-PCR at days P1 and P70; n = 8–15 for each bar. The
significance for each bar is indicated by p values, IUGR vs. CO; two-
tailed Mann-Whitney test. A: Expression of genes encoding the TGF-b
receptors tgfbr1, tgfbr2 and tgfbr3 at P1 (white bar) and P70 (striped
bar). B: Expression of genes encoding the regulatory smad2, smad3 and
smad4 at days P1 (white bar) and P70 (striped bar). C: Expression of
genes encoding the inhibitory smad7, smurf2 and smad anchor for
receptor activation (sara) at days P1 (white bar) and P70 (striped bar).
doi:10.1371/journal.pone.0026371.g004
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detect differences between IUGR and control animals. However,
other epigenetic mechanisms of transcriptional regulation via
transcription factors may contribute to the altered TGF-b1
expression. In line with this, the phosphorylation of both Smad2
and Smad3 is significantly derogated at P1 and P70 in the rat lung.
TGF-b regulates the expression and secretion of some ECM
molecules, including collagens, fibrillin, and matrix-metabolizing
enzymes [7], [8], [47]: the MMPs and their cognate inhibitors,
TIMPs. During early and late lung development both ECM
components and MMP-2/TIMP-1 are strongly expressed in
humans [48] and mice [49], and their deposition in the ECM
and its remodeling plays a pivotal role in alveolarization. In our
study, we have illustrated that the levels of collagen I, collagen III,
and fibrillin mRNA are consistently decreased. In animal models
of arrest of alveolarization, MMP-2 is reduced and TIMP-1 is
elevated [50], [51]. In contrast to these results, we demonstrate an
increased alveolarization and alveolar mass after IUGR, and
opposing regulation of TIMP-1 and MMP-2. Additionally, we
show that inhibition of the TGF-b activity in fibroblasts by
adenoviral Smad7 leads to reduced mRNA expression of TGF-b-
regulated ECM molecules. However, it is essential to differentiate
between the cell types of the compartments of the lung: in
epithelial cells (MLE-12) inhibition of TGF-b signaling led to a
tremendous upregulation of elastin and tenascin N, whereas elastin
expression was unaffected in fibroblasts (NIH/3T3) and murine
endothelial cells, and tenascin N expression was even decreased in
murine endothelial cells. Taken together, our data in vivo and in
vitro suggest that an abnormal downregulation of pulmonary TGF-
b activity after IUGR has an impact on the composition and
function of the ECM contributing to an impaired lung function.
What other role may the TGF-b system play during lung
development in IUGR animals? Proliferation and differentiation
of type II pneumocytes are key steps in the process of
alveolarization and regulated by TGF-b [52], [53]. Our study
shows that IUGR may result in a decreased activation of the TGF-
b system accompanied by diminished expression and cleavage of
caspase-3 and reduced cleavage of PARP, indicating clearly
disturbed apoptotic processes at both time points investigated.
These findings are endorsed by the fact that caspase-3 is a
downstream molecule of the TGF-b system [54], whereby TGF-b
signaling has potent antiproliferative and pro-apoptotic effects on
epithelial cells [55], [56], [57], [58]. Moreover, we demonstrate
that tgfbr3 expression is significantly upregulated in IUGR lungs
at P1. Consistent with these results, another group postulates that
TGF-b receptor III (TbRIII) may act as a protective factor in
apoptotic processes in cardiac fibroblasts by negative regulation
and inhibition of TGF-b signaling [59]. Considering these data, it
is conceivable that diminished TGF-b signaling in lungs after
IUGR inhibits apoptosis in fibroblasts and alveolar epithelial cells,
thereby contributing to an abnormal growth of pulmonary tissue
(Figure 8).
Additionally, compensatory mechanisms occur in order to
counter-regulate the reduced phosphorylation of Smad2/3 by
downregulation of the inhibitory intracellular molecules Smad7
and Smurf2. Furthermore, phosphorylation of Smad2/3 support-
ing molecules, e.g. Sara, is upregulated indicating a compensation
for the reduced activity of the TGF-b system.
There two major reasons for IUGR: first, placental insufficiency
with a combination of hypoxemia, inflammatory reaction and
nutrient restriction, second, maternal undernourishment due to
low protein diet. Of the different animal models of IUGR, we
chose the low protein diet model in the rat, based on the fact that it
is characterized by a low birth weight, development of arterial
hypertension and pronounced responsiveness to inflammatory
Figure 5. IUGR alters expression and phosphorylation of Smad proteins in rats. A: Representative immunoblots illustrating the expression
of TGF-b-specific Smad2, Smad3, the co-Smad, Smad4, and the inhibitory Smad, Smad7, in lungs extracted at days P1 and P70 from rats with and
without IUGR. b-actin served as loading control. Immunoblot data were quantified for Smad4 and Smad7 for both days P1 and P70 (Co as black bar,
and IUGR as white bar); n = 4–6 for each bar. The significance for each bar is indicated by p values, IUGR vs. CO; two-tailed Mann-Whitney test. B: The
expression of active TGF-b signaling components in lung homogenates of rats with and without IUGR was analyzed by immunoblotting of
phosphorylated (p) and total Smad2 and Smad3. b-actin served as loading control. Immunoblot data were quantified for pSmad2 and pSmad3 for
both days P1 and P70 (Co as black bar, and IUGR as white bar); n = 4–6 for each bar. The significance for each bar is indicated by p values, IUGR vs. CO;
two-tailed Mann-Whitney test. C: Immunhistochemical localization and expression pattern of pSmad2 and pSmad3 in lungs of rats with IUGR (right
column) and without IUGR (left column). A–F: representative fields illustrating the expression and localization of pSmad2 in bronchi (A–D) and in the
alveoli (E–F) of lungs extracted on day P70. G–L: representative fields illustrating the expression and localization of pSmad3 in bronchi (G–J) and in the
alveoli (K–L) of lungs extracted on day P70. M–N: negative control.
doi:10.1371/journal.pone.0026371.g005
Figure 6. Effect of IUGR on apoptosis in lungs of rats at days P1 and P70. Apoptosis is assessed by cleaved caspase-3 and cleaved fragment
of Poly (ADP-ribose) polymerase (PARP). A: Representative immunoblots illustrating the expression of cleaved and total caspase-3, fragments of PARP
and total PARP in lung homogenates of rats with IUGR and without IUGR (Co) at day P1 (A) and P70 (B). The b-actin served as loading control; n = 4–6
for each bar.
doi:10.1371/journal.pone.0026371.g006
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processes. However, undernourishment is not the leading cause of
IUGR in the western world, but in the developing countries.
Hence, the data presented in our study may be limited to a certain
group of IUGR infants and not completely alienable to IUGR
induced by placental insufficiency. Furthermore, rat lungs at birth
are at an earlier developmental stage than lungs of human
neonates born at term and therefore comparable to preterm
infants.
Taken together, the data presented here suggest that IUGR
affects lung development and lung function by at least two
functional consequences: 1) IUGR attenuates TGF-b signaling
after IUGR which leads to a dysregulated expression of ECM and
Figure 7. Effect of the inhibition of intracellular TGF-b signaling by adenoviral Smad7 overexpression on the expression of ECM
components in vitro. A: Basal expression of components of the TGF-b signaling pathway in MLE-12 cells following infection with adenoviral Smad7
(AdSmad7) and stimulation with TGF-b1 (2 ng/ml) for either 12 h or 24 h. Representative immunoblots illustrating the expression and
phosphorylation of Smad2 and Smad3 in MLE-12 cells are shown. Changes in the basal mRNA levels of genes encoding collagen I (ColI), tenascin N
(TenN), elastin (Eln) and metallo-matrixproteinase-2 (MMP-2) in MLE-12 cells infected by AdSmad7. Data represent the mean relative fold change in
mRNA expression assessed by real-time RT-PCR in MLE-12 cells 24 h after infection with AdSmad7. B: Induction of these four genes in native
fibroblasts (NIH/3T3), alveolar cells (MLE-12) and endothelial cells (End) (black bars) and after infection with AdSmad7 (white bars) one day prior to a
stimulation with TGF-b1 (2 ng/ml) for 12 h or 24 h. Fold changes were calculated by: (DDCt adSmad7, stim/DDCt adSmad7, unstim), and (DDCt control, stim/
DDCt control, unstim), where adSmad7 denotes infection with AdSmad7; control, no infection with AdSmad7; stim, ligand-stimulated; unstim,
unstimulated. The significance for each bar is indicated by p values, AdSmad7 vs. control.
doi:10.1371/journal.pone.0026371.g007
Figure 8. The role of transforming growth factor (TGF)-b signaling in lung disease subsequent to intrauterine growth restriction
(IUGR). A proposed model depicting the effects of decreased TGF-b signaling during the development of IUGR-associated lung disease is shown.
ECM - extracellular matrix.
doi:10.1371/journal.pone.0026371.g008
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ECM-remodeling components, and 2) IUGR decreases apoptosis
in the lung. This significantly contributes to the altered lung
development and impaired lung function seen after IUGR.
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Abstract Intrauterine growth restriction (IUGR) is a risk
factor for impairment of lung function in adolescence and
adulthood. Inflammatory and proliferative processes linking
IUGR and perturbed extracellular matrix (ECM) as an under-
lying mechanism have not been addressed so far. Therefore, in
this study, we aimed to investigate the developmental regula-
tion of inflammatory and profibrotic processes in the lung
subsequent to IUGR. IUGR was induced in rats by isocaloric
protein restriction during gestation. Lung function was
assessed with direct plethysmography at postnatal day (P) 28
and P70. Lungs were obtained at P1, P42, and P70 for assess-
ment of mRNA, protein expression, immunohistochemistry,
and gelatinolytic activity. Both respiratory system resistance
and compliance were impaired subsequent to IUGR at P28
and this impairment was evenmore pronounced at P70. In line
with these results, the expression of ECM components and
metabolizing enzymes was deregulated. The deposition of
collagen was increased at P70. In addition, the expression of
inflammatory cytokines and both the activity and the
expression of target genes of Stat3 signaling were dynamically
regulated, with unaltered or decreased expression at P1 and
significantly increased expression art P70. Taken together,
these data give evidence for an age-dependent impairment of
lung function as a result of a developmentally regulated in-
crease in inflammatory and profibrotic processes subsequent
to IUGR.
Keywords Intrauterine growth restriction . Lung disease .
Inflammation . Stat3 . Airway inflammation . Airway
hyperresponsiveness
Introduction
The incidence of respiratory illness has increased during the
past several decades in many parts of the world [1]. Bron-
chial asthma is the most common chronic childhood disease
in developed countries. Its prevalence has nearly doubled
over the last 2 decades, putting a serious socio-economic
burden on the children and their families [2]. The pathogen-
esis of bronchial asthma is based on the interaction between
multiple genetic and environmental factors [3]. Prenatal and
postnatal influences, such as maternal smoking during ges-
tation and recurrent respiratory tract infections during infan-
cy can adversely affect later respiratory health [4].
Barker et al. coined the term intrauterine programming to
reflect that a temporal change in the fetal environment such
as intrauterine growth restriction (IUGR) leads to a perma-
nent change of physiological processes later in life [5, 6].
Intrauterine growth restriction affects approximately 10% of
all newborns and is a major risk factor for the development
M. A. Alejandre Alcazar (*) : S. Appel : E. Rother :C. Vohlen :
J. Dötsch
Department of Pediatrics and Adolescent Medicine,
University of Cologne,
Kerpener Strasse 62,
50937 Cologne, Germany
e-mail: miguel.alejandre-alcazar@uk-koeln.de
I. Östreicher
Department of Neonatology, Charité University Medical Center,
Berlin, Germany
C. Plank
Department of Pediatrics and Adolescent Medicine,
University of Erlangen—Nuremberg,
Nuremberg, Germany
J Mol Med
DOI 10.1007/s00109-012-0860-9
of metabolic syndrome in adulthood [5]. Furthermore, there
is an increasing body of evidence that IUGR induces
changes in the developing lung with a persisting impairment
of pulmonary structure and function [7–9]. In addition,
recent epidemiological studies have demonstrated impaired
lung function with reduced forced expiratory volume
(FEV1) in young infants following IUGR [10].
However, the molecular pathomechanisms of IUGR-
associated lung disease have not been completely clarified
so far. Several studies indicate that a severely perturbed extra-
cellular matrix (ECM) metabolism contributes to the impair-
ment of lung function and suggest a regulatory effect of IUGR
on the pulmonary structure and production of ECM compo-
nents [9, 11]. Both lung structure and function are already
determined during early and late lung development [12, 13].
Interference with the developmental program of the lung
during any of these phases may render the lung less effective
in gas exchange and more susceptible to disease. Several
experimental studies have demonstrated morphologic pulmo-
nary alterations and imbalance of ECM composition in lungs
of animals subsequent to IUGR [7, 8]. Additionally, analysis
of lung structure in intrauterine growth restricted animals
revealed an impaired development of the lung. For example,
maturation of the surfactant system is controversially dis-
cussed: there are studies reporting a delayed maturation of
the surfactant proteins subsequent to IUGR [14], whereas
other groups either state no alterations [15, 16] or increased
maturation of the surfactant proteins after IUGR [17]. In line
with this developmental deregulation, Joss-Moore et al. re-
cently suggested a pivotal role of ECM components such as
elastic fibers in the pathomechanism of IUGR-associated lung
disease [11]. Although several studies have investigated the
synthesis of pulmonary ECM and impaired lung function
associated with IUGR, the molecular mechanism linking per-
turbed ECM with IUGR remains largely unclear to date.
Interestingly, human and animal studies demonstrate a
programming of inflammatory response subsequent to IUGR
[18, 19]. In line with these observations, Plank et al. high-
lighted a predisposition of former IUGR animals for renal
fibrosis and inflammation with a strikingly upregulation of
inflammatory and profibrotic marker [Interleukin-6 (IL-6),
tumor necrosis factor α (TNF-α), transforming growth factor
β (TGF- β)] and of ECM components (collagen I and colla-
gen IV) [20]. It is intriguing though that pulmonary inflam-
matory response as a link between perturbed ECM and IUGR
has not been addressed so far. However, increased expression
of cytokines like Interleukin (IL)-13 [21] as well as deregula-
tion of ECMmetabolism [22] are known to be involved in the
progression of respiratory diseases such as asthma. Further-
more, recent studies underline the central role of IL-6, trans-
forming growth factor (TGF)β1 and plasminogen activator
inhibitor-1 (PAI-1) in the development and progression of
dysregulated ECM and fibrosis [23, 24].
In this study, we tested the hypothesis that IUGR (1)
impairs lung function in a time dependent manner, (2)
deregulates both, the expression of profibrotic markers and
formation and remodeling of the ECM, and (3) has an
impact on pulmonary inflammatory response.
Methods
Animal procedures
All procedures performed on animals were done in accor-
dance with the German regulations and legal requirements
and were approved by the local government authorities
(Regierung von Mittelfranken). Adult and neonatal Wistar
rats were housed in humidity- and temperature-controlled
rooms on a 12:12-h light–dark cycle. IUGR in rats was
induced by isocaloric low protein diet (8% versus 17%
casein) as previously described [25]. On the first postnatal
day (P1) the litters were reduced to six pups per dam.
During lactation and subsequent to weaning at P23 the
animals were fed standard chow. We only used the male
rat offspring for the experiments.
Physiological data of control animals and intrauterine
growth restricted animals
Body weight was obtained at different time points: P1, P7,
P14, P21, P42, P70 by weighing each animal, and weight
gain as fold induction in relation birth weight was calculat-
ed. Lung weight was obtained by weighing the entire lung at
P1, P21, and P70. In addition, the ratio of lung weight to
body weight was obtained. Mothers were weighed during
gestation at gestational day (G) 1, G7, G14, G21, and G23
as well as during lactation at postnatal day (P) 1, P7, P14,
and P23 (day of weaning). Means±standard error of the
mean were calculated.
Measurement of airway responsiveness
At the age of P28 and P70, airway responsiveness was
assessed by measuring respiratory system resistance (Res)
and respiratory system compliance (Cdyn) with direct pleth-
ysmography (FinePointe™ RC; Wellington, NC, USA).
Rats were deeply anesthetized by intramuscular injection
of ketamine 100 mg/kg body weight and midazolam 5 mg/
kg body weight, tracheotomised and ventilated. Res and
Cdyn were measured at baseline, and after stimulation with
methacholine, a bronchoconstrictor well established for di-
agnosis of airway hyperresponsiveness.
J Mol Med
Tissue preparation
Following anesthesia with ketamine (100 mg/kg body
weight) and midazolam (5 mg/kg body weight), the animals
were killed. Neonatal animals were euthanized by decapita-
tion. The right lobe of the lung was removed and immedi-
ately snap-frozen in liquid nitrogen. The left lobe was
inflated via tracheotomy and pressure-fixed at 20 cm H2O
with 4% (mass/vol) paraformaldehyde. Lungs were sub-
mersed in 4% (mass/vol) paraformaldehyde overnight for
paraffin embedding and sectioned as described previously
[26]. Paraffin sections (1 μm) were mounted on poly-L-
lysine-coated glass slides, dewaxed with xylene (3–5 min)
and rehydrated in a graduated series of ethanol solutions
(100%, 95%, and 70% (vol/vol), and finally PBS).
RNA extraction and real-time PCR
Total RNA was isolated from unfixed lung tissue or
cultured cells as previously described [27]. Total RNA
was screened for mRNA encoding genes listed in Table 1.
Quantitative changes in mRNA expression were assessed
by quantitative real-time PCR as described previously
[25]. In all samples, the relative amount of specific
mRNA was normalized to the ubiquitously expressed
glyceraldehyd-3-phosphat-dehydrogenase (GAPDH), β-
Actin, as well as porphybilinogen-deaminase gene. Prim-
er pairs and TaqMan probes are listed in Table 1. Oligo-
nucleotides were designed with Primer Express software
(PerkinElmer, Foster City, CA, USA).
Western blot analysis
Protein extraction, gel electrophoresis and immunoblotting
were performed as previously described [26]. Blots were
probed with the following antibodies: monoclonal mouse-
anti-rat-proliferating cell nuclear antigen (PCNA; DAKO,
Glostrup, Denmark, Clone PC10, M0879, 1:10,000), poly-
clonal rabbit-anti-rat-phospho Stat3 (Cell Signaling, # 9131,
1:1,000), and monoclonal rabbit-anti-rat-Stat3 (Cell Signal-
ing, # 9139, 1:1,000). Monoclonal mouse-anti-rat-β-Actin
(Cell Signaling, MA, # 3700, 1:1,000) served as a loading
control. Anti-mouse IgG, HRP-linked (Cell Signaling, #
7076, 1:2,000), and HRP-linked anti-rabbit IgG (Cell Sig-
naling, # 7074, 1:2,000) were used as secondary antibodies.
Histology and immunostaining
Tissue preparation was performed as described previ-
ously [27]. Sections were incubated with the rabbit-
anti-rat collagen I (1:100; Biogenesis, UK). Immune
complexes were visualized with an avidin/biotin-DAB
(3,3-diamineobenzidine) detection system (Vector Lab,
Burlingame, CA, USA). Each slide was counterstained
with hematoxylin.
Gelatin zymography
Lung homogenates were incubated with non-denaturating
sample buffer (62.5 mM Tris–HCl pH 6.8, 10% glycerol,
2% SDS, 0.0025% bromphenol blue) for 10 min at 37°C
and then loaded onto 10% SDS-polyacrylamide gels con-
taining 0.1% gelatin. Following gel electrophoresis, SDS
was removed by washing the gel once for 30 min in rena-
turation buffer (2.5% Tx-100) and once more for 30 min in
developing buffer (50 mM Tris–HCl pH 8, 0.2 M NaCl,
5 mM CaCl2, 0.02% Brij 35). Developing of the gel was
performed over night at 37°C in developing buffer. For
staining of the gel we used 0.1% Coomassie brilliant blue
in 25% isopropanol and 10% acetic acid. Imaging was
performed with the Biodoc analyze system (Biometra), and
densitometry of white bands was measured using the ImageJ
software (NIH).
Analysis of data
The results of real-time PCR were calculated based on the
ΔΔCt method and expressed as fold induction of mRNA
expression compared to the corresponding control group
(1.0-fold induction). Densitometric measurement was per-
formed and values were normalized to β-actin. Quantitative
evaluation of the immunohistochemical results was per-
formed with the MetaVue™ Imaging System. The Collagen
I positive area in a defined area (3.2 mm2) is displayed in
percent. Results are shown as means±standard error of the
mean. Two-tailed Mann–Whitney test and two-way
ANOVA followed by a Bonferroni post-test were used to
assess the significance of differences between IUGR and
control animals at given time points. A p value<0.05 was
considered as significant.
Results
Intrauterine growth retardation after low protein diet
To analyze maternal weight gain during gestation and lac-
tation we determined maternal body weight from conception
(G1) until weaning (P23; Fig. 1a, b). As expected, maternal
weight gain was reduced in low protein diet (LP) dams
compared to controls during gestation (Fig. 1a). In contrast,
during lactation when both experimental groups of dams
received standard chow, no difference in weight gain was
detectable (Fig. 1b).
The number of animals per litter between control and
IUGR dams was not different (15.3±0.9 pups in NP mothers
J Mol Med
Table 1 Designed primer pairs
and TaqMan probes used in this
study
aTIMP-1, TIMP-2, elastin, and
fibrillin were detected by SYBR
Green analysis
AP-1 Forward 5′-AAACCTTGAAAGCGCAAAACTC-3′
Reverse 5′-GTGGTTCATGACTTTCTGTTTAAGCT-3′
Probe 5′-(FAM)-CTGGCGTCCACGGCCAACATG-(TAMRA)-3′
Collagen Iα Forward 5′-AGAGCGGAGAGTACTGGATCGA-3′
Reverse 5′-CTGACCTGTCTCCATGTTGCA-3′
Probe 5′-(FAM)-CAAGGCTGCAACCTGGATGCCATC-(TAMRA)-3′
GAPDH Forward 5′-ACGGGAAACCCATCACCAT-3′
Reverse 5′-CCAGCATCACCCCATTTGA-3′
Probe 5′-(FAM)-TTCCAGGAGCGAGATCCCGTCAAG-TAMRA)-3′
PAI-1 Forward 5′-TCCGCCATCACCAACATTTT-3′
Reverse 5′-GTCAGTCATGCCCAGCTTCTC-3′
Probe 5′-(FAM)-CCGCCTCCTCATCCTGCCTAAGTTCTCT-(TAMRA)-3′
IL-6 Forward 5′-TCCAAACTGGATATAACCAGGAAAT-3′
Reverse 5′-TTGTCTTTCTTGTTATCTTGTAAGTTGTTCTT-3′
Probe 5′-(FAM)-AATCTGCTCTGGTCTTCTGGAGTTCGGTTTCTA-(TAMRA)-3′
IL-10 Forward 5′-GAAGCTGAAGACCCTCTGGATACA-3′
Reverse 5′-CCTTTGTCTTGGAGCTTATTAAAATCA-3′
Probe 5′-(FAM)-CGCTGTCATCGATTTCTCCCCTGTGA-(TAMRA)-3′
IL-13 Forward 5′-GAGCTGAGCAACATCACACAAGA-3′
Reverse 5′-TGTCAGGTCCACGCTCCAT-3′
Probe 5′-(FAM)-CAGAAGACTTCCCTGTGCAACAGCAGC-(TAMRA)-3′
MCP-1 Forward 5′-CCTCCACCACTATGCAGGTCTC-3′
Reverse 5′-GCACGTGGATGCTACAGGC-3′
Probe 5′(FAM)-TCACGCTTCTGGGCCTGTTGTTCA-(TAMRA)-3′
OPN Forward 5′-AAAGTGGCTGAGTTTGGCAG-3′
Reverse 5′-AAGTGGCTACAGCATCTGAGTGT-3′
Probe 5′(FAM)-TCAGAGGAGAAGGCGCATTACAGCA-(TAMRA)3′
P21 Forward 5′-TGTCTTGCACTCTGGTGTCTCA-3′
Reverse 5′-CGCTTGGAGTGATAGAAATCTGTTAG-3′
Probe 5′(FAM)-CCCCTGAGAGGCCTGAAGACTCCC-(TAMRA)3′
TGFβ-1 Forward 5′-CACCCGCGTGCTAATGGT-3′
Reverse 5′-GGCACTGCTTCCCGAATG-3′
Probe 5′(FAM)-ACCGCAACAACGCAATCTATGACA-(TAMRA)3′
TNF-α Forward 5′-GACCCTCACACTCAGATCATCTTCT-3′
Reverse 5′-TTGTCTTTGAGATCCATGCCATT-3′
Probe 5′(FAM)-ACGTCGTAGCAAACCACCAAGCGGA-(TAMRA)3′
Adrenoceptor β1a Forward 5′-ATCGTAGTGGGCAACGTGTTG-3′
Reverse 5′-GGGACATGATGAAGAGGTTGGT-3′
Adrenoceptor β2a Forward 5′-GGATTGCCTTCCAGGAGCTT-3′
Reverse 5′-TGTCCTACCGTTGCTGTTGCTA-3′
Collagen IIIa Forward 5′-GGACCTCCTGGTGCTATTG-3′
Reverse 5′-GAATCCAGGGATACCAGCTG-3′
Elastina Forward 5′-GAAAACCCCCGAAGCCCT-3′
Reverse 5′-CCCCACCTTGATATCCCAGG-3′
Fibrillin Ia Forward 5′-TGCTCTGAAAGGACCCAATGT-3′
Reverse 5′-CGGGACAACAGTATGCGTTATAAC-3′
TIMP-1a Forward 5′-GGATATGTCCACAAGTCCCAG-3′
Reverse 5′-CAGGGCTCAGATTATGCCAG-3′
TIMP-2a Forward 5′-GGACCTGACAAGGACATCG-3′
Reverse 5′-GATGCTAAGCGTGTCCCAG-3′
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versus 15.9±0.8 pups in LP mothers, p>0.05). At day P1
the average body weight and total lung weight of the under-
nourished pups (IUGR) was significantly lower than those
of age-matched pups of dams fed with normal protein diet
(control group; Co; Fig. 1c, e). The IUGR animals remained
growth restricted until P42 (Fig. 1c). However, by P70, the
IUGR group demonstrated a catch-up growth with an in-
creased weight gain over time (Fig. 1d) and nearly reached
the same body mass as the control group (Fig. 1c). In line
with this result, the lung also exhibited a notable catch-up
growth (Fig. 1e), so that the lung weight between IUGR and
control animals did not differ at P70 (Fig. 1e). In addition,
we calculated the ratio of lung weight to body weight at P1,
P21, and P70 to quantify relative lung weight within the two
groups and did not detect any difference at either time point
(Fig. 1f). Taken together, low protein diet during gestation
led to IUGR and reduced lung weight at birth. Postnatal
maternal alimentation with standard chow induced marked
catch-up growth of lung and body weight in the offspring
until P70.
Effects of IUGR and catch-up growth on the airway
responsiveness
Next, we investigated the effect of IUGR on lung function
over time, assessed by respiratory airway resistance (Res)
and dynamic compliance (Cdyn). A marked, but not signif-
icant effect of IUGR on both Res and Cdyn was already
observed at P28 (Fig. 2a, b), where IUGR animals exhibited
a slightly increased Res and decreased Cdyn compared to the
control group (Fig. 2a, b). To further examine whether this
altered lung function deteriorates later in adulthood and to
demonstrate that this pulmonary impairment is not just
ascribable to the differences in body weight at the time of
assessment but to the effects of IUGR and postnatal catch-
up growth, we assessed Res and Cdyn at P70 as well.
Strikingly, the Res was significantly increased in IUGR
offspring even without methacholine challenge (Fig. 2a).
In addition, the Cdyn was significantly decreased under
baseline conditions subsequent to IUGR at P70 (Fig. 2b).
However, Cdyn of IUGR animals was unaffected by
Fig. 1 Body weight, weight gain and lung weight subsequent to
IUGR. a, b Maternal weight gain (%) during gestation (a) and during
lactation (b). Body weight at gestational day (a) 1 is 100%, and at
postnatal day (P) 1, respectively. n03–5 mothers per group. Low
protein diet during gestation (LP; white bars) and normal protein diet
during gestation (NP; control group; black bars). c, d body weight (g)
(c) and body weight gain (d) of rats after IUGR obtained at postnatal
day (P) 1, P7, P14, P21, P42, and P70. Intrauterine growth restriction
(IUGR; white bars); control animals (Co; black bars). e, f: lung weight
(e) and ratios of lung weight to body weight of rats (f) after IUGR at
P1, P21, and P70. Intrauterine growth restriction (IUGR; white bars);
control animals (Co; black bars). n014–24 (from three to five different
litters) for each bar. The significance for each bar is indicated by p
values, IUGR vs. CO and LP vs. NP. n.s. not significant, **p<0.01,
***p<0.001; two-tailed Mann–Whitney test
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inhalation of methacholine, while the control group
exhibited decreased Cdyn after inhalation of methacholine
Effect of IUGR and catch-up growth on the gene expression
of adrenoceptor β1 and β2
To clarify whether altered expression of adrenoceptors as
key molecules of the sympathetic nerve system (SNS)—
known to regulate bronchoconstriction—might be responsi-
ble for the observed differences in airway responsiveness.
Therefore, we measured gene expression of both adrenocep-
tors β1 and β2 by real-time RT-PCR (Fig. 3a, b). Interest-
ingly, no difference was detectable in both genes between
IUGR and control group at P1, P42, or P70. Thus, these
results give initial evidence, that there is no regulation of
adrenoceptors after IUGR.
Effects of IUGR on the production of extracellular matrix
components and extracellular matrix metabolizing enzymes
in the lung
To address whether the dramatic impairment of lung func-
tion is associated with altered composition and production
of ECM components, we assessed the expression of genes
encoding pivotal ECM molecules over time. Starting at P1,
the expression of ECM molecules such as coll III and
fibrillin were significantly downregulated, whereas elastin
and coll Iα were markedly upregulated, indicating a dereg-
ulation of the ECM production (Fig. 4). At P42 and P70, we
observed a striking increment of the expression of coll Iα,
fibrillin, and elastin (Fig. 4). These results are in line with
the quantification of the expression of collagen Iα as a
profibrotic marker, assessed by immunostaining at P70
(Fig. 5a). We observed a considerably increased deposition
of collagen Iα in the different compartments of the lung
(Fig. 5a, b). Next, we investigated ECM turnover assessing
the expression of genes encoding the tissue inhibitors of
metalloproteinases (TIMP). Interestingly, TIMP-1 and
TIMP-2 were markedly upregulated on the mRNA level at
P70 (Fig. 5d). Additionally, we analyzed pro-MMP-2—a
target of TIMP—by gelatine zymography in total lung ho-
mogenate. In line with increased expression of TIMP-1 and
TIMP-2, the abundance of pro-MMP-2 was considerably
decreased at P70 (Fig. 5e).
In addition, we investigated the expression of genes
encoding molecules regulating cell cycle and fibrotic pro-
cess. Both, p21, a regulator of cell cycle, and AP-1, a
profibrotic transcription factor and regulator of differentia-
tion and proliferation, were significantly upregulated at P70
(Fig. 5c).
Taken together, the expression pattern and turnover of
ECM components are dynamically regulated in the lung
subsequent to IUGR, exhibiting an increased expression,
deposition and regulation of ECM molecules at P70 over
time with a concomitant increase in expression of regulators
of cell cycle and senescence.
Pro-proliferative and pro-senescence state in lungs
following IUGR and catch-up growth
To address proliferation and senescence as a feature of
fibrotic processes, we assessed the expression of PCNA by
immunoblotting. We observed an increasing expression of
PCNA in the lungs subsequent to IUGR over time (Fig. 6a,
b). To sum up, these results indicate an augmented prolifer-
ative state in the mature lung subsequent to IUGR.
Fig. 2 Effect of IUGR and catch-up growth on respiratory function,
assessment of respiratory system resistance (Res) and respiratory sys-
tem compliance (Cdyn) by whole body plethysmography subsequent to
intrauterine growth restriction (IUGR) at postnatal day 28 (P28) and
P70. Res (a) and Cdyn (b) at P28 and P70; baseline (without nebuliza-
tion), and nebulization of methacholine (two doses, 6.25 mg/ml and
12.5 mg/ml). IUGR (filled upright triangle), control (Co; filled circle).
n04–17 for each bar (from three to five different litters). The signifi-
cance for each bar is indicated by p values, IUGR vs. CO, n.s. not
significant; *p<0.05, **p<0.01, ***p<0.001; two-way ANOVA test
followed by a Bonferroni post-test (a) and two-tailed Mann–Whitney
test (b)
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Developmental changes in expression of inflammatory
cytokines subsequent to IUGR and catch-up growth
To further elucidate the underlying mechanism of impaired
lung function, including parenchyma and airways, we
assessed the expression of mRNA encoding inflammatory
(Fig. 7a) and profibrotic (Fig. 7b) cytokines over time (P1,
P42, and P70). We observed a dynamically regulated ex-
pression pattern for all analyzed molecules, including
Interleukin 6 (IL-6), IL-10, IL-13, tumor necrosis factor
alpha (TNF-α), osteopontin (OPN), monocyte chemoattrac-
tant protein 1 (MCP-1), plasminogen activator inhibitor
(PAI-1), and transforming growth factor beta 1 (TGF-β1;
Fig. 7a and b). The expression of inflammatory mediators
subsequent to IUGR was decreased at P1, either non altered
or considerably increased at P42, and even further increased
at P70. Interestingly, the mRNA expression of proinflam-
matory cytokines was already upregulated at P42 and P70.
Fig. 3 Effect of IUGR and catch-up growth on the gene expression of
adrenoceptor β1 and β2. a Expression of adrenoceptor β1 (adrb1)
during late lung development and adulthood (P1, P42, and P70). b:
Expression of adrenoceptor β2 (adrb2) at P1, P42, and P70. The
mRNA expression was assessed by quantitative real-time PCR. The
control group was normalized to 1; n06–15 for each group (from three
to five different litters). The significance for each bar is indicated by p
values, IUGR vs. Co; n.s. not significant; *p<0.05, **p<0.01, ***p<
0.001; two-tailed Mann–Whitney test
Fig. 4 Effect of IUGR on the expression of extracellular matrix
(ECM) proteins and modulators of the ECM. Expression of extracel-
lular matrix (ECM) related genes encoding collagens (Col) Iα (a), Col
III (b), elastin (c), and fibrillin (d) in lungs extracted at postnatal day 1
(P1), P42, and P70 from rats after intrauterine growth restriction
(IUGR) and control rats. The mRNA expression, illustrated as relative
fold induction, was assessed by real-time PCR. The control group was
normalized to 1; n06–15 for each group (from three to five different
litters), n.s. not significant; *p<0.05, **p<0.01; two-tailed Mann–
Whitney test
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In contrast, the abundance of IL-10 mRNA, a mediator with
anti-inflammatory effects, was decreased at P42 and un-
changed at P70 (Fig. 7a). In conclusion, we observed a
dynamic regulation of inflammatory mediators in animals
subsequent to IUGR, starting with an attenuated inflamma-
tory state at P1, and then an inversion over time to a
markedly augmented inflammatory response.
Activation of Stat3 in the lung subsequent to IUGR
and catch-up growth
To further elucidate the intracellular signaling of inflam-
matory cytokines and the activity of these signaling
pathways, we assessed the expression and activation of
Stat3 by immunoblotting (Fig. 8a and b). Consistent with
the elevated expression of IL-6, we detected an increased
phosphorylation of Stat3 at P70, whereas the phosphorylation
was unchanged at P1 and P42. Furthermore, the target genes
of Stat3, such as TIMP-1 and AP-1 were concomitantly in-
creased at P70 (Fig. 5c, d). In conclusion, the activation of the
intracellular proinflammatory cascade as represented by Stat3
phosphorylation is markedly increased in lungs at P70 subse-
quent to IUGR.
Discussion
There is increasing evidence that prenatal factors, such as
nutritional supply, permanently influence pivotal processes
of lung development and maturation of pulmonary struc-
tures [9, 10]. The pathogenic mechanisms that results in an
impairment of lung function observed in IUGR-associated
lung disease are poorly understood. Although several stud-
ies have demonstrated an important role of ECM in lung
disease subsequent to IUGR, the impact of pulmonary
inflammation as a potential link between IUGR and
Fig. 5 Effect of IUGR and catch-up growth on ECM composition. a, b
The expression of extracellular matrix (ECM) molecule collagen I (col
I) in the lung was assessed by immunohistochemistry at postnatal day
70 (P70). a Representative pictures, illustrating positive col I staining
in the alveolar septae, and in perivascular, and peribronchial tissue. b
Quantitative evaluation of the immunohistochemical results was per-
formed with MetaVue™ Imaging System. V vessel, aw airway. n04–6
for each group (from three different litters). c, d The mRNA expression
of genes encoding activator protein 1 (AP-1), p21, tissue inhibitor of
metalloproteinases 1 (TIMP-1), and TIMP-2 was assessed by real-time
PCR at P70. n06–12 for each group (from three to five different
litters). e Analysis of MMP activity in lungs. Representative gelatin
zymography of lung tissue at P70 and detection of pro-MMP2 gelat-
inolytic activity at ∼70 kDa (a). Quantification pro-MMP-2 activity at
P70. n04–6 for each group. The significance for each bar is indicated
by p values, IUGR (white bar) and control group (black bar), n.s. not
significant; *p<0.05, **p<0.01, ***p<0,001; two-tailed Mann–Whit-
ney test
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pulmonary disease has not been addressed to date. In
this study, we aimed to examine the inflammatory pro-
cesses as well as ECM over time, starting at P1 and
terminating at P70.
In line with a report by Joyce et al. [28], our study shows
airway hyperresponsiveness following IUGR. Obstructive
lung diseases are associated with an enhanced deposition
and a deregulated expression of ECM components [21].
Fig. 6 Effect of IUGR and catch-up growth on proliferation. a, b
Representative immunoblots of proliferating cell nuclear antigen
(PCNA) (a) and the quantification of the expression by densitometric
analysis (b) at postnatal day 1 (P1), P42, and P70, using constitutively
expressed β-actin as loading control. The significance for each bar is
indicated by p values, intrauterine growth restriction (IUGR; white bar)
and control group (black bar); n.s. not significant; *p<0.05, **p<0.01;
two-tailed Mann–Whitney test, n04–6 for each group (from three to
five different litters)
Fig. 7 Effect of IUGR and catch-up growth on the expression of
proinflammatory and profribrotic cytokines in the lung. a Expression
of proinflammatory genes encoding Interleukin-6 (IL-6), IL-13, tumor
necrosis alpha (TNF-α), and IL-10 during late lung development and
adulthood (P1, P42, and P70). b Expression of profibrotic genes
encoding osteopontin (OPN), monocyte chemottractant protein 1
(MCP-1), transforming growth factor beta (TGF-β), TGF-β1, and
plasminogen activator inhibitor-1 (PAI-1) at P1, P42, and P70. The
mRNA expression was assessed by quantitative real-time PCR. The
control group was normalized to 1; n06–15 for each group (from three
to five different litters). The significance for each bar is indicated by p
values, IUGR vs. Co; n.s. not significant; *p<0.05, **p<0.01, ***p<
0.001; two-tailed Mann–Whitney test
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Pulmonary structure and ECM have been previously inves-
tigated and demonstrated to be affected by intrauterine
growth restriction. How are the ECM components regulated
over time subsequent to IUGR? Experimental studies
revealed a dysregulated lung development [7] and altera-
tions of lung structure [8] in adult animals subsequent to
IUGR induced by placental insufficiency. Similarly, a very
recent study of our group demonstrated that rats following
IUGR exhibit an increased mean linear intercept (MLI) at
P70, while septal thickness remains unaffected, indicating
an elevated amount of alveolar tissue [15]. In line with these
morphometric results, analysis of key enzymes regulating
apoptotic processes revealed a dampened apoptosis at P1.
Thus, consistent with the given dampened apoptosis during
late lung development [15], and the significantly increased
proliferative state shown in the present study, data we de-
scribe in both studies give a strong body of evidence that the
balance between apoptosis and proliferation is perturbed
and proliferation is favored the more development and age
proceed. Furthermore, the results in the present study
demonstrate a decreased production of ECM at P1 (collagen
III and fibrillin) and an increasing deposition of ECM mol-
ecules, such as collagen Iα and fibrillin at P70. Even more
interesting than the dynamic regulation of the gene expression
of ECM components is the evidence of an augmented depo-
sition of collagen Iα in the different compartments of the lung
at P70, indicating profibrotic processes. Experimental studies
of Maritz et al. [8, 29] support these profibrotic processes
shown in this study giving evidence of a persistently thicker
blood–air barrier and thicker septa. In accordance with dysre-
gulated lung morphology, we demonstrated the reduced MLI
in a previous study. Here, we show a deregulation of ECM
deposition, finally leading to loss of function and thereby to
impaired lung function. However, possibly, the profibrotic
Fig. 8 Stat3 signaling in lungs subsequent to IUGR and catch-up
growth. a Representative immunoblots, illustrating the expression
and phosphorylation of Signal transducer and activator of transcription
3 (Stat3) in lungs subsequent to intrauterine growth restriction (IUGR)
at postnatal day (P1), P42, and P70. Expression and phosphorylation of
Stat3 was assessed by immunoblot, using constitutively expressed β-
Actin as loading control. b Quantification of the expression and phos-
phorylation of Stat3 by densitometric analysis, using β-Actin as load-
ing control. The significance for each bar is indicated by p values,
IUGR (white bars) vs. CO (black bars), n.s. not significant; *p<0.05,
**p<0.01; two-tailed Mann–Whitney test, n04–6 for each group
(from three to five different litters)
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processes in our animal model with catch-up growth are in an
initial state and therefore P70 is too early for the animals to
exhibit a thickening of the septal wall. Later time points will
be essential to get a broader understanding of the dynamics
and the consequences of the deregulated ECM.
The ECM is deposited by fibroblasts and is continuously
remodeled by matrix remodeling proteases. MMP-2 and
TIMP-2 are strongly expressed in rodents during lung de-
velopment [30] and in fibrotic processes [31], indicating a
pivotal role and finely tuned regulation of matrix remodel-
ing in the lung. In our study, we have illustrated that IUGR
markedly decreased the protein expression of pro-MMP-2 at
P70. Interestingly, this deregulation was accompanied by a
significantly increased expression of the inhibitors of metal-
loproteinases, TIMP-1 and TIMP-2, and an augmented de-
position of collagen Iα in the lung. In conclusion, our data
collectively suggest that IUGR would swing the balance in
favor of interstitial ECM deposition and would prevent
turnover of ECM components in the lung. In addition, we
demonstrate an elevation of p21 at P70. Several studies
report the impact of p21 on the regulation of cell cycle and
cell aging/senescence, by inhibiting the activity of cyclin-
dependent kinases [32]. Regulation of p21 expression is
mediated by various pathways, such as Stat-signaling [33],
activated by inflammatory cytokines.
It is intriguing that inflammatory response over time and
pulmonary inflammation as a potential pathomechanism for
impaired regulation of tissue remodeling and subsequent
fibrosis in IUGR animals has not been addressed to date.
First, we chose to quantify mRNA expression of several
genes encoding cytokines known to have an important im-
pact on inflammatory processes. Strikingly, this study clear-
ly reveals a continuously increasing expression of
inflammatory cytokines, such as IL-6, IL-13 and PAI-1,
starting being markedly decreased at P1 and significantly
upregulated at later time points (P42 and P70). These find-
ings are in line with studies demonstrating a predisposition
for fibrosis and inflammation in other organs subsequent to
IUGR [20] and the notable role of IL-6 in the pathomechan-
ism of fibrosis [34]. For example, Plank et al. illustrated the
devastating course of thy1-glomerulophritis in IUGR-rats
with clear features of renal inflammation and fibrosis [25].
Consistent with these results, the renal expression of IL-6,
PAI-1, and MCP-1 was dramatically upregulated and the
kidneys displayed an increased deposition of ECM in a rat
model of glomerulonephritis following IUGR [25]. Howev-
er, inflammatory cytokines, such as IL-6, are not just crucial
for inflammatory processes but also for normal lung devel-
opment. Interestingly, we demonstrated a significant down-
regulation of IL-6 at the transition from saccular to alveolar
phase at P1. The diminished abundance of IL-6 at this
crucial stage of late lung development may contribute to
the deregulation of lung morphogenesis. The evidence that
IL-6 mediates the catch-up growth of hypoplastic lungs [35]
demonstrates its impact on lung development and underlines
our idea. At P42 and P70, however, the picture is reversed:
the expression of IL-6, IL-13, PAI-1, and TNF-α is signif-
icantly increased. Airway overexpression of IL-6 contrib-
utes to subepithelial fibrosis with collagen deposition [36].
The elevated expression of IL-6 could be a link to the
observed catch-up growth in animals subsequent to IUGR
in our model. Zhu and colleagues [37] showed in mice that
an overexpression of IL-13 in the lungs causes an asthmatic
phenotype with mononuclear inflammation, subepithelial
fibrosis, and airway obstruction. Furthermore, Hattori and
colleagues [38] demonstrated that PAI-1-deficient mice are
protected from bleomycin-induced pulmonary fibrosis. PAI-
1 and the plasminogen system play an important role in
airway remodeling by inhibiting MMP and therefore pre-
venting degradation of ECM as it is seen in asthmatic lung
diseases [39]. To highlight the incremental inflammatory
response induced by IUGR, we analyzed the intracellular
signaling of several cytokines, focusing on the Stat3 path-
way and its target genes, such as TIMP-1 and AP-1. The
decision to focus on Stat3 signaling was based two crucial
findings in our group: first, previous studies of Plank et al.
demonstrated in an experimental model of glomerulonephri-
tis that IUGR aggravates the course of the disease and led to
fibroproliferative processes, impairment of renal function
and increased inflammatory response. Interleukin-6 (IL-6)
was the cytokine with the most striking increment in gene
expression [25]. Interestingly, this cytokine is also elevated
in the present study. Furthermore, the downstream pathway
of IL-6 is Stat3-mediated. Second, very recent experiments
from our group focusing on renal endocrine function subse-
quent to catch-up growth show also a strong increment in
IL-6 gene expression. In accordance with these findings
investigation of Stat3 signaling in the present study demon-
strates a significant deregulation. Strikingly, we detected an
augmentation in phosphorylation over time, starting with no
changes at P1 and terminating with a significant increment
on phosphorylation compared to the control group at P70.
The fact that the increment of inflammatory response is
paralleled by elevated expression and deposition of ECM
components is especially interesting and leads to the as-
sumption that inflammation may be a potential underlying
mechanism of the profibrotic pulmonary processes. Further-
more, this study demonstrates that pulmonary impairment
subsequent to IUGR is accompanied by postnatal catch-up
growth. This may represent an additional pathogenetic fac-
tor for the impairment of the lung seen in our animals.
However, that cannot be completely clarified in our study
and require further experiments.
The impact and the underlying mechanisms of increased
inflammatory response in IUGR-associated lung disease
remains poorly understood. Epigenetics is one of the key
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mechanisms widely discussed and increasingly recognized
in the broad field of developmental programming. Several
studies demonstrated persistent changes in methylation of
promoter regions of crucial developmental genes following
fetal and postnatal programming, ultimately leading to phys-
iological dysfunction [40–43]. In the present study, expres-
sion of numerous cytokines is increased in lungs after
IUGR. Before addressing epigenetics, it will thus be crucial
to identify the key player in mediating the observed inflam-
matory response. Intensive research is encouraged to delin-
eate the underlying mechanism and to find treatment
strategies to improve or even prevent lung diseases caused
by IUGR. It will be promising to determine the effect of an
anti-inflammatory therapy on the development of IUGR-
associated lung diseases in further studies in order to address
the question whether such treatment strategies may help to
prevent the onset of pulmonary damage and improve long
term lung function following IUGR.
Taken together, the present results demonstrate that
IUGR impairs lung function, leads to a dynamic upregula-
tion of inflammatory signaling and subsequently to a profi-
brotic remodeling of ECM over time. Thus, this study does
not only contribute to a better general understanding of
pathological consequences in the increasingly important
clinical group of IUGR infants, but also elucidates the
pathomechanistic aspects of IUGR-associated lung disease.
This will ultimately allow defining more effective preven-
tive and therapeutic strategies of pulmonary disease.
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Abstract
Background. Intrauterine growth restriction (IUGR) is
associated with an increased risk of renal diseases in
adulthood. However, while low-birth-weight-infants
often undergo accelerated postnatal growth, the impact
of postnatal environmental factors such as nutrition and
early postnatal stressors on renal development and func-
tion remains unclear. In this context, Neuropeptide Y
(NPY) may act as a critical factor. NPY is a sympathetic
coneurotransmitter involved in blood pressure regulation
and tubular function. Yet, little is known about the ex-
pression and function of endogenous NPY in the kidney
and the functional relevance for the transmission of per-
sistent postnatal-induced effects.
Methods. (1) IUGR was induced inWistar rats by isocaloric
protein restriction in pregnant dams. (2) Litter size was
reduced to 6 (LSR6) or 10 (LSR10)male neonates. To differ-
entiate the effect of postnatal nutrition and stressors, we addi-
tionally included home-cage-control animals without any
postnatal manipulation. Animals were sacriﬁced at Day 70.
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Results. Litter size reduction (LSR) to 6 but not IUGR
increased messenger RNA expression of endogenous
NPY and down-regulated the NPY-receptors Y1 and Y2.
Furthermore, dipeptidylpeptidase IV (DPPIV)—an enzyme
that cleaves NPY—was decreased after LSR. Expression
and the phosphorylation of mitogen-activated protein
kinase 42/44 (intracellular signalling pathway of the
receptor Y1) were altered. An impaired renal function
with pronounced kaliuresis and natriuresis was observed
at Day 70 after LSR.
Conclusions. Postnatal nutrition and stressors such as LSR
lead to dysregulated signalling of NPY. These data dem-
onstrate that factors in the early postnatal environment ex-
ert important changes in the tubular function, which may
predispose to corresponding pathology.
Keywords: NPY, NPY receptor Y1; Kaliuresis; Natriuresis; postnatal
enviroment; IUGR
Introduction
Epidemiological studies have shown an association
between low-birth-weight (LBW) and an increased risk
of cardiovascular and renal diseases [1–6]. Several animal
models have replicated the consequences of intrauterine
growth restriction (IUGR). IUGR was induced either by
protein restriction during gestation [7] or by uterine artery
ligature [8]. Barker et al. [9, 10] coined the concept of
‘perinatal programming’ postulating that early perinatal
events predispose for diseases in later life. However, epi-
demiological data have revealed that LBW itself is not the
only factor that predisposes for diseases in later life. The
mechanisms by which the pre- and postnatal environment
programmes renal function are still unclear [11–14].
Newborns with LBW undergo early postnatal over-
nutrition. Enhanced early nutrition of LBW infants may
be adverse for the postnatal development of the kidney
and hypertension [15]. The sympathetic nerve system
(SNS) among other systems plays a pivotal role in the
development of renal hypertension and tubular function
[16, 17]. Data from Va´sa´rhelyi [18] show an association
between LBW and natriuresis in later life. Lenaerts et al.
and McDonough [16, 19, 20] indicate a role of the SNS in
the aetiology of increased renal sodium excretion. The role
of the early postnatal stressors, such as litter size reduction
(LSR), in the development of hypertension and imbalance
of renal homoestasis has not been addressed so far. Neuro-
peptide Y (NPY) is a 36 aminoacid coneurotransmitter,
which affects renal function in several direct and indirect
ways. It is released from renal sympathetic nerves [21–23]
and acts directly via NPY-receptors, especially Y1 and Y2
on renal tubules leading to alterations of intrarenal tubular
transport processes and renin release [24]. It has been
shown that NPY regulates natriuresis, diuresis [25–27]
and kaliuresis via the NPY-receptor Y1 [26, 28, 29].
NPY-receptor Y1 is a G-Protein-coupled receptor, trans-
ducing extracellular stimuli into intracellular signals. One
intracellular signalling pathway which plays a pivotal role
is the mitogen-activated protein kinase (MAPK) 42/44 [30]
and an activation of Na1-K1-ATPase [28, 31, 32]. G-pro-
tein receptors activate the phosphorylation of MAPK 42/
44. Activated MAPK 42/44 pathway has been reported to
regulate Na1/Pi cotransporter in the renal tubuli and to
control the activity of the Na1-K1-ATPase. Initial evi-
dence for a role of endogenous NPY in the regulation of
renovascular function has come from studies on reserpi-
nized pigs [32]. In addition, several studies demonstrate
that NPY inhibits renin release and lowers plasma renin
activity [26, 33–35] via Y1-receptor [26, 35, 36]. Renin,
as part of the Renin-Angiotensin-Aldosterone-System
(RAAS) plays a pivotal role in the regulation of natriuresis
and kaliuresis.
Studies in rats show that neonatal perturbations can
exert a signiﬁcant behavioural and biological effect,
which translates into various adaptational changes within
the adult animal [37–39]. Most studies have focused on
early stressors such as maternal deprivation, neonatal han-
dling and infection [40–42]. They agree that such early
life events alter among others, NPY release and signal
transduction [43–46]. Therefore, the aim of this study
was to investigate the effects of altered prenatal and early
postnatal management on renal function in later life and to
elucidate the possible associated alterations of endoge-
nous NPY-system.
Materials and methods
Animal procedures
All procedures performed on animals were done in accordance with
guidelines of the American Physiological Society and were approved
by the local government authorities (AZ # 621-2531.31-11/02 and AZ
# 621-2531.31-14/05; Regierung von Mittelfranken). Virgin female
Wistar rats were obtained from our own colony and were housed in a
room maintained at 22  2C, exposed to a 12-h dark/light cycle. The
animals were allowed unlimited access to standard chow (#1320; Altro-
min, Lage, Germany) and tap water. Two simultaneous sets of experi-
ments, completely independent from each other were performed. The
ﬁrst included pre- and postnatal nutritional interventions, the second
was restricted to postnatal interventions only.
(1) Intrauterine growth restriction (IUGR) was induced in Wistar rats by
isocaloric protein restriction in pregnant dams as previously described
[7]. They were fed either a normal protein (Co) diet containing 17.0%
protein (casein) or a low-protein (IUGR) isocaloric diet containing
8.0% protein (casein) throughout pregnancy. Rats delivered sponta-
neously at Day 23 of pregnancy. On the ﬁrst day of life, the litters were
reduced to six male pups per dam. During lactation, dams were fed
standard chow. The offspring were nursed by their own mothers until
weaned at Day 23 to standard chow. Male animals were sacriﬁced at
Day 70 deﬁning four groups: IUGR 6 (six animals, three dams), Non
IUGR 6 (six animals, three dams), IUGR 10 (six animals, three dams)
and non-IUGR 10 (six animals, three dams).
(2) In the model of postnatal LSR, the litters were either reduced to
10 (LSR10) or 6 (LSR6) pups on the ﬁrst day of life. Each group
(LSR6 and LSR10) was formed of males from three to ﬁve different
litters. During lactation, rat mothers were fed standard chow. The
weaning was at Day 23 after birth. We included home-cage-control
(HCC, mean litter size of 16) animals without any postnatal
manipulation during lactation, rat mothers were fed standard chow.
After weaning, animals were equally fed ad libitum with standard
chow. HCC, LSR10 and LSR6 animals were sacriﬁced at Day 70 of
life deﬁning three groups: HCC (ﬁve animals, three dams), LSR10
(ten animals, four dams), LSR6 (eight animals, three dams).
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Physiological data of animals after IUGR and/or LSR
Body weight (gram) and body length (centimeter) was obtained at different
time points: birth, Day 23 and Day 70 by weighing each animal. Body
length was obtained by measuring from nose to anus and tail length begin-
ning at tail insertion at birth.
Metabolic studies
Metabolic studies including standardized analyses of renal function were
performed at the age of 70 days. The following protocol was carried out at
each time point: 24 h before sacriﬁce, the animals were housed individu-
ally in a metabolic cage for 24 h allowing exact quantiﬁcation of food and
water intake as well as urine excretion. Next, a retro-orbital blood sample
of 2 mL was collected at the end of the 24-h period. Haemoglobin, potas-
sium and sodium concentration in plasma were analysed. Fractional ex-
cretion of sodium (FeNa) and fractional excretion of potassium (FeK) was
calculated:
FeNa ð%Þ : ðurine-sodium3plasma creatinineÞ
=ðplasma-sodium3urine creatinineÞ;
FeK ð%Þ : ðurine-potassium3plasma creatinineÞ
=ðplasma-potassium3urine creatinineÞ:
Tissue preparation
At Day 70, the experiment was terminated as previously described [7].
Then, the kidneys were excised and a portion was immediately placed
frozen in liquid nitrogen. For histology, another portion of renal tissue
was ﬁxed in 4% paraformaldehyde in phosphate-buffered saline (PBS; 20
Table 1. Designed primer pairs and TaqMan probes used in this study
NPY Forward 5#-AGCAGAGGACATGGCCAGATAC-3#
Reverse 5#-TGAAATCAGTGTCTCAGGGCTG-3#
Probe 5#-(FAM)-CAATCTCATCACCAGACAGAGATATGGCAAGA-(TAMRA)-3#
Y1 Forward 5#-CCACCTCACGGCCATGAT-3#
Reverse 5#-TGGAAATTTTTGTTCAGGAATCC-3#
Probe 5#-(FAM)-TCCACCTGCGTCAACCCCATCTTTTA-(TAMRA)-3#
Y2 Forward 5#-GGTGAGTTGCCCCCTGATC-3#
Reverse 5#-ACCACCTGCACCTCAACCA-3#;
Probe 5#-(FAM)-AGCCGGAGCTCATAGACAGCACCAA-(TAMRA)-3#
Renin Forward 5#-ACCAGGGCAACTTTCACTACGT-3#
Reverse 5#-GAGACCCCCTTCATGGTGATC-3#
Probe 5#-(FAM)-AGCATCAGCAAGGCCGGCTCC-(TAMRA)-3#
MCR Forward 5#-CCAAGGTACTTCCAGGATTTAAAAAC-3#
Reverse 5#-AACGATGATAGACACATCCAAGAATACT-3#
Probe 5#-(FAM)-TGCCTCTCGAGGACCAAATCACCCT-(TAMRA)-3#
ATR1a Forward 5#-TCACAGTGTGCGCGTTTCAT-3#
Reverse 5#-TGGTAAGGCCCAGCCCTAT-3#
Probe 5#-(FAM)-TGAGTCTCGGAATTCGACGCTCCC-(TAMRA)-3#
ATR1b Forward 5#-TTCTGCTCACGTGTCTCAG-3#
Reverse 5#-GATGATGCAGGTGACTTTGG-3#
Probe 5#-(FAM)-TGAAGTCTCGCCTCCGCCGC-(TAMRA)-3#
GAPDH Forward 5#-ACGGGAAACCCATCACCAT-3#
Reverse 5#-CCAGCATCACCCCATTTGA-3#
Probe 5#-(FAM)-TTCCAGGAGCGAGATCCCGTCAAG-TAMRA)-3#
b-Actin Forward 5#-TGAGCTGCCTGACGGTCAG-3#
Reverse 5#-TGCCACAGGATTCCATACCC-3#
Probe 5#-(FAM)-CACTATCGGCAATGAGCGGTTCCG-(TAMRA)-3#
Fig. 1. Physiological data of animals with LSR to either 10 or 6. (A) Body weight (g) and (B) body length (cm) per week from birth until Week 3.
Animals after LSR to 6 (LSR6, inverted triangles) have in the ﬁrst 3 weeks after birth an increased body weight gain compared to animals with LSR to 10
(LSR10, triangles). At Weeks 2 and 3, the group with LSR6 has a signiﬁcant increased body weight per week compared to the control group with LSR10
(*P < 0.05, ***P < 0.001; two-way ANOVA test and Bonferroni correction).
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Fig. 2. Continues
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mM Tris–Cl, 137 mM NaCl; pH7.6). Electrolytes in serum and urine
samples were analysed with the automatic analyser Integra 800 (Roche
Diagnostics, Mannheim, Germany).
RNA extraction and real-time polymerase chain reaction
RNA extraction and quantitative real-time reverse transcription–
polymerase chain reaction (RT–PCR) analysis was performed as
described previously [7] for NPY, NPY-receptor Y1 (Y1), Y2, mineral
corticoid receptor (MCR), renin, angiotensin receptor (ATR) 1a and
ATR1b. The results were conﬁrmed by normalization to ‘housekeeping
genes’ b-actin and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). Primer pairs and TaqMan probes used are listed in Table 1.
Unless otherwise indicated, the oligonucleotides for each gene investi-
gated were designed as previously described [7].
Protein isolation and immunoblotting
Protein extraction from rat kidneys, gel electrophoresis and immunoblot-
ting were performed as described previously [47]. Blots were probed with:
rabbit anti-phospo-p42/44 MAPK (Thr202/Tyr204) (catalogue number
4370, 1:1000; Cell Signalling Technology, New England Biolabs, Frank-
furt, Germany), p42/44 MAPK (catalogue number 9102, 1:1000; Cell
Signalling, New England Biolabs), mouse anti-5E8 (DPPIV) (catalogue
number HM3021, 1:625; Cell Sciences, Canton, MA), while goat anti-
b-actin (designated I-19, catalogue number SC-1616, 1:1000; Santa Cruz
Biotechnology, San Francisco, CA) served as loading control. Horseradish
peroxidase-conjugated anti-rabbit (catalogue number 7074, 1:1500; Cell
Signalling Technology, Minneapolis, MA) and anti-goat (catalogue num-
ber 305-035-045, 1:1500; Jackson ImmunoResearch Laboratories, Suf-
folk, UK) was used with a dilution 1:1500. Densitometric analysis of
the bands was performed using Advanced Image Data Analyzer-Software
(Version 4.15; Fuji Photo Film Co., Omiyama, Japan) and normalized to
total amount of b-actin per lane. Pixel densities were corrected for back-
ground staining in the same ﬁlm.
Immunohistochemistry
Immunohistohemistry was performed as previously described [7, 47]. The
expression was assessed with rabbit anti-NPY (catalogue number NA1233,
1:100; Biotrend, Cologne, Germany), goat anti-NPY-receptor 1 (catalogue
number Cs21990, 1:400; Santa Cruz Biotechnology, San Francisco),
sheep anti-11b-hydroxysteroid dehydrogenase Type 2 (11b-HSD2)
(catalogue number AB1296, 1:200; Chemicon) and mouse anti-smooth
muscle actin (catalogue number M0851, 1:200; Dako). Immune complexes
were visualized with ﬂuorescent secondary antibodies: Cy3 goat anti-rabbit
(catalogue number 111-166-003, 1:400; Jackson ImmunoResearch Labora-
tories), Alexa 488 donkey anti-goat (catalogue number A11055, 1:400;
Invitrogen, Karlsruhe, Germany) and Cy2 donkey anti-mouse (catalogue
number 715-226-150, 1:400; Jackson ImmunoResearch Laboratories). Cell
nuclei were labelled with 4#,6-diamidino-2-phenylindole (DAPI) (catalogue
number D1306, 1: 1000; Invitrogen).
For the immunohistochemical analysis of DPPIV, the sections were
treated as previously explained. After quenching of endogenous peroxidase
activity with 1.5% (vol/vol) H2O2 (35%), 20% methanol and 0.1 M PBS for
20 min at room temperature, sections were incubated with blocking buffer
(catalogue number AL120R500; DCS, Hamburg, Germany) for 45 min at
room temperature. The expression was assessed with mouse anti-5E8
(DPPIV) (catalogue number HM3021, 1:100; Cell Sciences, Canton,
MA). Immune complexes were visualized with an avidin/biotin-DAB
(3,3#-diaminobenzidine) detection system (Vector Lab, Burlingame,
CA, USA).
Tissue-speciﬁc DPPIV-like enzymatic activity
Synthesis of the histochemical substrate H-Gly-L-Pro-1-hydroxy-4-
naphthylamide hydrochloride as well as histochemistry were conducted
as previously described [48]. As a further control for speciﬁcity and in
addition to the use of DPPIV-deﬁcient animals, this histochemical activity
assay was also performed using a DPPIV-speciﬁc inhibitor, which was
added to the incubation solution in a ﬁnal concentration of 2 lM. Light
microscopy investigations were carried out on a Nikon Eclipse 80i micro-
scope (Nikon GmbH, Duesseldorf, Germany) and representative pictures
were taken with a MicroFire digital microscope camera (Optronics,
Goleta, CA).
Analysis of data
The results of RT–PCR were calculated based on the DDCt method as
described in detail previously [7] and expressed as fold induction of
mRNA expression compared to the corresponding control animal groups.
Mean mRNA expression in control animals was deﬁned as 1.0-fold
induction. For quantitiative immunoblot analysis, a densitometry was
performed normalized to b-actin of the same animal probe.
Two tailed Mann–Whitney test, one-way analysis of variance
(ANOVA) test, two-way ANOVA test, Bonferroni correction test and
Dunnett’s test were used to test signiﬁcance at the given time points.
A P-value <0.05 was considered signiﬁcant. The procedures were carried
out using the GraphPad Prism software (Version 4.0; GraphPad Software,
San Diego, CA). Values are displayed as means  standard deviations of
the mean.
Results
Localization of NPY, NPY-receptor Y1 and DPPIV in the
kidney
NPY and Y1-receptor localization in the kidney. NPY
and Y1-receptor were detected in both the renal cortex
and renal medulla. NPY is localized perinuclear and in
the cytoplasm (Figure 2A and B). Both NPY (Figure 2A
and B) and Y1-receptor (Figure 3A) were colocalized with
11b-HSD, a marker of distal tubuli and collecting ducts of
the renal cortex and renal medulla. Y1-receptor was ob-
served in the cytoplasm and in the membrane of the cells
of the distal and collecting renal duct (Figure 3A).
NPY and Y1-receptor are colocalized in the kidney. NPY
and Y1-receptor were detectable in both the cells of the
distal and the collecting ducts of the kidney. A coimmu-
nostaining demonstrated a colocalization of NPY and Y1 in
the tubuli of the renal cortex (Figure 4A) and in the renal
medulla (Figure 4B).
NPY and Y1-receptor are colocalized in the macula
densa. NPY was determined in the tubuli of the renal
cortex and medulla by immunoﬂuorescence. Furthermore,
it was demonstrated that NPY is localized adjacent to the
macula densa, characterized by a positive staining for actin
and loco tipico in the renal morphology (Figure 5A). NPY
and Y1-receptor are colocalized adjacent to the glomeruli
in loco tipico of the macula densa (Figure 5B).
Fig. 2. Continued
Fig. 2. Localization of NPY in the kidney and the expression pattern after LSR and IUGR. (A and B) NPY expression is assessed with immunﬂuor-
escence (green), nuclear staining with DAPI (blue). The localization of NPY in the kidney was shown with colocalization with 11b-HSD (red) as a
marker for the distal (A) and the collecting tubuli (B) of the kidney. Colocalization of NPY and 11b-HSD in the distal and collecting tubuli is yellow
(merge). (C and D) Two independent animal models: one model of IUGR combined with LSR (C) and the other, postnatal LSR only (D). The mRNA
expression of NPY is not altered after IUGR (IUGR6 versus non-IUGR6, IUGR10 versus non-IUGR10) but signiﬁcantly increased after LSR to 6 (non-
IUGR-6 versus non-IUGR10, IUGR6 versus IUGR10; LSR6 versus LSR10 and HCC) (C and D). (*P< 0.05, ***P< 0.001; one-way ANOVA test and
Bonferroni correction).
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Localization and activity of DPPIV in the kidney. DPPIV
was detectable in the cortex (Figure 6A), in renal ducts
(Figure 6A) and in glomeruli (Figure 6A). However, there
was almost no staining for DPPIV in the medulla (Figure
6A). The activity of DPPIV was detected in the cortex and
proximal and distal tubuli (Figure 6B).
IUGR and the NPY-system
IUGR after low protein diet. Low protein (LP) diet of the
pregnant dams (IUGR) led to a reduction of birth weight,
body length and tail length at birth in their offspring in
comparison to litters of normal protein-fed dams (non-
IUGR). The offspring of the IUGR mothers reached body
weight of the offspring of non-IUGR mothers until Day 42.
At Day 70, body weight was comparable in both groups
(Table 2). In respect to LSR, we demonstrated a signiﬁcant
increased weight gain in the group with a litter size of 6
(IUGR 6, non-IUGR 6) compared to the group with a litter
size of 10 (IUGR 10, non-IUGR 10) at Day 23. At Day 70,
body weight was comparable in all groups (non-IUGR10,
non-IUGR6, IUGR10 and IUGR6) (Table 2).
mRNA expression of endogenous NPY in the kidney
after IUGR. No alteration of the mRNA expression of
NPY was detected after IUGR without LSR (IUGR10)
at Day 70 (Figure 2C). Whereas both the group after
IUGR with LSR to 6 (IUGR6) and the group without
IUGR but with LSR to 6 (non-IUGR6) showed an up to
10-fold induction of the mRNA expression of NPY com-
pared with the analogical groups with LSR to 10 (IUGR10;
non-IUGR10) at Day 70 after birth (Figure 2C).
The impact of postnatal LSR on the NPY-system and
tubular function
Physiological data after LSR: diuresis, haemoglobin,
plasma sodium and plasma sodium. Diuresis was not
altered after LSR. It was comparable in LSR6, LSR10
and HCC. Neither alterations in the haemoglobin
Fig. 3. Localization of Y1-receptor in the kidney and the expression pattern of Y1- and Y2-receptor after LSR. (A) Y1-receptor expression is assessed with
immunﬂuorescence (green), nuclear staining with DAPI (blue). The renal localization of Y1-receptor is shown by colocalization with 11b-HSD (red) as a
marker for the distal and collecting tubuli of the kidney. Colocalization of Y1-receptor and 11b-HSD in the distal and collecting is yellow (merge). (B) The
mRNA expression of Y1- and Y2-receptor is signiﬁcantly decreased after LSR to 6. (*P< 0.05, **P< 0.01; one-way ANOVA test and Bonferroni correction).
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concentration nor hyponatraemia or hypokalaemia were
detectable after LSR (Table 3).
Excreted fraction of the ﬁltered sodium (FeNa) and
potassium (FeK) after LSR. Metabolic studies at Day
70 demonstrated that both FeNa and FeK (Figure 8C
and D) are signiﬁcantly increased after LSR6 (postnatal
LSR, no IUGR). Additionally, absolute excretion of potas-
sium (Figure 8B) but not absolute excretion of sodium
(Figure 8A) was increased after LSR, while diuresis was
only slightly affected (Table 3). Natriuresis and kaliuresis
was linked to postnatal LSR only.
Postnatal growth after LSR. No differences in body
weight or body length were observed at Day 1 after birth.
Reduction of the litter size to 6 (LSR6) led to a signiﬁcant
increased weight in weeks 2 and 3 after birth (Figure 1A),
whereas body length was not different from the control
group (LSR10) (Figure 1B).
mRNA expression of NPY and NPY-receptor 1 and 2
(Y1, Y2) after LSR. A LSR to 6 after birth led to an up to
10-fold induction of the mRNA expression of NPY (Figure
2D) and a decrease of the Y1-and Y2-mRNA at Day 70 of
life (Figure 3B) compared to the control group (HCC) and,
respectively, LSR10.
mRNA expression of renin, MCR, ATR1a, ATR1b
after LSR. Renin expression is signiﬁcantly up-regulated
(Figure 5C), whereas MCR and ATR1a expression
(Figure 5C) did not change after LSR (LSR6, LSR10)
compared to the control group (HCC). ATR1b expression
was decreased after LSR to 6 compared to LSR10 and
HCC (Figure 5C).
Localization and activity of DPPIV in the kidney and
expression after LSR. Localization and activity of DPPIV
was predominantly detectable in the renal cortex and
almost not in the medulla. Protein analysis in our study
demonstrated a decrease of DPPIV expression after LSR
to 6 (LSR6) compared to the control group with LSR to 10
(LSR10) or without LSR (HCC) (Figure 6C).
MAPK 42/44 and its phosphorylation are dysregulated
after LSR. LSR6 led to decrease of phosphorylation of
MAPK 42/44 compared to the control group (LSR10,
HCC). Furthermore, an increase of total MAPK 42/44
was detected after LSR to 6 (LSR6) (Figure 7).
Discussion
This is the ﬁrst study demonstrating early postnatally ac-
quired alterations of the kidney physiology. LSR immedi-
ately after birth leads to an altered expression pattern of
endogenous NPY and NPY-receptor 1 (Y1), which is as-
sociated with an impaired tubular function resulting in
increased natriuresis and kaliuresis at Day 70 after birth. In
contrast, IUGR itself does not alter the mRNA expression of
NPY.
IUGR is associated with an increased sodium excretion
in the renal ducts after IUGR in piglets [49]. Furthermore,
LBW leads to increased sympathetic nerve trafﬁc [50].
That may be the link between low birth weight and altered
tubular function. It is well known that the postnatal envi-
ronment inﬂuences kidney development and nephron num-
ber. Bearing in mind the differences in the animal models,
Wlodek et al. [51, 52] showed that both IUGR and LSR
impair renal function in later life. Consistently, Boubred
et al. [53] showed that early postnatal overfeeding induced
Fig. 4. Colocalization of NPY and Y1-receptor in the kidney. The expression of NPY and Y1 in the kidney is demonstrated by immunoﬂuorescence.
Both Y1-receptor (green) and NPY (red) are detectable in the tubuli of both the renal cortex (A) and in the renal medulla (B). Colocalization (yellow) of
NPY and Y1-receptor is observed in the membrane of the tubuli of the renal cortex (A) and in the collecting ducts of the renal medulla (B).
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Fig. 5. Colocalization of NPY and Y1-receptor in the macula densa and dysregulation of renin after LSR. (A) Localization of NPY is assessed with
immunoﬂuorescence. NPY (green) is localized adjacent to the macula densa (red; actin-positive staining and loco tipico). Merge shows the adjacent
localization of NPY to the macula densa. Where high-magniﬁcation images (lower row) are derived from the low magniﬁcation image (upper row), the
magniﬁed area is demarcated with a solid-lined box. (B) NPY (red) and Y1-receptor (green) localization is assessed with immunoﬂuorescence. There is
co-staining adjacent to the glomerulus in loco tipico of the macula densa (yellow, arrow). (C) The mRNA expression of renin but not of MCR and ATR1a
is increased after LSR to 6 (LSR6) compared to control group without LSR (HCC). Additionally the expression of ATR1b is decreased after LSR6
compared to the control. (*P < 0.05; one-way ANOVA test and Bonferroni correction).
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by LSR in rat enhances postnatal nephrogenesis but the
blood pressure, and the glomerulosclerosis score are still
elevated. Additionally, Boubred et al. [54] demonstrated
that reduced nephron number alone due to IUGR may
not be sufﬁcient to induce physiological alterations, and
early postnatal overfeeding acts as a ‘second hit’. Our data
shows that LSR and not IUGR itself leads to increased
postnatal weight gain. Furthermore, we could demonstrate
that LSR but not IUGR is associated with an up-regulation
of the mRNA expression of NPY. Hence, there seems to be
an association between increased postnatal weight gain due
to LSR and the dysregulation of the NPY-system. There-
fore, we focused this study on the effect of LSR on the
NPY-system and renal function.
Our data demonstrate a signiﬁcant up-regulation of the
mRNA expression of NPY and a down-regulation of the
Y1- and Y2-receptor after LSR to 6. Already a litter size of
10 slightly downregulates the Y1-receptor, whereas the
Fig. 6. Protein expression of DPPIV after LSR and its activity and the localization in the kidney. DPPIV is a peptidase known to cleave peptide hormones
such as NPY. Therefore, we assessed immunohistochemistry to characterize the localization (A) and the activity (B) within the kidney. It is expressed and
active ubiquitously in the renal cortex (A,B), in the tubuli (A,B) and in the glomeruli (A,B). Almost no staining was detectable in the renal medulla (A,B).
Analysis of the protein expression was assessed with western blotting. Densitometric analysis showed a signiﬁcant down-regulation of DPPIV in the
animals with LSR to 6 (LSR6) compared with the control group without LSR (HCC) (D). (*P< 0.05; one-way ANOVA test and Bonferroni correction).
Table 2. Physiological data of IUGR animals and controls with and without LSRa
Non-IUGR 10 Non-IUGR 6 IUGR 10 IUGR 6
Birth weight (g) 6.2 6 0.43 (n ¼ 39) 5.405 6 0.403 (n ¼ 22)
Body length at birth (cm) 5.0 6 0.17 (n ¼ 39) 4.88 6 0.1 (n ¼ 39)
Tail length at birth (cm) 1.63 6 0.95 (n ¼ 39) 1.46 6 0.1 (n ¼ 39)
Body weight at weaning Day 23 (g) 51.8 6 5.8 (n ¼ 9) 69.00 6 6.1 (n ¼ 24)*** 50.95 6 6,7 (n ¼ 6) 60.97 6 3.15 (n ¼ 12)*
Body weight at Day 70 (g) 351.9 6 21.28 (n ¼ 9) 373.6 6 18.07 (n ¼ 12) 379.9 6 16.52 (n ¼ 6) 354.7 6 24.41 (n ¼ 11)
aValues are given as means 6 standard deviations. ***P < 0.001, respectively, *P < 0.05 versus non-IUGR. ***P < 0.001: non-IUGR10 versus non-
IUGR6, *P < 0.05: non-IUGR6 versus IUGR6.
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NPY-expression is not altered yet. Maybe the up-regulation
of NPY after LSR to 6 is a compensatory mechanism to the
decreased expression of the Y1-receptor.
The results demonstrated in this study show that post-
natal LSR to 6 alters tubular function. A signiﬁcant in-
crease of both natriuresis and kaliuresis was observed at
Day 70 after birth. Additionally, a slight increment of
diuresis was measured. One underlying mechanism of
renal tubular function is the RAAS. Therefore, we ana-
lysed renin, the mineralcortcoid receptor, and the angio-
tensin (AT) receptors. No changes in the group with LSR
compared to the control group without LSR were detect-
able with regard to mRNA expression of the mineralcorti-
coid receptor and AT-receptor 1a in the kidney, whereas
renin mRNA expression is increased and AT-receptor 1b
is decreased at Day 70 after birth. Renin release is regu-
lated by multiple mechanisms. Several studies describe a
direct effect of NPY on the renin release [33, 35, 36].
Consistent with the localization of NPY next to the macula
densa—shown in our study—it can directly act through a
paracrine effect on the macula densa and inﬂuence the
expression of renin. According to Aubert et al. [34]
NYP inhibits renin release in the kidney. Hence, the
RAAS activation would be suppressed and less aldoster-
one is secreted. Consequently, that leads to increased
natriuresis and decreased kaliuresis. The expression of
one of the corresponding receptors of RAAS (AT-receptor
1b) is decreased in the LSR6-group. That can be reactive
to the increased expression of renin. These ﬁndings may
have an inﬂuence on renal blood ﬂow and blood pressure.
Further studies will have to address blood pressure after
LSR. In our study, the expression of endogenous NPY
is increased and the Y1-receptor is decreased. Consistent
with the decreased expression of the Y1-receptor, we
observe less phosphorylation of MAPK42/44 due to a
reduced activation through G-protein coupled receptors.
The activity of the NPY-system through Y1-receptors
seems to be decreased. That leads to a diminished activity
of Na1-K1-ATPase and of Na1/Pi cotransporter in the
renal tubuli. In addition, these results may explain why
renin expression is not suppressed but increased. Activa-
tion of the RAAS is the consequence. That may contribute
to the increase of kaliuresis.
To demonstrate that NPY is expressed endogenously in
the renal tubular cells and not just as previously described
in the end of the sympathetic nerves, we analysed the local-
ization of NPY and Y1-receptor with a renal tubular
marker. Both NPY and Y1-receptor are localized in the
distal tubuli and collecting ducts of the renal system. We
conclude that endogenous renal NPY is expressed not just
in the end of sympathetic nerves but also and predomi-
nantly in the renal tubular cells itself and may have para-
crine effects in the kidney.
Fig. 7. MAPK 42/44 and its phosphorylation after LSR. Analysis of the phosphorylation of MAPK 42/44 and total MAPK 42/44 after LSR to 6 (LSR6)
was assessed by western blotting. Densitometric analysis demonstrated a decreased phosphorylation of MAPK 42/44, whereas the expression of total
MAPK 42/44 after LSR to 6 (LSR6) was increased. (*P < 0.05, **P < 0.01; one-way ANOVA test and Bonferroni correction).
Table 3. Physiological data of animals with and without LSR
HCC LSR10 LSR6
Diuresis (mL/24 h) 0.504 6 0.116 0.562 6 0.136 0.595 6 0.193
Haemoglobin (g/dL) 14.9 6 0.725 14.62 6 0.691 15.21 6 1.208
Na1-concentration
plasma (mmol/L)
144.0 6 4.355 138.6 6 2.970 136.4 6 1.734
K1-concentration
plasma (mmol/L)
2.602 6 0.112 2.583 6 0.366 2.807 6 0.396
2462 M.A. Alejandre Alca´zar et al.
 at U
SB
 K
oeln on M
ay 2, 2012
http://ndt.oxfordjournals.org/
D
ow
nloaded from
 
NPY is inactivated by several peptidases, one key regu-
lator is DPPIV. It is a peptidase with the capability of
hydrolyzing postproline bonds and it cleaves NPY. Some
previous studies have described an expression of DPPIV in
the kidney, but none have addressed the expression pattern
within the kidney. This study demonstrates that it is pre-
dominantly localized and active immunhistochemically in
the renal cortex, especially in renal ducts and in the glo-
meruli, and also slightly in the renal medulla. Furthermore,
DPPIV is signiﬁcantly decreased after LSR6 on protein
level. Consequently, we assume that NPY is less cleaved
in the kidney of LSR6 animals due to the insufﬁcient level
of its regulating peptidase. Hence, the NPY levels are
increased.
Additional extrarenal factors may inﬂuence renal
function and body weight, i.e. SNS or metabolic syndrome.
That may have an impact on the expression of the NPY-
system and its signalling. Further investigations are neces-
sary to elucidate these issues.
To sum up, LSR and increased postnatal weight gain
lead to increased natriuresis and kaliuresis in this animal
model. A potential underlying mechanism may be seen in
the intrinsic kidney-associated NPY-system. On the one
hand, NPY inﬂuences kaliuresis indirectly through renin
via the Y1-receptor. In addition, NPY also has a direct
RAAS-independent effect on kaliuresis and natriuresis
via Y1-/Y2-receptor. Both receptors are G-Protein-coupled
receptors acting via MAPK42/44. Due to reduced expres-
sion of Y1-receptor, its intracellular signalling through
MAPK 42/44 is signiﬁcantly decreased. The NPY-system
regulates both kaliuresis and natriuresis and may be a
potential mechanism in the tubular dysfunction after LSR.
In conclusion, we provide direct experimental evidence
in rats illustrating that tubular function is inﬂuenced by the
postnatal environment. Furthermore, this study also shows
a potential role of the endogenous NPY-system in the reg-
ulation of tubular function as well as a mediating system
transmitting early in life acquired physiological changes.
Given that the NPY-system is also amenable to pharma-
logical and genetic manipulation in the kidney, it provides a
potential target in this context.
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Early Postnatal Hyperalimentation Impairs Renal
Function via SOCS-3 Mediated Renal Postreceptor
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Pathology (K.A.), and Experimental Therapy (S.v.H.), Franz-Penzoldt Center, University Hospital Erlangen,
D-91054 Erlangen, Germany
Early postnatal hyperalimentation has long-term implications for obesity and developing renal
disease. Suppressor of cytokine signaling (SOCS) 3 inhibits phosphorylation of signal transducer
and activator of transcription (STAT) 3 and ERK1/2 and thereby plays a pivotal role in mediating
leptin resistance. In addition, SOCS-3 is induced by both leptin and inflammatory cytokines. How-
ever, little is known about the intrinsic-renal leptin synthesis and function. Therefore, this study
aimed to elucidate the implications of early postnatal hyperalimentation on renal function and on
the intrinsic-renal leptin signaling. Early postnatal hyperalimentation in Wistar rats during lacta-
tionwas inducedby litter size reductionat birth (LSR) either to LSR10or LSR6, comparedwithhome
cage control male rats. Assessment of renal function at postnatal day 70 revealed decreased glo-
merular filtration rate and proteinuria after LSR6. In line with this impairment of renal function,
renal inflammation and expression as well as deposition of extracellular matrix molecules, such as
collagen I, were increased. Furthermore, renal expression of leptin and IL-6 was up-regulated
subsequent toLSR6. Interestingly, thephosphorylationof Stat3andERK1/2 in thekidney,however,
was decreased after LSR6, indicating postreceptor leptin resistance. In accordance, neuropeptide
Y (NPY) gene expression was down-regulated; moreover, SOCS-3 protein expression, a mediator
of postreceptor leptin resistance, was strongly elevated and colocalized with NPY. Thus, our find-
ings not only demonstrate impaired renal function and profibrotic processes but also provide
compelling evidence of a SOCS-3-mediated intrinsic renal leptin resistance and concomitant up-
regulated NPY expression as an underlying mechanism. (Endocrinology 153: 1397–1410, 2012)
Childhood obesity is becoming a worldwide epidemic,with a continuous increase in prevalence that has tri-
pled in the last 3 decades (1). Projections of the Interna-
tional Obesity Task Force indicate that by 2020 the prev-
alence of childhood overweight and obesity will be more
than 35% in Europe and more than 45% in the United
States (2). Obesity entails a risk for chronic kidney disease
(CKD) (3, 4), independent of diabetes and hypertension
(5). In accordancewith these studies, the incidenceofCKD
and end-stage renal disease is increasing in our society.
Moreover, there are further sequelae of obesity, such as
cardiovascular disease (6) and inflammation. However,
these data are alarming and underline obesity being a
threat not only to adults but also to children and adoles-
cents (7, 8).
The termof fetal programmingof diseases in adulthood
was coined by Barker (9). Specifically, they postulate that
an insult, acting during a phase of sensitivity in prenatal
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period, induces physiological alterations predisposing for
disease later in life. Plagemann (10) extended the concept
of fetal programming on postnatal events, such as nutri-
tional factors. This associationwas namedmetabolic pro-
gramming and defines a basic biological phenomena that
putatively underlie relationships between nutritional ex-
periences of early life and organogenis as well as future
disease in adolescence and adulthood (10, 11). Regarding
renal development, nephrogenesis is predominantly com-
pleted prenatally in the human. However, renal matura-
tion proceeds postnatally and consists of increment of glo-
merular size together with tubular length. In accordance,
a few studies demonstrated that postnatal nutrition influ-
ences nephrogenesis and renal maturation in human and
rodents (12–14). Moreover, early postnatal hyperalimen-
tation (pHA) (15) inducedby increased food intake during
lactation period leads to metabolic programming and is
therefore known to be a risk factor for development of
obesity and obesity-related diseases (10, 11, 16).
Leptin is a 16-kDa protein, encoded by the ob gene and
mainly produced in adipocytes. In accordance, hyperlep-
tinemia is closely linked to obesity and further partially
contributes to renal damage not only due to its profibrotic
effects but also as a stimulator of the sympathetic nervous
system (SNS). Leptin-mediated sympathetic stimulation is
thought to play a pivotal role in obesity-related nephrop-
athy (1) Interestingly, recent studies have demonstrated
that placenta, skeletal muscle, and kidney are additional
sites of leptin synthesis (17, 18). Leptin exerts diverse ac-
tions (19), extending beyond those involved in regulation
of appetite and body weight. Some of these include pro-
liferation, sympathetic nervous activation, fibrosis, and
inflammation (20–22). In addition, leptin induces the syn-
thesis of TGF-1 in glomerular endothelial cells and sen-
sitizes mesangial cells to the effects of physiological levels
of TGF-1 (20, 23). In line with this, glomerular expres-
sion of type IV collagen is significantly enhanced in leptin
treated animals (24).
Leptin exerts its function via ObRb initiating tyrosine
phosphorylation by Janus tyrosine kinase 2. Phosphory-
lated Janus tyrosinekinase2 recruits signal transducer and
activator of transcription 3 (Stat3). Next, phosphorylated
Stat3 dimerizes and translocates to the nucleus regulating
gene expression (25), such as suppressor of cytokine sig-
naling 3 (SOCS-3), which acts as a leptin and IL-6 induc-
ible inhibitor of leptin signaling and thereby presents one
postreceptor cause of leptin resistance (26, 27). Further-
more, leptin regulates the expression of neuropeptide Y
(NPY) via Stat3 signaling (28, 29);NPY is a coneurotrans-
mitter of the SNS and among other functions a regulator
of inflammatory response and renal function (30) (31).
Moreover, recent studies demonstrated that early pHA
results in early onset of leptin resistance in the arcuate
nucleus (32).
However, to date, the role of intrinsic renal leptin sig-
naling and its impact on renal function subsequent to early
pHA remains to be elucidated. Therefore, here we tested
the hypothesis that early pHA contributes to impaired re-
nal function via altered intrinsic renal leptin signaling in a
rat model.
Materials and Methods
Animal procedures
All procedures performed on animals were approved by the
local government authorities (Regierung vonMittelfranken, AZ
no. 621-2531.31-11/02 andAZno. 621-2531.31-14/05).Virgin
femaleWistar rats were obtained fromour own colony andwere
housed ina roommaintainedat222C, exposed toa12-hdark,
12-h light cycle. The animals were allowed unlimited access to
standard chow (no. 1320; Altromin, Lage, Germany) and tap
water. The litter size reduction at birth (LSR) occurred at either
LSR10 or LSR6 pups on the first day of life as previously de-
scribed (30). During lactation rat mothers were fed standard
chow. The weaning was at postnatal day (P) 23. We included
home-cage control (HCC;mean litter size of 16) animalswithout
any postnatal manipulation during lactation.
HCC, LSR10, and LSR6 animals were killed at P70 defining
three groups: HCC (five animals), LSR10 (10 animals), and
LSR6 (eight animals).
Cell culture
Five different cell lines were used: 1) murine endothelial cells
(mEnd), 2) rat mesangium cells (MC), 3) human kidney cells
(HKC8), 4) murine renal cortical collecting duct cells (M1), and
5) rat pheochromocytoma cell line (PC-12). All cell lines were
maintained and passaged according to the recommendations of
the American Type Culture Collection (http://www.atcc.org).
The mEnd were kindly provided by Professor Dr. H. Schneider
(University Hospital of Erlangen).
Physiological data of animals after litter size
reduction
Body weight (grams) and body length (centimeters) were ob-
tained at five time points: birth, postnatal wk 1, wk 2, wk 3, and
wk 10 by weighing each animal. Body length was obtained by
measuring from nose to tail insertion.
Metabolic studies and physiological parameters
Metabolic studies including standardized analyses of renal
function and blood pressure were performed at the age of P70.
The following protocol was carried out at each time point: 24 h
before the animals were killed, the animals were housed indi-
vidually in a metabolic cage for 24 h, allowing exact quantifi-
cation of food andwater intake aswell as urine excretion.On the
day the animals were killed, all animals were instrumented with
femoral catheters under 5mg/kgmidazolam and 100mg/kg ket-
amine anesthesia ip for intraarterial blood pressure measure-
ments. At the end of the operation, animals were antagonized
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with 0.2 ml atipamezole (5 mg/ml; Antisedan; Pfizer GmbH,
Karlsruhe, Germany). Two hours after anesthesia, mean arterial
blood pressure was recorded on a polygraph (Hellige, Freiburg,
Germany) in conscious rats for30min in theanimals’ homecages
as described previously (33). Retroorbital blood samples of 2 ml
were obtained at the time the animals were killed. Creatinine in
serum and urine samples was analyzed with the automatic an-
alyzer Integra 800 (Roche Diagnostics, Mannheim, Germany).
Leptin ELISA
Measurement of leptin levels was performed using commer-
cial available ELISA systems (Leptin DuoSet; R&D Systems,
Minneapolis, MN) according to the manufacturer’s instruction
and as described previously (34).
Tissue preparation
The kidneys were excised and a portion was immediately
frozen in liquid nitrogen at P70. For histology, another portion
of renal tissuewas fixed in 4%paraformaldehyde in PBS (20mM
Tris-Cl; 137 mM NaCl, pH7.6).
RNA extraction and semiquantitative and real time
PCR
Total RNAwas isolated fromunfixed renal tissue or cultured
cells and semiquantitative PCRwas performed as previously de-
scribed (33), using the 7500 real-time PCR system (Applied Bio-
systems, FosterCity,CA). In all probes the relative amount of the
specific mRNA was normalized to the ubiquitously expressed
-actin and glyceraldehyde-3-phosphate dehydrogenase gene.
The primers and Taq-Man probes are listed in Table 1.
Protein isolation and immunoblotting
Protein isolation and immunoblotting were performed as de-
scribed elsewhere (30). In brief, blots were probed with the fol-
lowing antibodies: monoclonal rabbit-antirat-phospho-p42/44
MAPK (ERK1/2) (Cell Signaling, Danvers, MA; no. 4370,
1:1000), polyclonal rabbit-antirat-p42/44 MAPK (ERK1/2)
(Cell Signaling; no. 9102, 1:1000), polyclonal rabbit-antirat-
phospho-Stat3 (Cell Signaling; no. 9131, 1:1000), monoclonal
rabbit-antirat-Stat3 (Cell Signaling; no. 9139, 1:1000), poly-
TABLE 1. Designed primer pairs and TaqMan probes used in this study
Primers (5–3)
NPY Forward, AGCAGAGGACATGGCCAGATAC
Reverse, TGAAATCAGTGTCTCAGGGCTG
Probe (FAM), CAATCTCATCACCAGACAGAGATATGGCAAGA (TAMRA)
Y1 Forward, CCACCTCACGGCCATGAT
Reverse, TGGAAATTTTTGTTCAGGAATCC
Probe (FAM), TCCACCTGCGTCAACCCCATCTTTTA (TAMRA)
Leptin Forward, ATGACACCAAAACCCTCATCAAG
Reverse, TGAAGTCCAAACCGGTGACC
Probe (FAM), TCAATGACATTTCACACACGCAGTCGG (TAMRA)
ObRa Forward, TCAGAGCACCCAGGGAACC
Reverse, ATAGCCCCTTGCTCTTCATCAG
Probe (FAM), TCAGAGTCAACCCTCAGTTAAATATGCAACGCT (TAMRA)
ObRb Forward, CAGGTGTCTATCTCTGAAGTAAG
Reverse, GATAGGCCAGGTTAAGTGCAG
Probe (FAM), TCACATACAGAAATTCCCAGTGTAACAAAACC (TAMRA)
IL-6 Forward, TCCAAACTGGATATAACCAGGAAAT
Reverse, TTGTCTTTCTTGTTATCTTGTAAGTTGTTCTT
Probe (FAM), AATCTGCTCTGGTCTTCTGGAGTTCCGTTTCTA (TAMRA)
IL-10 Forward, GAAGCTGAAGACCCTCTGGATACA
Reverse, CCTTTGTCTTGGAGCTTATTAAAATCA
Probe (FAM), CGCTGTCATCGATTTCTCCCCTGTGA (TAMRA)
PAI-1 Forward, TCCGCCATCACCAACATTTT
Reverse, GTCAGTCATGCCCAGCTTCTC
Probe (FAM), CCGCCTCCTCATCCTGCCTAAGTTCTCT (TAMRA)
-Actin Forward, TGAGCTGCCTGACGGTCAG
Reverse, TGCCACAGGATTCCATACCC
Probe (FAM), CACTATCGGCAATGAGCGGTTCCG (TAMRA)
GAPDH Forward, TGTGAAGCTCATTTCCTGGTATGA
Reverse, CTCTCTTGCTCTCAGTATCCTTGCT
Probe (FAM), CCAAGGAGTAAGAAACCCTGGACCACCC (TAMRA)
Adrenoceptor 1a Forward, GCTGCTCAAGTTTTCTCGAGAGA
Reverse, AAGACCCAATGGGCATCACTAG
Adrenoceptor 1d Forward, GTCCTGCCTCTGGGCTCTCT
Reverse, GGGTAGATGAGCGGGTTCAC
Adrenoceptor 1 Forward, ATCGTAGTGGGCAACGTGTTG
Reverse, GGGACATGATGAAGAGGTTGGT
Adrenoceptor 2 Forward, GGATTGCCTTCCAGGAGCTT
Reverse, TGTCCTACCGTTGCTGTTGCTA
GAPDH, Glyceraldehyde-3-phosphate dehydrogenase.
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clonal rabbit-antirat-IL-6 (Abcam, Cambridge, UK; 6672,
1:400), andmonoclonalmouse-antirat-proliferating cell nuclear
antigen (PCNA) (Dako, Glostrup, Denmark; clone PC10,
M0879, 1:1000), and polyclonal rabbit-antirat-Socs3 (Cell Sig-
naling; no. 2923, 1:1000), whereas monoclonal mouse-antirat-
-actin (Cell Signaling; no. 3700, 1:1000) served as a loading
control. Antimouse IgG, horseradish peroxidase-linked (Cell
Signaling; no. 7076, 1:2000), and antirabbit IgG, horseradish
peroxidase-linked (Cell Signaling; no. 7074, 1:2000) were used
as secondary antibody.
Renal histology
The degree of mesangial matrix expansion and sclerosis
within the glomerulus as an indexof progressionwasdetermined
on periodic acid-Schiff-stained paraffin sections using a scoring
system [glomerulosclerosis index (GSI)] as described before (35).
Using light microscopy at a magnification of400, the glomer-
ular score (0–4) of each animal was derived as the mean of 100
randomly sampled glomeruli, and the resulting index in each
animal was expressed as a mean of all scores obtained. For eval-
uation of vascular damage, 20 vessels per kidney were randomly
sampled using hematoxylin-eosin stained sections at a magnifi-
cation of200 and graded using a semiquantitative scoring sys-
tem with a score from 0 to 4: score 0, no vascular damage; score
4, vascular fibrinoid necrosis.
Tubulointerstitial damage was assessed on periodic acid-
Schiff-stained paraffin sections at amagnification of200 using
a semiquantitative scoring system (tubulointerstitial lesion
score) (35). Here interstitial fibrosis, inflammation, tubular dil-
atation, and tubular atrophy were graded (0–3) in 20 randomly
selected fields per kidney.
All histological studies were carried out by an investigator
unaware of the experimental group to which each kidney
belonged.
Immunofluorescence
Immunostaining was assessed as previously described (30, 35).
Sectionswere incubatedwith therelevantprimaryantibody: rabbit-
C
A
B
FIG. 1. Physiological parameters after litter size reduction. A, Body weight (grams) and body length (centimeters) at postnatal wk 1, postnatal wk
2, postnatal wk 3, and postnatal wk 10. Animals after litter size reduction to 6 (LSR6, Œ) exhibit from the postnatal wk 2 forward an increased
body weight compared with either animals with litter size reduction to 10 (LSR10, f) or the HCC group (●). At postnatal wk 3 (time of weaning),
LSR6 has a significant increased weight compared with LSR6 and HCC, whereas there is no difference between LSR10 and HCC. Interestingly, at
postnatal wk 10, the difference in weight persists to be significant between both LSR6 and LSR10, and in accordance, the group LSR10 was
significantly heavier than the HCC group. With regard to body length, there was no difference between the groups detected. B, Systolic and
diastolic blood pressure (RRsyst and RRdiast) and MAP (millimeters of mercury) at P70: rats after LSR6 (white bar) exhibit a significantly decreased
RRsyst compared with LSR10 (striped bar) and HCC (black bar). Regarding RRdiast and MAP, no significance difference was measured. C, Plasma
leptin levels in the blood at P70: leptin concentrations in plasma (picograms per milliliter) were slightly elevated after LSR6 and LSR10. Significance
for each bar is indicated by P values (two way ANOVA test and Bonferroni posttest). n.s., Not significant.
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anti-NPY (Biotrend; Cologne, Germany; NA1233, 1:1000), goat
anti-NPY receptor 1 (catalog no. Cs21990; Santa Cruz Biotech-
nologies, San Francisco, CA; 1:400), rabbit-anti-leptin (Acris,Her-
ford, Germany; SP5130P, 1:50), rabbit-anti-Socs3 (Abcam, Cam-
bridge UK; ab16030, 1:100), goat-anti-Tamm-horsefall protein
(THP) (ICN Biomedical, Eschwege, Germany; 55140, 1:500),
sheep anti-11-hydroxysteroid dehydrogenase (11HSD) type 2
(Chemicon, Billerica, MA; AB1296, 1:200), mouse-anticalbindin
(Swant, Bellinzona, Switzerland; 300, 1:200). Immune complexes
were visualized with fluorescent secondary antibodies: Cy3 goat
antirabbit (catalog no. 111-166-003; Jackson ImmunoResearch,
Suffolk, UK; 1:400), Alexa 488 donkey antigoat (catalog no.
A11055; Invitrogen,Karlsruhe,Germany;1:400), andCy2donkey
antimouse (catalog no. 715-226-150; Jackson ImmunoResearch;
1:400). Cell nuclei were labeled with 4,6-diamidino-2-phenylin-
dole (DAPI; catalog no. D1306; Invitrogen; 1:1000).
Quantitative immunostaining
Tissue preparation was performed as described elsewhere
(30). Sections were incubated with the relevant primary anti-
body: rabbit-antirat-collagen I (Biogenesis; 1:100) and goat-an-
tirat-collagen IV (Southern Biotech, BIOZOL Diagnostica Ver-
trieb GmbH, Eching, Germany, AL; 1:500). Immune complexes
were visualizedwithanavidin/biotin-3,3-diamineobenzidinede-
tection system (Vector Laboratories, BIOZOLDiagnostica Ver-
trieb GmbH, Eching, Germany). Each slide was counterstained
with hematoxylin.
Quantitative evaluation of the immunhistochemical results
was performed with a MetaVue imaging system (Molecular De-
vices, Sunnyvale, CA). Collagen positive area in a defined area
(3.2 mm2) is displayed in percentage.
Analysis of data
The results of real-timeRT-PCRwere calculated based on the
change in delta delta cycle threshold valuemethod and expressed
as fold induction of mRNA expression compared with the HCC
(1.0-fold induction). Values are shown as means SEM. A two-
tailed Mann-Whitney U test, one-way ANOVA followed by a
Dunn’s test and a two-way ANOVA followed by a Bonferroni
posttest were used to test significance at the given time points. A
P  0.05 was considered as significant.
Densitometric analysis of protein bandswas performed using
Advanced Image Data Analyzer software (version 4.15; Fuji
Photo Film Co., Omiyama, Japan) and Bio-Rad ImageLab soft-
ware (Bio-Rad, Munich, Germany). Band intensities from sam-
pleswere normalized for loading using the-actin band from the
same sample.
Results
Increased weight gain during lactation without
hyperleptinemia or hypertension subsequent to
litter size reduction
We characterized initially the phenotype of the animals
after early pHA at P70. To assess renal function and leptin
signaling subsequent to early pHA and
before the onset of metabolic syndrome,
we chose P70. That age enables to differ-
entiate between the effects early postna-
tal nutrition andmetabolic syndrome in-
duced diseases. Body weight during
lactation period (postnatal wk 2 and 3)
and at postnatal wk 10 was signifi-
cantly increased after litter size reduc-
tion to10 (LSR10) andLSR6compared
with the HCC (Fig. 1A). Body length
did not differ between the groups (Fig.
1A). Toruleoutapronouncedmetabolic
syndrome at P70, we assessed leptin lev-
els in plasma (picograms per milliliter)
and blood pressure [systolic (RRsyst; mil-
limeters of mercury), diastolic (RRdiast;
millimeters of mercury), and mean arte-
rial pressure (MAP)]. We found no evi-
dence thatMAPwas altered. In contrast,
wemeasured a significantly loweredRR-
syst after LSR6, whereas RRdiast was un-
changed (Fig.1B).Leptin levels inplasma
were slightly but not significantly in-
creased in LSR10 and LSR6 compared
with HCC (Fig. 1C). Glucose levels did
not differ in the three groups (data not
FIG. 2. Renal physiological parameters and indices of renal damage after litter size reduction
at P70. A, Analysis of glomerular filtration rate (GFR) and protein excretion in the urine for
24 h and creatinine level in the serum revealed an impaired renal function after litter size
reduction to 6 (LSR6) at P70: rats after litter size reduction to 6 (LSR6; white bar) exhibit
reduced GFR (milliliters per kilogram per minute) compared with LSR10 (striped bar) and HCC
(black bar). The protein excretion [calc. UProt/Ucrea (micrograms per milliliter)/(milligrams per
deciliter)] was significantly increased in LSR6 compared with HCC. In addition, creatinine
(milligrams per deciliter) in the serum was markedly elevated in the LSR6. B, Indices of
glomerulosclerosis (GSI), tubulointerstitial damage (TSI), and vascular damage (VI) after litter
size reduction. Significance for each bar is indicated by P values (one way ANOVA test and
Dunn’s posttest). n.s., Not significant.
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shown).Taken together,LSR6 leads toapersistent increased
weight gain. Furthermore, the rats display no significant hy-
perleptinemia, normal glucose plasma levels (data not
shown), no glycosuria, and rather a hypotensive than a hy-
pertensive state at P70.
Impaired glomerular and tubular function after
early pHA
To assess renal function the animals
then underwent metabolic analysis in
metabolic cages for 24 h at P70. The glo-
merular filtration rate (GFR) was signif-
icantly decreased and protein excretion
elevated. In addition, we recently dem-
onstrated that early pHA leads to an in-
crease of both excreted fraction of the fil-
tered sodium and excreted fraction of the
filteredpotassium(30).Furthermore,mea-
surement of creatinine in the serum clearly
showed an increased creatinine level sub-
sequenttoLSR6.Tofurtherhistologically
evaluate renal damage, we assessed im-
munohistochemistry and applied indices
for glomerular, tubulointerstitial, and
vascular damage. They were slightly in-
creased after LSR6 but did not reach sig-
nificance at such an early time P70 (Fig.
2B). Thus, early pHA impairs renal func-
tion, in particular leading to decreased
GFR and proteinuria.
Dysregulated proliferation and
extracellular matrix composition
after early pHA
To elucidate whether early pHA has
long-term effect on proliferation and
extracellular matrix (ECM), we as-
sessed immunostaining for collagen I
and collagen IV. Semiquantitative eval-
uation demonstrates an increased pos-
itive staining for both collagen I and
collagen IV in glomeruli and tubuloint-
erstitium (Fig. 3B). In addition, the gene
expression of ECM-metabolizing en-
zymes, such as tissue inhibitor of met-
alloproteinases (TIMP)-1 and TIMP-2
were considerably down-regulated
(Fig. 3A). Finally, we assessed immu-
noblotting for PCNA and detected a
significant up-regulation at P70 after
LSR6 (Fig. 4A). Additionally, we ex-
amined PCNA by immunostaining for
differentiation of glomerular and tubu-
lointerstitial compartment. Both glom-
eruli and tubulointerstitium showed in-
FIG. 3. Decreased expression of ECM-metabolizing enzymes and increased renal deposition
of collagen I and collagen IV after early pHA at P70. A, Expression of leptin signaling target
genes encoding ECM-metabolizing enzymes TIMP-1 and TIMP-2 was assessed by quantitative
RT-PCR. B, The deposition of the ECM components collagen I and collagen IV in the
glomerulus and in the interstitium was detected by immunohistochemistry. The areas
illustrated were representative for the staining pattern observed in five to 10 different
kidneys. Semiquantitative analysis of the expression of collagen I and collagen IV in the
glomerulus and interstitium was assessed by the MetaVue imaging system (Molecular
Devices). Litter size reduction to 6 (LSR6; white bar), LSR10 (striped bar), and HCC (black bar)
are shown. Significance for each bar is indicated by P values (one way ANOVA test and
Dunn’s posttest). n.s., Not significant.
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creased positive staining for PCNA in the animals after
LSR6 (Fig. 4B). Taken together, these results give strong
evidence of dysregulated proliferation and profibrotic
processes subsequent to early pHA.
Increased expression of renal-specific leptin
expression after early pHA
The results obtained so far indicate a vital role of
early pHA in renal physiology and an impact on regu-
lation of profibrotic processes before histological
changes are seen. To gain a mechanistic view, we ana-
lyzed the expression pattern of the obesity-related pep-
tide hormone leptin and leptin receptors (ObRb,ObRa)
by quantitative RT-PCR. The mRNA expression of
genes encoding leptin and ObRb was significantly in-
creased in the LSR6 (Fig. 5A). To further differentiate
the localization of leptin within the kidney, we assessed
immunocytochemistry. Leptin was colocalized with
THP, a marker of the thick ascending limb of the Hen-
le’s loop (Fig. 5B). To determine a regulation of ObR
subsequent to an increment of leptin expression, we
assessed the expression of ObR by immunoblotting.We
did not detect any notable alterations after early pHA
(Fig. 5C). We next assessed mRNA expression of leptin
in the retroperineal and epigonadal tissue and com-
pared the expression of leptin in adipose tissue to kidney
subsequent to early pHA (LSR6). There was no differ-
ence in leptin expression in the adipose tissue within the
groups (Fig. 5D). On the contrary, as
expected, the expression of leptin was
clearly higher in the adipose tissue
than in the kidney in the LSR6 (Fig.
5E). In summary, our findings show a
striking increase of renal-specific ex-
pression and a distinct renal localiza-
tion of leptin subsequent to early
pHA,whereas the expression of leptin
is not altered in white adipose tissue.
Inhibition of intrinsic renal STAT3
and ERK1/2 signaling after early
pHA
To analyze the activation of the
Stat3 and Erk1/2 pathway, we per-
formed immunoblotting (Fig. 6, A and
B). Phosphorylation of both Stat3 and
Erk1/2 was already decreased after
LSR10 and even more predominantly
after LSR6 compared with the control
group (HCC), demonstrating an addi-
tional litter size-dependent effect on
phosphorylation. Unphosphorylated
Stat3 was significantly increased (Fig.
6A), whereas total, unphosphorylated Erk1/2 was un-
changed (Fig. 6B).Thus, the activationof Stat3andErk1/2
signaling is strongly attenuated after early pHA.
Functional impact of inhibition of intrinsic renal
STAT3 and ERK1/2 signaling on leptin target genes
after early pHA
To further delineate functional impact of inhibition of
leptin signaling pathway, we analyzed mRNA expression
of corresponding target genes, such as IL-10 (Fig. 7A),
TIMP-1, andTIMP-2 (Fig. 3A). PhosphorylatedStat3and
Erk1/2 induce IL-10, TIMP-1, and TIMP-2 expression.
Consistently, the mRNA expression of IL-10, TIMP-1,
andTIMP-2 is decreased in the group of LSR10 and LSR6
due to the reduced degree of phosphorylation of Stat33
and Erk1/2.
Next, we continued our study with the expression pat-
tern of another pivotal target gene of leptin signaling:
NPY, a conerurotransmitter of the sympathetic system,
and its receptor NPY receptor 1 (Y1). Strikingly, the
mRNA expression of NPY was significantly increased in
LSR6, whereas Y1 was significantly decreased (Fig. 6C).
To further differentiate the expression of NPY and NPY
receptor Y1 within renal compartments, we analyzed en-
dothelial cells (mouse),MC (rat),HKC8 (human), and the
M1 cell line (derived from the mouse cortical collecting
duct) with PCR and immuncytochemistry. Consistent with
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FIG. 4. Increased renal intrinsic proliferative processes after early pHA at P70. A, Expression
of PCNA as a marker for proliferation was assessed by immunoblotting, using constitutively
expressed -actin as loading control. These data were quantified by densitometric analysis. B,
Proliferative effect after postnatal hyperalimentation was assessed by quantification of PCNA-
positive cell in glomeruli and interstitium. Litter size reduction to 6 (LSR6; white bar), LSR10
(striped bar), and HCC (black bar) are shown. Significance for each bar is indicated by P values
(one way ANOVA test and Dunn’s posttest). n.s., Not significant.
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the mRNA results,NPYwas expressed in endothelial, MC,
and M1 cells but not in HKC8 cells. The Y1 receptor was
detectable inall fourcell lines.PC-12(rat) servedasapositive
control (Fig. 6C). Taken together, these results demonstrate
a functional impact of the renal specific reduced leptin sig-
naling on its specific target genes.
Renal-specific proinflammatory state and altered
expression of renal adrenoceptors after early pHA
The results obtained so far demonstrate an impaired
leptin signalingwith subsequent regulation of target genes
encoding inflammatory cytokines (IL-10), and coneu-
rotransmitter (NPY). To elucidate whether this intrinsic
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FIG. 5. Intrinsic renal and adipose tissue expression of leptin, obese receptor b (ObRb), and ObRa after early pHA at P70. A, Renal leptin and
leptin receptor expression at P70 and renal localization of leptin: mRNA expression of the genes encoding leptin, obese receptor b (ObRb), and
ObRa (alternative splice form of ObRb) was assessed by quantitative real-time PCR. The mRNA expression of leptin and ObRb was significantly and
of ObRa slightly increased in the group of litter size reduction to 6 (LSR6, white bar) compared with LSR10 (striped bar) and HCC (black bar). B,
The localization of leptin in the renal distal tubuli and collecting ducts was examined by coimmnuostaining with THP. C, Expression of leptin
receptor (ObR) was assessed by immunoblot in LSR6 (white bar), LSR10 (striped bar), and HCC (black bar); -actin was used as loading control. The
results were analyzed and quantified by densitometry. D, The mRNA expression of leptin in retroperitoneal and epigonadal adipose tissue was
assessed by quantitative real-time-PCR. LSR6 (white bar), LSR10 (striped bar), and HCC (black bar). E, Comparison of the mRNA expression of
leptin in adipose tissue (retroperitoneal and epigonadal, black bar) and kidney (white bar) in LSR6. Significance for each bar is indicated by P values
(one way ANOVA test and Dunn’s posttest). n.s., Not significant.
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renal leptin resistance goes along with a dysregulated in-
flammatory and sympathetic response after pHA, we an-
alyzed renal cytokine expression and expression of adre-
noceptors in the animals. We demonstrated that early
pHA increases markedly the expression of IL-6 and plas-
minogen activator inhibitor (PAI)-1 after LSR10 and even
more pronounced after LSR6 (Fig. 7A). Additionally, we
confirmed the mRNA expression data for IL-6 with im-
munoblotting (Fig. 7A). Interestingly, we detected a sig-
nificant up-regulation ofmRNAexpression of adrenocep-
tors-1a and -1d compared with the HCC, whereas
adrenoceptors-1 and -2 were significantly down-regu-
lated (Fig. 7B). Taken together, these data underline the
clear effect of pHA on the regulation of the inflammatory
response and the sympathic nerve system.
Up-regulation of STAT3 and ERK1/2 inhibitor
SOCS-3 after early pHA
It remains unclearwhat specifically leads to an intrinsic
renal postreceptor leptin resistance subsequent to early
pHA. To further identify the underlyingmechanism of the
inhibition of the Stat3 and Erk1/2 signaling pathway, we
analyzed SOCS-3, an inhibitor of phosphorylation of
Stat3 and Erk1/2. Strikingly, immunoblotting of SOCS-3
demonstrates an up-regulation of SOCS-3 after pHA (Fig.
8A). To further delineate the renal compartment of local-
izationof SOCS-3,we assessed immunhistochemical anal-
ysis: first, we could demonstrate a colocalization of
SOCS-3 with 11HSD (a marker for the distal tubules in
the cortex and outer medulla), calbindin (calbindin is
found in distal convoluted tubule with the signal extend-
ing into the connecting ducts), and THP (a marker of the
proximal tubules) (Fig. 8B), but no stainingwas detectable
in the glomeruli (Fig. 8C).
To show next that SOCS-3 is colocalized with NPY in
the kidney,NPYwas detectable in the glomeruli, the distal
(costaining with 11HSD), and the proximal (costaining
with THP) tubulus system (Fig. 8C). Additionally, we
could demonstrate a colocalization of SOCS-3 and NPY.
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FIG. 6. Early postnatal hyperalimentation inhibits the phosphorylation of both Stat3 and Erk1/2 after early pHA at P70. A, Expression and
phosphorylation of Stat3 was assessed by immunoblot, using constitutively expressed -actin as loading control. These data were quantified by
densitometric analysis. B, Protein expression and phosphorylation of Erk1/2 was monitored by immunoblot; -actin was used as loading control.
The results were analyzed and quantified by densitometry. C, Expression of NPY and the NPY-receptor 1 (Y1) in vitro and in vivo after litter size
reduction: a significant increase of mRNA expression of NPY and reduced of Y1 after litter size reduction to 6 (LSR6) compared with LSR10 and
HCC is seen. Additionally, in vitro analysis by RT-PCR revealed the mRNA expression pattern of NPY and Y1 in different compartments of the
kidney [mEnd, MC, HKC8, and cortical collecting duct cells (M1)]. PC-12 served as positive control for NPY and Y1. NPY mRNA was detected in
the mEnd, MC, and M1 cells but not in HKC8 cells, whereas mRNA expression of Y1 was detectable in all cell lines. Immuncytochemistry for
expression of NPY and Y1 in these cell lines demonstrates a positive staining for NPY in mEnd, MC, and M1 cells but not in HKC8-cells and for Y1
in all cell lines. Litter size reduction to 6 (LSR6; white bar), LSR10 (striped bar), and HCC (black bar) is shown. The significance for each bar is
indicated by P values (one way ANOVA test and Dunn’s posttest). n.s., Not significant.
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To sumup, SOCS-3, a crucial mediator of postreceptor
leptin resistance is significantly up-regulated in the kid-
neys subsequent to pHA and specifically localized with
leptin’s target gene NPY.
Discussion
This study demonstrates for the first time a renal postre-
ceptor leptin resistance with impaired glomerular and tu-
bular function in rats after early pHA (15).Moreover, our
findings give strong evidence that earlypHAleadsnotonly
to an increased renal expressionof proinflammatory (such
as IL-6) but also to a dramatic up-regulation of renal-
specific leptin resistance. Clinical studies support these
results demonstrating elevated seruminflammatorymark-
ers in overweight children and adolescents (36) as well as
in patients with CKD (37). Arising evidence for obesity-
related nephropathy in infant, adolescent, and adult hu-
mans (8, 9, 38, 39) endorses these results.
Note that in the presented study, the impaired glomer-
ular and tubular function was not (or not yet) accompa-
nied by a metabolic syndrome. We could detect neither
increased glucose levels nor hypertension or hyperleptine-
mia subsequent to early pHA. This is consistent with sev-
eral studies giving evidence that obese individuals often
develop progressive renal dysfunction before the occur-
rence of diabetes and severe hypertension (40, 41).
Obesity is a self-perpetuating and devastating process:
adipose tissue-secreted adipocytokines, such as IL-6 and
PAI-1, exert inflammatory and atherosclerotic effects, in-
crease sympathetic activity, contribute to insulin resis-
tance and hypertension, and impair renal function. In ad-
dition to cytokines, there are also peptide hormones (such
as leptin) linked topHAobesity-related diseases (42). Lep-
tin exerts both systemic and organ specific function. Ac-
cordingly, there are several studies demonstrating an in-
trinsic renal synthesis (18) and function of leptin (17, 20,
21). Notable among these are profibrotic, proliferative
effects (17, 23), and stimulationof SNS (22). Leptin affects
blood pressure through stimulation of the central and pe-
ripheral sympathetic nervous systems. In the present
study, leptin plasma levels were not significant elevated in
the group after early pHA, and accordingly, blood pres-
sure was not increased. However, the intrinsic renal ex-
pression of leptin and its receptor (obRb) is strikingly up-
regulated after early pHA. Thus, intrinsic renal leptinmay
exhibit an auto- and paracrine effect, independent of cir-
culating leptin secreted by adipose tissue.
Both IL-6 and leptin have direct impact on the regula-
tionof renal cell proliferation (20,24), differentiation, and
production of components and metabolizing enzymes of
the ECM (17, 43–45) via Stat3 and Erk1/2. This is in line
with data presented in our study giving strong evidence
that an elevated expression of leptin goes along with dys-
regulated ECM turnover: decreased expression of ECM
metabolizing enzymes (TIMP-1 and TIMP-2) and in-
creased deposition of collagen I and collagen IV in the
renal interstitium and glomeruli. In this context, intrinsic
renal leptin could play a vital role mediating proliferative
and profibrotic effect.
The intracellular pathway of leptin occurs predomi-
nantly via phosphorylation of Stat3 and Erk1/2. Target
FIG. 7. Intrinsic renal inflammatory state and expression of genes encoding adrenoceptors-1a,-1d, -1, and -2 after early pHA at P70. A,
Intrinsic renal inflammatory state after early pHA at P70: mRNA expression of genes encoding IL-6, IL-10, and PAI-1 was assessed by quantitative
real-time-PCR. Litter size reduction to 6 (LSR6; white bar) showed a dramatic increased mRNA expression of inflammatory cytokines IL-6 and PAI-I
and decreased mRNA expression of antiinflammatory and leptin-inducible gene IL-10 compared with LSR10 (striped bar) and HCC (black bar).
Quantification of immunoblotting of IL-6 showed an increased renal protein expression of IL-6 after LSR6 compared with LSR10 and HCC. B,
Intrinsic renal expression of genes encoding adrenoceptor-1a, adrenoceptor-1d, adrenoceptor-1, and adrenoceptor-2 was assessed by
quantitative real-time-PCR. Litter size reduction to 6 (LSR6; white bar) exhibited a significant increased expression of adrenoceptor-1a compared
with HCC (black bar) and an increased expression of adrenoceptor-1d compared with LSR10 (striped bar) and HCC. The expression of
adrenoceptor-1 and adrenoceptor-2 was significantly down-regulated in the LSR6 and LSR10 group compared with HCC. Significance for each
bar is indicated by P values (one way ANOVA test and Dunn’s posttest). n.s., Not significant.
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genes, such as TIMP-1 and TIMP-2
(46, 47), and antiinflammatory cyto-
kines such as IL-10 (48) are up-regu-
lated through leptin signaling, whereas
the sympathetic coneurotransmitter
NPY is inhibited (28, 29). We report in
our study a decreased expression of
genes encoding IL-10, TIMP-1, and
TIMP-2 and an increased expression of
NPYafterpHA.These findingsare con-
sistent with reduced phosphorylation
of Stat3 and Erk1/2 observed subse-
quent topHA.Thus, increasedNPY ex-
pression and the impaired Stat3 and
Erk1/2 signaling display a peripheral
leptin resistance subsequent to pHA. In
addition to regulatory function regard-
ing energy homeostasis, NPY has direct
proinflammatoryandrenal tubular func-
tion affecting natriuresis and kaliuresis
via NPY receptors Y1 and Y2 (30, 31).
Thus, NPY and the neuroimmune inter-
action might enhance the inflammatory
response after early pHA and contribute
to the obesity-related nephropathy. The
question arose as to howan increased re-
nal NPY expression exerts greater in-
flammatoryeffectviaadecreasedexpres-
sion Y1 receptor. Sympathetic nerve
system activation results in the release of
NPY concomitantly with cat-
echolamines. NPY as a sympathetic co-
neurotransmitter exerts its inflammatory
effects mainly via Y1 receptor, which is
present on the surface of inflammatory
cells,particularlymacrophagesandgran-
ulocytes (31, 49, 50). Therefore, the in-
flammatory action of NPY may not be
mediated by renal Y1 receptors but by
granulocytes and/or macrophages and
thereby secondary exert inflammatory
response on renal tissue. Furthermore,
NPYhas inhibitoryeffectonreninrelease
(51) and also secondary on the renin-an-
giotensin-aldosterone system (RAAS).
We already demonstrated dysregulation
of the RAAS and especially a down-reg-
ulation of angiotensin receptor II in kid-
ney subsequent to early pHA (30). In line
with this, the regulatory effect ofNPYon
RAAS and SNSmay be a potential cause
of the slight hypotensive phenotype sub-
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FIG. 8. Renal localization and expression of SOCS-3 after early pHA at P70. A, Expression of SOCS-3
was assessed by immunoblot, using constitutively expressed -actin as loading control. These data
were quantified by densitometric analysis. Litter size reduction to 6 (LSR6;white bar), LSR10 (striped
bar), and HCC (black bar) are shown. Significance for each bar is indicated by P values (one way
ANOVA test and Dunn’s posttest). n.s., Not significant. B, Localization of SOCS-3 was detected by
immunofluorescence staining. Representative sections are illustrated, using SOCS-3 (green) and
11HSD (red) as a marker for the distal tubules in the cortex and outer medulla, calbindin as a marker
of the distal convoluted tubule and the connecting ducts, THP (red) as a marker of the proximal
tubules, and DAPI (blue) as a nuclear marker. C, The renal localization of NPY (red) and the
colocalization of NPYwith SOCS-3 (green) was assessed by immunofluorescence. Colocalizaion of NPY
(green) with 11HSD (red) and THP (red) and DAPI (blue) as a nuclear marker are illustrated. SOCS-3
(green) and NPY (red) colocalization is illustrated below.
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sequent to pHA at P70. Further studies are necessary to elu-
cidate in detail the short- and long-term effect of early pHA
on blood pressure.
Hyperalimentation is known to induce leptin resistance
subsequent to hyperleptinemia. But how could intrinsic
renal leptin resistance be mediated without systemic hy-
perleptinemia and an underlying metabolic syndrome?
There is also controversially discussed obesity-induced
leptin-independent leptin resistance (52): 1) endoplas-
matic reticulum stress-associated leptin resistance (53)
and 2) inflammation (IL-6) and therefore postreceptor-
mediated leptin resistance (27, 45). SOCS-3 is an inhibitor
of Stat3 and Erk1/2 phosphorylation and is thought to be
causal for postreceptor leptin resistance (27). This is the
first study to our knowledge so far addressing the renal
expression of SOCS-3. SOCS-3 is strikingly up-regulated
subsequent to pHA. Interestingly, we did not detect
SOCS-3 in the glomeruli. Hence, in the glomeruli, leptin
can exert its glomerular proliferative effect. Rodrigues et
al. (28) support our findings demonstrating that pHA
leads to a higher SOCS-3 expression in the hypothalamus.
Regarding its functional role, however, Gomez-Guerrero
and colleagues (54) gave evidence that SOCS-3 improves
renal function indiabetic rodents and reduces renal lesions
in an animalmodel of diabetic nephropathy. In contrast to
our study, interestingly, SOCS-3 was localized not only in
the interstitial compartment of diabetic kidneys but also in
the glomeruli. These facts indicate that the underlying
pathomechanism of hyperglycemia induced renal damage
is different from the mechanism investigated in our study
subsequent to pHA.
Injury to the developing andmaturing kidney, like obe-
sity and early pHA, may disrupt critical signaling path-
ways that regulate cell proliferation, ECM composition,
and renal function. There are numerous underlyingmech-
anisms discussed: 1) cytokines (IL-6, PAI-1) secreted by
adipose tissue or other organs directly induce renal cell
proliferation and fibrotic processes; 2) hyperleptinemia
due toobesity andpHAstimulate sympathetic activity and
thereby contributes to renal damage; and 3) hyperleptine-
mia-independent intrinsic renal leptin resistance leads to
increased expression of NPY and altered expression of
ECM-metabolizing enzyme and ECM components, and
enhances proinflammatory processes. In the context of
increased sympathetic activity subsequent to pHA, it is
noteworthy that pHA increases the expression of renin
(30). In line with this, we observed in our study a down-
regulation of adrenoceptors-1a and -1d after early
pHA, whereas adrenoceptor-1 and -2 were signifi-
cantly up-regulated, indicating a regulation of the sympa-
thetic system after pHA. However, because we have not
focused on the regulation of the sympathetic nerve system
in this study, this idea requires further investigation.
In conclusion, early pHA contributes to impaired renal
function in later life.This studypresents evidence for a role
of SOCS-3 inmediating postreceptor leptin resistance and
subsequent regulation of sympathetic activity (NPY) and
inflammatory response in the underlying pathomecha-
nism of pHA-induced nephropathy. Amore profound un-
derstanding of the underlyingmechanistic aspects of early
postnatal hyperalimentation will ultimately allow defin-
ing more effective preventional and therapeutic strategies
of nephropathy in childhood and beyond.
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Hypothalamic JNK1 and IKK Activation and Impaired
Early Postnatal Glucose Metabolism after Maternal
Perinatal High-Fat Feeding
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Inga Bae-Gartz, Christina Vohlen, Bernhard Roth, and Jo¨rg Do¨tsch
Department of Pediatrics, University Hospital of Cologne, 50924 Cologne, Germany
Hypothalamic inflammation has been demonstrated to be an important mechanism in the patho-
genesis of obesity-induced type 2 diabetesmellitus. Feeding pregnant and lactating rodents a diet
rich in saturated fatty acids has consistently been shown to predispose the offspring for the de-
velopment of obesity and impaired glucose metabolism. However, hypothalamic inflammation in
the offspring has not been addressed as a potential underlying mechanism. In this study, virgin
female C57BL/6 mice received high-fat feeding starting at conception until weaning of the off-
spring at postnatal d 21. The offspring developed increased body weight, body fat content, and
serum leptin concentrations during the nursing period. Analysis of hypothalamic tissue of the
offspring at postnatal d 21 showed up-regulation of several members of the toll-like receptor 4
signaling cascade and subsequent activation of c-Jun N-terminal kinase 1 and IB kinase- inflam-
matory pathways. Interestingly, glucose tolerance testing in the offspring revealed signs of im-
paired glucose tolerance along with increased hepatic expression of the key gluconeogenic en-
zyme phosphoenolpyruvate carboxykinase. In addition, significantly increased hepatic and
pancreatic PGC1 expression suggests a role for sympathetic innervation in mediating the effects
of hypothalamic inflammation to the periphery. Taken together, our data indicate an important
role for hypothalamic inflammation in the early pathogenesis of glucose intolerance after mater-
nal perinatal high-fat feeding. (Endocrinology 153: 770–781, 2012)
In diet-induced obesity, the hypothalamus has beenshown to become dysfunctional due to the development
of inflammation. Important mediators of this inflamma-
tory response include saturated fatty acids (stearic acid)
and several cytokines, including TNF and IL-6 (1–4).
Hypothalamic inflammation subsequently leads to central
resistance to fuel-sensinghormones (i.e. leptin and insulin)
and loss of the homeostatic control of food intake and
energy expenditure (5–8). In detail, hypothalamic inflam-
mationmediated by TNF directly attenuates the anorex-
igenic effect of leptin with a notable reduction in local
leptin signaling and an increase in SOCS3 expression (3).
Additionally, hypothalamic TNF action has been shown
to have functional impact on several peripheral organs:
centrally applied TNF reduces the expression of thermo-
genic proteins in brown adipose tissue and skeletal muscle
and impairs insulin secretion in isolated pancreatic islets
(3, 9). Consistently, these effects are blunted in TNF re-
ceptor knockout mice (3, 10). In addition, Calegari et al.
(4) could demonstrate that intracerebroventricular injec-
tion of either saturated fatty acids or low doses of TNF
leads to dysfunctional insulin secretion and activates the
expression of a number of markers of apoptosis in pan-
creatic islets via activation of the toll-like receptor 4
(TLR4) signaling cascade. Thus, fatty acid-induced hypo-
thalamic inflammation and the resulting central and pe-
ripheral consequences represent a crucial pathomecha-
nism for the development of obesity and type 2 diabetes.
Increasing evidence from human and animal studies
supports the idea that maternal consumption of a high-fat
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diet (HFD) during early fetal life puts the offspring at a
lifelong risk for obesity and related negative metabolic
outcomes (i.e. type 2 diabetes mellitus) (11–15). It is con-
ceivable that the fetal and neonatal hypothalamus acts as
an important target for maternal nutritional and hor-
monal cues during gestation and lactation. However, the
underlyingmolecularmechanisms remain unclear to date.
Several reports document deregulated expression of hy-
pothalamic neuropeptides and hormone receptors in-
volved in homeostatic control in newborn and adult rats
aftermaternal perinatalHFDfeeding (16,17). Inaddition,
chronic maternal high-fat feeding has been shown to in-
duce changes in hypothalamic melanocortin expression
and IL-1 signaling in the offspring of nonhuman pri-
mates (18). This is further supported by observations in
other brain regions that document increased IL-1, IL-6,
and TLR4 expression in the offspring of obese rat dams,
which is associated with changes in anxiety and spatial
learning in adulthood (15, 19). Thus, it is clear that ma-
ternal constitution and dietary choice has profound influ-
ence on innate immune response within the brain of the
offspring with subsequent lifelong functional consequences.
Data on hypothalamic inflammation in the offspring after
maternal HFD feeding are sparse. Therefore, this study
aimed to 1) determine the potential hypothalamic inflam-
matory response in the offspring at postnatal d 21 (P21) as a
consequence of increased maternal dietary fat intake
throughout gestation and lactation, 2) elucidate which in-
tracellular signaling pathways are involved, and 3) investi-
gate the timely order of onset of central and peripheral
inflammation in relation to the metabolic phenotype.
Materials and Methods
Animals
All animal procedures were conducted in compliance with
protocols approved by local government authorities (Bezirksr-
egierung Ko¨ln) and were in accordance with National Institutes
of Health guidelines. Mice (C57BL/6) were bred locally at a
designated animal unit of the University Hospital of Cologne
(Cologne, Germany). Virgin female mice were housed individ-
ually and were maintained at 22 C on a 12-h light, 12-h dark
cycle. They were mated at 10 wk of age (22 g in body weight)
and assumed to be pregnant when a vaginal plug was expelled.
Immediately after detection of vaginal plugging, dams were fed
ad libitum either a standard laboratory chow (no. 1310; Al-
tromin, Lage, Germany) containing 40% carbohydrates, 22.5%
protein, and 5.0% fat (13% of calories from fat) or a high-fat-
containing diet (HFD) (no. C1057) containing 26.9% carbohy-
drates, 21%protein, and35.1%fat (55.2%of calories from fat).
Water was available ad libitum, and food was withdrawn only
if required for an experiment. Bodyweight of the pupswasmon-
itored daily starting immediately after birth (P1). On P3, litter
size was adjusted to six for each litter. Smaller litters were ex-
cluded from the experiment. On P21, the dams underwent an ip
glucose tolerance test (ipGTT) and were subsequently killed. In
a subset of male pups (n  6–12 per group, five to 10 distinct
litters), ipGTT was performed at P21. These animals were ex-
cluded from further organ analysis. The remaining male pups
were killed on P21. The hypothalamus was dissected as previ-
ously described (20), and samples of liver and pancreatic tissue
were taken out and immediately frozen at 80 C for further
analysis. Both epigonadal fat pads were dissected, and their
weight was determined.
Body weight measurement
Body weight in dams was monitored on gestational d 6 (G6),
G12, and G18 and P1 and P21. Male pups were weighed daily
between P1 and P21.
Analytical procedures
Blood glucose values were determined from whole venous
blood using an automatic glucose monitor (GlucoMen; A.Men-
arini Diagnostics, Berlin, Germany). Random fed blood glucose
levelsweremeasured2–3hafterbeginningof the lightphasewith
free access to food/lactating dam. Serum leptin and insulin were
measured by ELISA using mouse standards according to the
manufacturer’s guidelines [mouse leptin ELISA (EZML-82K)
with a sensitivity of 0.05 ng/ml and intraassay variation of
8.35% and mouse insulin ELISA (EZRMI-13K) with a sensitiv-
ity of 0.01 ng/ml and intraassay variation of 1.06%; Millipore
Corp., Billerica, MA].
Intraperitoneal glucose tolerance test
Glucose tolerance tests were performed as previously de-
scribed (21). Briefly, animals were fasted overnight (16–17 h).
After determination of fasted blood glucose levels, each animal
received an ip injection of 20%glucose (10ml/kg bodyweight
2 g glucose/kg bodyweight). Blood glucose levels weremeasured
after 15, 30, 60, and 120 min.
Insulin signaling
Mice were anesthetized by ip injection of a mixture of mida-
zolam (5mg/kg) and ketamine (100mg/kg), and adequacy of the
anesthesia was ensured by loss of pedal reflexes. The abdominal
cavity of the mice was opened, and 125-l samples containing 5
U regular human insulin (Actrapid; Novo Nordisk Pharma
GmbH, Mainz, Germany) diluted in 0.9% saline were injected
into the inferior vena cava. Sham injectionswere performedwith
125l of 0.9% saline. Livers and hypothalami were harvested 5
min after injection, and proteins were extracted from tissues for
Western blot analysis.
RNA isolation and microarray analyses
Total RNA was isolated from dissected hypothalamic, pan-
creatic, and liver tissue as previously described (22), followed by
deoxyribonuclease treatment to remove any contaminating
genomic DNA. Microarray experiments of mice hypothalamic
RNAwere performed as single-color experiments using 4 44K
Mouse (v2) Whole Genome Arrays from Agilent Technologies
(Santa Clara, CA). For each sample, 1g total RNAwas linearly
amplified and transcribed to Cy3-labeled cRNA using the Low
InputQuick Amp Labeling Kit and hybridized to the array using
theGene ExpressionHybridizationKit (both fromAgilent Tech-
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nologies) according to the manufacturer’s protocol. After wash-
ing and scanning,microarray rawdatawere extracted usingAgi-
lent’s Feature Extraction Software (version 10.8). Principal
component analysis and hierarchical cluster analysis were per-
formed using the Rosetta Resolver software version 7.2 (Rosetta
Inpharmatics LCC, Seattle, WA). For hierarchical cluster anal-
ysis, gene expression values were transformed to Z-scores, and
cosine correlation and average linkage were used as metric and
heuristic criteria, respectively.
mRNA quantification by quantitative PCR (qPCR)
TotalRNAwas screened formRNAencodingTLR4,myeloid
differentiation primary response gene 88 (MyD88), IL-1 recep-
tor-associated kinase 1 (IRAK1), TNF receptor-associated fac-
tor 6 (Traf6), TNF, IL-6, proopiomelanocortin (POMC),
cocaine and amphetamine regulated transcript (CART), agouti-
related peptide (AgRP), neuropeptide Y (NPY), orexin, TRH,
phosphoenolpyruvate carboxykinase (PEPCK), forkhead box
protein 1 (FOXO1), peroxisome proliferator-activated receptor
 coactivator 1- (PGC1). Quantitative changes in mRNA ex-
pression were assessed by quantitative real-time PCR as de-
scribed previously using the IQ TM SYBR-Green Supermix and
a Bio-Rad iQ5-Cycler (Bio-Rad Laboratories, Hercules, CA) or
the 7500 real-timePCRsystem (AppliedBiosystems, FosterCity,
CA) (22). In all samples, the relative amount of specific mRNA
was normalized to the ubiquitously expressed -actin gene. Oli-
gonucleotides were designed with Primer Express software
(PerkinElmer, Foster City, CA). Primer pairs and TaqMan
probes are listed in Table 1.
Western blotting
Frozen dissected hypothalamic, pancreatic, and liver tissue
was homogenized in lysis buffer as previously described (24).
Protein concentration was determined with a Bio-Rad DC pro-
tein assay (Bio-Rad). Lysates resolved on a 10% reducing SDS-
PAGE gel were transferred to a nitrocellulose membrane. Blots
were probed with the following antibodies: monoclonal rabbit
antimouse phospho-IB kinase-/ (IKK/) (Cell Signaling,
Danvers, MA; no. 3101, 1:1000), monoclonal rabbit antimouse
phospho-Akt (Cell Signaling; no. 4058, 1:1000), polyclonal rab-
bit antimouse phospho-stress-activated protein kinase/c-Jun N-
terminal kinase (pSAPK/JNK) (Thr183/Tyr185) (Cell Signaling;
no. 9251), monoclonal rabbit antimouse IKK (Cell Signaling;
no. 2370, 1:1000), polyclonal rabbit antimouse Akt (Cell Sig-
naling; no. 9272, 1:1000), polyclonal rabbit antimouse SAPK/
JNK (Cell Signaling; no. 9252, 1:2000). Monoclonal mouse an-
timouse -actin (Cell Signaling; no. 3700, 1:1000) served as a
loading control. Antimouse IgG, horseradish peroxidase-linked
(Cell Signaling; no. 7076, 1:2000), and horseradish peroxidase-
linked antirabbit IgG (Cell Signaling; no. 7074, 1:2000) were
used as secondary antibodies.
Analysis of data
The results of real-timeRT-PCRwere calculated based on the
delta-deltaCt method and expressed as fold induction of mRNA
expression comparedwith the corresponding control group (1.0-
fold induction). Densitometric analysis of protein bands was
performedusingBio-Rad ImageLab software (Bio-Rad,Munich,
Germany). Band intensitieswere normalized to the-actin band.
Values are shown asmeans SEM. Two tailedMann-WhitneyU
test and one-way ANOVA followed by a Dunn’s post hoc test
was used to test significance of differences between HFD and
control animals at given time points. Over time, ANOVA was
used to test significance of body weight changes and blood glu-
cose levels during glucose tolerance testing. AP value0.05was
considered significant.
Results
To investigate the effects of increasedmaternal dietary fat
intake on the offspring,we characterized the experimental
(HFD) and control dams throughout pregnancy and lac-
tation. Litter size and pregnancy length did not differ be-
tween both groups (data not shown). Maternal body
weight gain was monitored throughout the experiment
and revealedno significant difference between control and
HFD dams at either time point (Fig. 1A). Moreover, ran-
dom fed blood glucose levels were measured on G6 and
G12.Therewas nodifference in random fedblood glucose
levels between normal chow- andHFD-fed dams at either
time point (Fig. 1B). To evaluate whether HFD dams de-
veloped impaired glucose tolerance over the 6-wk period
ofHFD feeding (conception untilweaning),we performed
ipGTT in the dams at the end of lactation (P21).However,
therewas no detectable difference in plasma glucose clear-
ance between HFD and control dams (Fig. 1C). Taken
together, HFD dams presented no alterations in the as-
sessed parameters of energy and glucose homeostasis
throughout pregnancy and lactation.
Next, offspring of both HFD and control dams were
metabolically characterized. Interestingly, offspring of
HFDdamswas significantly lighter than control offspring
at the day of birth but gained weight more rapidly
throughout the first 2 wk of lactation resulting in a sig-
nificantly increased body weight from P16 onward (P 
0.01 on P16, P  0.001 on P17, and P  0.0001 from
P18–P21) (Fig. 2A). The increased body weight in HFD
offspring was accompanied by significantly increased
white adipose tissue mass at P21 represented by a 2-fold
increase in weight of epigonadal fat pad (P 0.009) (Fig.
2B). Along with increased fat mass, serum leptin levels at
P21 were significantly elevated in HFD offspring com-
pared with controls (P  0.004) (Fig. 2C).
To assess the effects ofmaternal high-fat feeding during
pregnancy and lactation on parameters of glucose homeo-
stasis, we first determined random fed and fasting blood
glucose levels. Random fed blood glucose levels were
slightly increased in HFD offspring at P15 (P  0.036)
(Fig. 2D). However, fasting blood glucose levels as well as
serum insulin levels at P21were comparable between both
groups (data not shown). Strikingly, glucose tolerance
testing at P21 revealed significantly increased plasma glu-
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cose levels 15 and 30 min after ip glucose administration
in HFD offspring when compared with controls (P 
0.001 and P  0.0001) (Fig. 2E).
To investigate central processes that might possibly
contribute to the metabolic phenotype at P21, we next
performed genome-wide gene expression arrays with hy-
TABLE 1. Primer pairs and TaqMan probes
Gene Sequence (5–3)
-Actin
Forward TGACAGGATGCAGAAGGAGATTACT
Reverse GCCACCGATCCACACAGAGT
Probe (FAM)-ATCAAGATCATTGCTCCTCCTGAGCGC-(TAMRA)
TNF
Forward GGCTGCCCCGACTACGT
Reverse GACTTTCTCCTGGTATGAGATAGCAA
Probe (FAM)-CCTCACCCACACCGTCAGCCG-(TAMRA)
IL-6a
Forward ACAAAGCCAGAGTCCTTCAGAGA
Reverse CCTTCTGTGACTCCAGCTTATCTGT
TLR4
Forward GGTGAGAAATGAGCTGGTAAAGAATT
Reverse GCAATGGCTACACCAGGAATAAA
Probe (FAM)-TGCCCCGCTTTCACCTCTGCC-(TAMRA)
MyD88
Forward TGGCCATCTGCCTAGTAAAGCT
Reverse CAGTAGCAGATAAAGGCATCGAAAA
Probe (FAM)-TTGATGACCCCCTAGGACAAACGCC-(TAMRA)
IRAK1
Forward TAGCTTGCTGCTGCATGCA
Reverse CCTGCCTGAAGCCCTTCTAGT
Probe (FAM)-AGAGGCCCCCCATGACCCAGGTATAC-(TAMRA)
TRAF6
Forward ATCTCGAGGATCATCAAGTACATTGT
Reverse TGTGTGTATTAACCTGGCACTTCTG
Probe (FAM)-TTGTCCCCAGTGCCAACGTCCTTT-(TAMRA)
AgRP
Forward GAAGAAGCTCAAGAGTAAACGCATT
Reverse GGAGCCACGCCCATCTG
Probe (FAM)-TTGGCACTGCCTCCCACACTGG-(TAMRA)
NPY
Forward AGCAGAGGACATGGCCAGATAC
Reverse TGAAATCAGTGTCTCAGGGCTG
Probe (FAM)-GTTAAACCTTCGATTCCGACCTC-(TAMRA)
Orexin
Forward GCGCAGAGCTAGAGCCACAT
Reverse TGCTAAAGCGGTGGTAGTTACG
Probe (FAM)-CTGCTCTGGTCGCGGCTGTCC-(TAMRA)
POMC
Forward GACACGTGGAAGATGCCGAG
Reverse CAGCGAGAGGTCGAGTTTGC
Probe (FAM)-CAACCTGCTGGCTTGCATCCGG-(TAMRA)
CART
Forward GAAGAAGCTCAAGAGTAAACGCATT
Reverse CCGATCCTGGCCCCTTT
Probe (FAM)-CTACGAGAAGAAGTACGGCCAAGTCCCC-(TAMRA)
TRH
Forward GGATGGAGTCTGATGTCACCAA
Reverse TCTGTTTCTTCCCAGCTTCTTTG
Probe (FAM)-ATGGAAGTCAGAGGATGC-(TAMRA)
PGC1
Forward TCGAAAAAGAAGTCCCATACACAA
Reverse TTCCACACTTAAGGTTCGCTCAATA
Probe (FAM)-CACCAAATGACCCCAAGGGTTCCC-(TAMRA)
FOXO1a
Forward CAATGGCTATGGTAGGATGG
Reverse TTTAAATGTAGCCTGCTCAC
PEPCK
Forward CCACAGCTGCTGCAGAACAC
Reverse GAAGGGTCGCATGGCAAA
Probe (FAM)-AGGGCAAGATCATCATGCACGACCC-(TAMRA)
a IL-6 and FOXO1 were measured by the SYBR-Green method. No probe was needed.
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pothalamic tissue of HFD and control offspring at P21.
Intriguingly, unsupervised principal component analysis
revealed that global gene expression information differed
markedly between the two cohorts, suggesting profound
maternal diet-induced changes in the gene expression pat-
tern in the hypothalami of HFD offspring (Fig. 3A). For
analysis of selected candidate genes associated with in-
flammation, expression informationof a panel of 41 genes
was extracted fromwhole-genomemicroarray expression
profiles. Expression information of these inflammation-
associated candidates allowed a clear separation of both
groups (HFD vs. control) in a supervised hierarchical clus-
ter analysis (Fig. 3B). For validationof themicroarraydata
and to further evaluate changes in expression of the most
prominent candidate genes in fatty acid-induced inflam-
mation, quantitative PCR was performed in hypothalami
of control and HFD offspring at P21. Hypothalamic ex-
pression of TNF was slightly reduced after maternal
HFD feeding, but expression of IL-6 was significantly in-
creased in the hypothalamus of HFD offspring compared
with controls at P21 (P  0.018) (Fig. 4A). Interestingly,
in bothmicroarray and qPCR experiments, hypothalamic
expression of TLR4 was markedly increased in offspring
of HFD-fed dams (P  0.018) (Figs. 3B and 4B). More-
over, expression of downstream members of the TLR4
inflammatory response machinery (MyD88, IRAK1, and
TRAF6) were also significantly increased in bothmicroar-
ray and qPCR analyses of hypothalami after maternal
HFD feeding at P21 (P  0.005; P 
0.017; P  0.014) (Fig. 4B).
To evaluate the functional conse-
quence of the observed increase in
expression levels of proinflammatory
genes in the hypothalamus of HFD off-
spring at P21, we next determined the
protein amounts and phosphorylation
of inflammation mediating kinases
JNK1 and IKK in hypothalamic tissue
of HFD and control offspring at P21.
Total amounts of both JNK1 and IKK
were significantly increased in the hy-
pothalamus of HFD offspring com-
pared with controls at P21 (P  0.024
andP0.036) (Fig. 4,CandD).More-
over, HFD offspring showed a robust
increase in phosphorylated protein
amount of both JNK1 and IKK com-
paredwith controls (P0.024 andP
0.024) (Fig. 4, C and D), indicating
increased intracellular inflammatory
signaling within the hypothalamus.
Taken together, maternal HFD feed-
ing-induced up-regulation of IL-6 and genes involved in
the TLR4 signaling cascade with subsequently increased
inflammatory signaling on the level of JNK1 and IKK in
the hypothalamus of the offspring at P21.
To next assesswhether increased hypothalamic inflam-
mation is associated with functional changes in the neu-
ronal networks known to be involved in the regulation of
energy and glucose homeostasis, we determined expres-
sion levels of orexigenic (AgRP and NPY) and anorexi-
genic (orexin,POMC,CART, andTRH) neuropeptides in
the hypothalamus of HFD and control offspring at P21.
Interestingly, expression levels of both orexigenic and an-
orexigenic neuropeptides tended to be increased in HFD
offspring compared with controls, indicating a generally
disturbed regulatory environment after maternal HFD
feeding (P  0.027 for AgRP, P  0.053 for orexin, P 
0.051 for POMC, and P  0.054 for TRH) (Fig. 4E).
Furthermore, we testedwhether the observed hypotha-
lamic inflammation might be part of a multi-organ in-
flammatory response resulting from maternal HFD feed-
ing. Focusing on liver and pancreas as two major
regulators of glucose balance, we next determined local
mRNA levels of TNF, IL-6, and members of the TLR4
signaling cascade at P21. Interestingly, we did not detect
an increase in hepatic or pancreatic expression levels in
HFD offspring compared with controls at P21 (Fig. 5,
A–D). Additionally, we quantified protein amounts of
JNK1 in liver ofHFD and control offspring at P21. Again,
FIG. 1. A, Maternal mean body weight (SEM) in control (black bars) and HFD (white bars)
dams during pregnancy (G6, G12, G18, and G19) and lactation (P1 and P21). B, Random fed
blood glucose levels in control (black bars) and HFD (white bars) on G12 and G18 and on P1
and P21. C, ipGTT in control (f) and HFD () dams at P21. Per group, n  8; G, gestational
day.
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we did not observe a difference in either total or phos-
phorylated protein amounts of hepatic JNK1 (Fig. 5E).
Based on these findings, it can be hypothesized that
HFD induces a local IL-6 and TLR4-mediated hypo-
thalamic inflammation as an early event in the patho-
genesis of glucose intolerance after maternal perinatal
HFD feeding.
Fatty acid-induced hypothalamic inflammation has
been shown to alter -cell function via sympathetic inner-
vation of the pancreas (4). Moreover, pancreatic expres-
sion levels ofPGC1have been demonstrated to rise upon
sympathetic nerve input and therefore serve as a measure
of sympathetic innervation (4). Thus, we next determined
expression levels of PGC1 in liver and pancreatic tissue
of HFD and control offspring at P21. In liver, PGC1
expression showed a significant 2-fold increase (P 
0.016) (Fig. 6A). In pancreatic tissue, PGC1 expression
even underwent an almost 30-fold in-
duction after maternal HFD feeding
(P  0.036) (Fig. 6B).
To investigate whether hepatic insu-
lin resistance might be responsible for
the observed increase in PGC1 ex-
pression, we quantified insulin-stimu-
lated AKT phosphorylation in the liver
of HFD and control offspring at P21.
Phosphorylation of AKT was slightly
increased after insulin stimulation in
HFDoffspring comparedwith controls
at P21, arguing against hepatic insulin
resistance at that stage (Fig. 6C).
Finally, we also assessed expres-
sion of the key gluconeogenic enzyme
PEPCK in the liver of HFD and con-
trol offspring. PEPCK expression is
known to be directly regulated by
PGC1 via the forkhead transcription
factor FOXO1 (25–27). Interestingly,
hepatic mRNA levels of PEPCK
showed a significant 4-fold induction
in HFD offspring at P21 (P  0.012)
(Fig. 6D). Hepatic FOXO1 expres-
sion was also significantly increased
(P  0.009) (Fig. 6D).
Discussion
This study aimed to determine the ef-
fects ofmaternal perinatalHFDfeeding
on the metabolic phenotype and pa-
rameters of inflammation in the hypo-
thalamus of the offspring at P21. Met-
abolic characterization of the offspring revealed an
expected, yet compared with other studies early onset of
increased body weight, increased white adipose tissue
mass, and hyperleptinemiawithin the first 3wkof life (11,
28). Interestingly, HFD offspring also presented early
signs of impaired glucose metabolism at P21. In detail,
fasting blood glucose levels were unaltered, but random
fed blood glucose levels were significantly increased and
plasma glucose clearance in an ipGTT was delayed. This
impairment in glucose tolerance is of special interest, be-
cause neonatal rat pups (P1) have already been shown to
display elevated blood glucose levels immediately after
birth with simultaneous up-regulation of hepatic gluco-
neogenic genes after maternal HFD feeding (29). More-
over, up-regulation of gluconeogenic enzymes has also
been demonstrated in adult (P70) offspring after maternal
FIG. 2. A, Mean body weight (SEM) of control (f) and HFD () male offspring between P1
and P21. B, Epigonadal fat pad weight in control (black bars) and HFD (white bars) male
offspring at P21. C, Serum leptin levels in control (black bars) and HFD (white bars) male
offspring at P21. D, Random fed blood glucose levels in control (black bars) and HFD (white
bars) male offspring at P15. E, ipGTT in control (f) and HFD () male offspring at P21. Per
group, n  6–18 (five to 12 different litters). *, P  0.05; **, P  0.01; ***, P  0.001;
****, P  0.0001. Co, Control.
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perinatal HFD feeding. These animals
simultaneously displayed hyperinsulin-
emia with no significant change in fast-
ing blood glucose levels or GTT abnor-
malities (28). Taken all three time
points into account, maternal perinatal
HFD feeding leads to increased expres-
sion of hepatic gluconeogenic enzymes
in the offspring, which starts at birth
and continues into adulthood. At P21,
HFD offspring display a transient im-
pairment in glucose tolerance, which
haspreviously been reported and iswell
documented in a recent review article
on maternal high-fat feeding and off-
spring glycemic control (30). In our an-
imals, insulin levels at this time are still
within the normal range. However, at
P70, the picture appears to be reversed:
reactive hyperinsulinemia seems to
compensate for increased hepatic glu-
cose output, and glucose clearing ca-
pacity is balanced out. For a more pro-
found understanding of the time course
of changes in glycemic control, itwill be
inevitable to assess additional time
points during development. Future
studies should focus on the transient
nature of abnormalities in glycemic
control for a better understanding of
key pathogenic processes.
Early hypothalamic inflammation
as a potential pathomechanism for im-
paired regulation of energy and glucose
homeostasis in the offspring of HFD-
fed dams has not been addressed to
date. In the present study, we observed
both divergent global expression pat-
terns in the hypothalami of control and
HFD offspring and differential up-reg-
ulation of several inflammation-related
genes in HFD offspring, suggesting dis-
tinct changes in hypothalamic gene ex-
pression patterns depending on the
composition of the maternal diet dur-
ing pregnancy and lactation. In partic-
ular, the TLR4 signaling cascade ap-
peared to be affected bymaternalHFD.
TLR4 has recently been reported to act
as amolecular target for saturated fatty
acids in the hypothalamus and trigger
an intracellular signaling network that
FIG. 3. A, Three-dimensional view of a principal component analysis performed with global
gene expression information on male control (blue dots) and HFD (red dots) offspring at P21.
B, Supervised hierarchical cluster analyses of control or HFD offspring using gene expression
information of selected candidate genes involved in inflammation. Expression values were
transformed to Z-scores and were clustered using cosine correlation and average linkage as
metric and heuristic criteria, respectively. Genes are arranged horizontally and experiments
vertically. Per group, n  5 (five different litters).
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induces inflammatory response in rodents (6, 31). We
detected marked up-regulation of TLR4 and several
members of its downstream signaling cascade in the hy-
pothalamus of HFD offspring, which can be seen inde-
pendently of local TNF activity because hypothalamic
TNF expression is even reduced at the same time. Sub-
sequently, phosphorylation of JNK1 and IKK was sig-
nificantly increased at P21. The association between in-
creased expression of keymolecules of the TLR4 signaling
cascade and simultaneous activation of JNK1 and IKK is
a novel finding and suggests a role of TLR4-mediated hy-
pothalamic inflammation in the pathogenesis of obesity
and type 2 diabetes. Furthermore, it provides a potential
link between HFD-induced hypothalamic inflammation
and perinatal programming ofmetabolic disease. The fact
that among the studied organs the hypothalamus is the
first tissue to show signs of inflammation is especially in-
triguing. First, this demonstrates once more an evident
vulnerability of the fetal and neonatal hypothalamus to
maternal nutritional and hormonal cues. Second, it sup-
ports the hypothesis that the observed metabolic pheno-
type might indeed result from changes in central regula-
tory systems rather than being caused by peripheral effects
of nutritional or hormonal factors. One recent rodent
studydescribedhypothalamicTLR4/nuclear factor-Bac-
tivation as a consequence of maternal perinatal consump-
tion of a diet rich in trans fatty acids (32). Interestingly, the
offspring presented with accelerated postweaning body
weight gain and impaired satiety sensing as adults despite
the fact that the general amount of maternal fatty acid
FIG. 4. A, Relative hypothalamic mRNA expression of TNF and IL-6 in HFD offspring at P21 determined by qPCR. Average expression level in
control offspring was set to 1. B, Relative hypothalamic mRNA expression of TLR4, MyD88, IRAK1, and TRAF6 in HFD offspring at P21 determined
by qPCR. Average expression level in control offspring was set to 1. C, Western blot analysis of protein extracted from hypothalamic tissue of
control and HFD male offspring at P21. Quantification of JNK1 and pJNK1 relative to loading control (-actin) in control (black bars) and HFD
(white bars) offspring. D, Western blot analysis of protein extracted from hypothalamic tissue of control and HFD male offspring at P21.
Quantification of IKK and pIKK relative to loading control (-actin) in control (black bars) and HFD (white bars) offspring. E, Relative
hypothalamic mRNA expression of hypothalamic neuropeptides (AgRP, NPY, orexin, POMC, CART, and TRH) in HFD offspring at P21 determined
by qPCR. Average expression level in control offspring was set to 1. Per group, n  6–10 (five to eight different litters) for qPCR; n  3–6 per
group (three to six different litters) for Western blots. *, P  0.05; **, P  0.01. Co, Control.
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intakedidnotdiffer betweenexperimental andcontrol groups.
Thus, the inflammatory response within the hypothalamus
must be crucial for the resulting metabolic predisposition, in-
dependent of an inflammation-causing factor.
It is conceivable that in our experimental setting direct
action of altered levels of circulating adipokines or cyto-
kines may act in concert with nutritional factors to mod-
ulate hypothalamic inflammation. In
light of elevated serum leptin levels in
HFDoffspring at P21, it is important to
appreciate that leptin itself is able to
modulate the inflammatory response in
mouse glial cells (33). In addition, lep-
tin can potentiate microglial activation
in response to lipopolysaccharides, in-
dicating that leptin has an important
role in microglial function and inflam-
mation (34). Furthermore, changes in
circulating as well as locally released cy-
tokines might contribute to the observed
hypothalamic inflammatory response.
Therefore, determining serum cytokine
levels aswell as assessing fromwhich cell
type or nuclear region the observed in-
crease in hypothalamic cytokine expres-
sion in HFD offspring at P21 arises will
help to better understand the underlying
inflammatory processes.
With regard to the regulatory impact
of the observed increase in inflamma-
tory response in our experimental
group, the interpretation of the ob-
served trend toward an increased hy-
pothalamic expression of both orexi-
genic and anorexigenic neuropeptides
at P21 is demanding. Previous studies
have shown that postnatal overnutri-
tion results in hyperleptinemia and in-
creasedhypothalamicNPYandPOMC
mRNA levels in adult rats (35). Fur-
thermore, hypothalamic TNF action
has been shown to influence hypotha-
lamicNPY,AgRP, and POMCmRNA
levels (9). Moreover, exposure of adult
mice to HFD was recently associated
with reactive gliosis within the hypo-
thalamus, thereby affecting the struc-
tureof theblood-brainbarrier such that
the POMC and NPY cell bodies and
their dendrites may become less ac-
cessible to blood vessels (36). Thus,
changes in neuropeptide expression in
our experimental setting might also be a result of reactive
gliosis and subsequently disturbed hypothalamic cyto-
architecture. Histological studies will help to clarify
whether and to what extent gliosis or proliferative neu-
ronal processes within the hypothalamus might play a
role in the context of altered neuropeptide expression in
the offspring of HFD-fed dams.
FIG. 5. A, Relative hepatic mRNA expression of TNF and IL-6 in HFD offspring at P21
determined by qPCR. Average expression level in control offspring was set to 1. B, Relative
pancreatic mRNA expression of TNF and IL-6 in HFD offspring at P21 determined by qPCR.
Average expression level in control offspring was set to 1. C, Relative hepatic mRNA
expression of TLR4, MyD88, IRAK1, and TRAF6 in HFD offspring at P21 determined by qPCR.
Average expression level in control offspring was set to 1. D, Relative pancreatic mRNA
expression of TLR4, MyD88, IRAK1, and TRAF6 in HFD offspring at P21 determined by qPCR.
Average expression level in control offspring was set to 1. E, Western blot analysis of protein
extracted from liver of control and HFD male offspring at P21. Quantification of JNK1 and
pJNK1 is relative to loading control (-actin) in control (black bars) and HFD (white bars)
offspring. Per group, n  6–10 (five to eight different litters) for qPCR; n  3–6 per group
(three to six different litters) for Western blots. **, P  0.01. Co, Control.
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Several groups have very recently demonstrated that
hypothalamic inflammation results in altered sympa-
thetic innervation and subsequent dysfunction in periph-
eral organs (4, 37). In detail, obesity-associated activation
of IKK and NFB in the mediobasal hypothalamus in
adult mice has been shown to induce hypertension via
sympathetic up-regulation (37). Furthermore, fatty acid-
induced hypothalamic inflammation has been shown to
cause pancreatic islet dysfunction via modulation of the
sympathetic innervation (4). Taking this into account, it is
conceivable that early hypothalamic in-
flammation after maternal HFD feed-
ing in our animalmodelmay also result
in altered sympathetic innervation of
peripheral organs. Peripheral expres-
sion of the transcriptional coactivator
PGC1 has previously been shown to
increase upon fatty acid-induced hypo-
thalamic inflammation and lead to a
loss of first-phase insulin secretion (4).
This up-regulation is dependent on
sympathetic innervation of the organ,
because sympathectomy in the animals
returnsperipheral PGC1 levels and in-
sulin secretion capacity back to normal
(4).Moreover, PGC1 has been shown
to directly increase gluconeogenic gene
expression via the forkhead transcrip-
tion factor FOXO1 in the liver and to
suppress membrane depolarization in
pancreatic -cells with subsequent im-
pairment of insulin secretion (25, 26,
38). Thus, PGC1 is an important
modulator of several key mechanisms
in the control of glucose homeostasis.
Interestingly, PGC1 expression was
markedly increased in liver as well as
pancreatic tissue of HFD offspring at
P21. This supports the hypothesis of an
elevated sympathetic tone after hypo-
thalamic inflammation, which results
in disturbed regulation of glucose ho-
meostasis. Independent of sympathetic
innervation, insulin can directly sup-
press PGC1 expression in the liver via
phosphorylation of AKT (39). Thus,
hepatic insulin resistance with subse-
quently reduced AKT phosphorylation
could provide an explanation for ele-
vated hepatic PGC1mRNA levels. In-
terestingly, we did not detect signs of
hepatic insulin resistance as assessed
by quantification of insulin-stimulated AKT phosphor-
ylation in HFD offspring at P21. Thus, hepatic insulin
action is unlikely to contribute to the disturbance in
glucose homeostasis in our animal model at this stage
during development. However, we cannot rule out that
the observed hyperleptinemia and subsequently in-
creased central leptin action might further contribute to
enhanced sympathetic outflow to the periphery (40,
23). Functional analysis of leptin’s action on hypotha-
lamic neurons in HFD offspring will be necessary to
FIG. 6. A, Relative hepatic mRNA expression of PGC1 in control (black bar) and HFD (white
bar) offspring at P21 determined by qPCR. Average expression level in control offspring was
set to 1. B, Relative pancreatic mRNA expression of PGC1 in control (black bar) and HFD
(white bar) offspring at P21 determined by qPCR. Average expression level in control offspring
was set to 1. C, Insulin-stimulated AKT phosphorylation in liver of control (black bars) and
HFD (white bars) male offspring at P21. D, Relative hepatic mRNA expression of FOXO1 and
PEPCK in HFD offspring at P21 determined by qPCR. Average expression level in control
offspring was set to 1. Per group, n  6–10 per group (five to eight different litters) for qPCR;
n  3–6 per group (three to six different litters) for Western blots. *, P  0.05; **, P  0.01.
Co, Control.
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properly evaluate leptin’s contribution to sympathoac-
tivation at P21.
Taken together, maternal HFD consumption during
gestation and lactation leads to accelerated body weight
and body fat gain, impaired glucose tolerance, and most
importantly, hypothalamic inflammationatP21 in theoff-
spring. Expression analysis of hepatic and pancreatic tis-
sue suggests increased sympathetic innervation of both
organs. This in turn contributes to the development of
impaired glucose tolerance by up-regulation of gluconeo-
genesis andpresumably disturbance of insulin secretion.A
fuller understanding of themolecularmechanisms leading
to this predisposition will ultimately allow the develop-
ment of effective preventive strategies against perinatal
programming of obesity and type 2 diabetes.
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